Abstract

Aims

To provide a comprehensive overview of the current evidence on objectively measured neighbourhood built environment exposures in relation to cardiovascular disease (CVD) events in adults.

Methods and results

We searched seven databases for systematic reviews on associations between objectively measured long-term built environmental exposures, covering at least one domain (i.e. outdoor air pollution, food environment, physical activity environment like greenspace and walkability, urbanization, light pollution, residential noise, and ambient temperature), and CVD events in adults. Two authors extracted summary data and assessed the risk of bias independently. Robustness of evidence was rated based on statistical heterogeneity, small-study effect, and excess significance bias. Meta-meta-analyses were conducted to combine the meta-analysis results from reviews with comparable exposure and outcome within each domain. From the 3304 initial hits, 51 systematic reviews were included, covering 5 domains and including 179 pooled estimates. There was strong evidence of the associations between increased air pollutants (especially PM2.5 exposure) and increased residential noise with greater risk of CVD. Highly suggestive evidence was found for an association between increased ambient temperature and greater risk of CVD. Systematic reviews on physical activity environment, food environment, light pollution, and urbanization in relation to CVD were scarce or lacking.

Conclusion

Air pollutants, increased noise levels, temperature, and greenspace were associated with CVD outcomes. Standardizing design and exposure assessments may foster the synthesis of evidence. Other crucial research gaps concern the lack of prospective study designs and lack of evidence from low-to-middle-income countries (LMICs).

Registration

PROSPERO: CRD42021246580

The built environment and cardiovascular disease. IHD, ischaemic heart disease; CeVD, cerebrovascular disease; CVD, cardiovascular disease.
Graphical abstract

The built environment and cardiovascular disease. IHD, ischaemic heart disease; CeVD, cerebrovascular disease; CVD, cardiovascular disease.

Lay Summary

  • This study is a review of published systematic reviews on the relation between the neighbourhood built environment and cardiovascular disease (CVD) in adults.

  • There was strong evidence of a relation between increased air pollutants and a greater risk of CVD. There was also strong evidence of a relation between increased residential noise and a greater risk of CVD. There was highly suggestive evidence of a relation between increased ambient temperature and a greater risk of CVD.

  • Systematic reviews that examined other aspects of the built environment, such as the physical activity environment, food environment, light pollution, and urbanization, were scarce or lacking.

Introduction

Cardiovascular diseases (CVD) are the leading cause of the global disease burden.1 Worldwide CVD cases have doubled in the past 20 years. In 2019, 523 million cases led to 18.6 million deaths and 34.4 million years lived with disability.2 The burden of CVD is not only an individual health issue but also a societal burden that strains healthcare and economic systems. The World Heart Federation estimates that the global cost of CVD will rise from roughly $863 billion in 2010 to $1044 billion in 2030.3 Therefore, it is important to deepen our understanding of the determinants of CVD in individuals and populations and develop sustainable strategies for reduction and prevention.

Lifestyle behaviours, like physical inactivity and unhealthy diet, are important risk factors of CVD.1,2,4 Ecological models suggest that these behavioural risk factors are driven by contextual characteristics in the social, policy, and built environments, also known as ‘upstream determinants’.5–7 The paradigm in CVD research has shifted, with the focus moving to these upstream determinants as promising entry points for population-level action to prevent CVD.8 The majority of the world’s population resides and spends most of its time in highly organized built environments. The built environment is a subset of the exposome, which is the sum of all environmental drivers of health and disease throughout life.9 The built environment is defined as all aspects of a person’s surroundings that are man-made or modified, such as buildings, parks, facilities, and infrastructure.10 Its direct effects, like air pollution, noise levels, and ambient temperature, are often included.11

The mechanisms by which the built environment might affect CVD are not well established. Conceptually, there are two main pathways proposed.12 The first pathway is between active built environmental exposure and behavioural risk factors.12 For active exposure, one needs to actively use of the environment to be exposed. Attributes such as walkability, which is comprised of individual elements like sidewalks, connected streets, and proximity to key destinations, can facilitate a more active lifestyle.13,14 Access to and availability of certain food resources may either improve or diminish diet quality, depending on whether these food resources are greengrocers or fast-food outlets, for example.15 The second pathway is between passive built environmental exposure and CVD. This includes exposures that occur when one is simply present in the environment, such as air pollution, residential noise, and ambient temperature.12 Exposure to increased levels of air pollution can promote systemic inflammation and oxidative stress. As a result, a variety of pathological processes, such as increased thrombosis, hypercoagulability, and endothelial dysfunction, could eventually lead to CVD.16,17 Noise and ambient temperature may cause typical physiological responses including hypertension, vasoconstriction, and tachycardia that may lead to CVD.18,19

The two aforementioned pathways are not mutually exclusive, which increases complexity of research in this field.11 Many environmental aspects may be interrelated. For example, the benefits of living in a dense, walkable environment might be diminished by increased exposure to traffic-related air pollution.20 Attributes may also operate at multiple scales or contexts, from neighbourhoods to entire regions or from rural to urban areas. Consequently, the same built environmental aspects may have different effects from different perspectives or contexts. Urbanization, a context indicator of the urban development level, serves as a container of the abovementioned built environmental aspects. It is worthwhile to study urbanization as a proxy of a built environment and its confounding or interaction effect with other aspects. Furthermore, 55% of the world's population lives in urban areas, a proportion that is expected to increase to 68% by 2050.21 It is therefore relevant to understand what this means in terms of CVD risk.

Over the past two decades, a significant number of systematic reviews have examined the relationship between the built environment and CVD. However, these studies often address single (sub)domains of exposures, or the built environment was not the primary focus of the reviews. It is difficult for readers to assess and synthesize the piecemeal published evidence. As such, we aimed to provide a comprehensive overview of the current evidence, identify crucial research gaps, and determine the implications for public health, clinical medicine, policy, and regulation. To accomplish this, we conducted an umbrella review of systematic reviews and meta-analyses to investigate associations between the built environment and CVD events in adults. This review may also serve as a reference point for those who are new to the field.

Methods

The current umbrella review was conducted according to the protocol published in the International Prospective Register of Systematic Reviews (PROSPERO; ID CRD42021246580) and adheres to the guidelines of Transparent Reporting of Systematic Reviews and Meta-analyses (PRISMA) (see Supplementary material online, Appendix S1, for PRISMA checklist).

Literature search

We searched seven databases on 16 April 2021: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica Database (EMBASE), Cumulative Index for Nursing and Allied Health Literature (CINAHL), Scopus, the Cochrane Database of Systematic Reviews (CDSR), the Joanna Briggs Institute (JBI) Database of Systematic Reviews and Implementation Reports, and PROSPERO. We built a search algorithm using search terms based on definitions and synonyms of the built environment, its attributes, and definitions of CVD events. A detailed search strategy for each database is presented in Supplementary material online, Appendix S2. We also screened the reference lists of the included reviews to identify additional eligible reviews.

Inclusion and exclusion criteria

We included systematic reviews of primary studies of the general population if they (i) reported on objectively measured long-term neighbourhood environmental exposures and covered at least one domain, including air pollution [e.g. particulate matter (PM), carbon monoxide (CO), nitrogen oxides (NO and NO2), sulphur dioxide (SO2), and ozone (O3)], food environment (e.g. neighbourhood fast-food outlet density), physical activity environment (e.g. greenspace and walkability), urbanization, light pollution (light at night), residential noise from road, rail, and/or air traffic, and ambient temperature; (ii) reported associations between these factors and CVD events [i.e. prevalence, incidence, or mortality of coronary heart disease (CHD), stroke, transient ischaemic attack (TIA), peripheral arterial disease (PAD), atrial fibrillation (AF), aortic disease, and heart failure (HF) but not congenital heart disease) in adults (i.e. ≥ 18 years); (iii) used a systematic literature search, i.e. a reproducible search strategy with search strings corresponding to databases; and (iv) were published between 1 January 2000 and 16 April 16 2021 in English. In the domain of temperature, the studies of short-term and long-term were mixed and meta-analysed in systematic reviews. Therefore, the criteria of long-term exposure were not applied too strictly for temperature.

We excluded reviews if they (i) only focused on specific populations such as children, pregnant women, CVD patients, or patients whose CVD risk may be influenced by other conditions (e.g. cancer, diabetes, and chronic renal failure); (ii) were published as conference abstracts, case reports, editorials, and letters to editors; (iii) reviewed studies on the indoor built environment (e.g. home environment), occupational environment (e.g. workplace environment), or subjective assessments of environmental characteristics (e.g. perceptions of neighbourhood safety); or (iv) only examined acute (short-term) exposure.

Study selection and data extraction

After removing duplicate records, two authors (M.L. and P.M.) screened all titles and abstracts independently. Then, these authors screened the full texts of potentially eligible articles separately and cross-checked a sample of each other’s work. Screening was done using Rayyan software, a non-commercial, web-based application.22 The two authors resolved any disagreements with discussion or, if no consensus could be reached, with discussion with other authors (T.M.L., E.J.T., I.V., and J.L.). Two authors (M.L. and P.M.) conducted the data extraction and verified each other’s work. For each eligible review, they extracted the following information: first author, year of publication, study design, study population, countries in which primary data were collected, exposure domain and type of environmental exposures, measures of the exposures, type and measure of the outcome studied, and summary of the (stratified) results. In the event that an included review was based on a meta-analysis, the following information was also extracted (where available): the pooled effect estimates and 95% confidence intervals (CIs), the effect size (ES) in the study with the largest study sample, the between-study heterogeneity using -statistic, the results of the Egger’s regression asymmetry test and excess statistical significance test, and the 95% prediction interval (PI).

Overlap of primary studies assessment

We assessed the overlap of primary studies across included reviews by a measure of corrected covered area (CCA).23 The first occurrence of a primary study in included reviews was defined as the index study. We created a cross-table of index studies and reviews for each built environmental domain (see Supplementary material online, Appendix S4). The CCA-score was categorized into limited overlap (score: 0–5), moderate overlap (score: 6–10), high overlap (score: 11–15), and very high overlap (score: > 15).23

Risk of bias assessment

We assessed the risk of bias in included systematic reviews using the validated Risk of Bias in Systematic Reviews (ROBIS) tool.24 Any disagreements in the assessment were resolved with discussion.

Statistical analysis

For the syntheses of quantitative research, we used statistical methods in accordance with the most up-to-date recommendations.25–28 Specifically, to rate the robustness of evidence for each review that reported pooled results from a meta-analysis, we considered the following statistics:

  • Statistical heterogeneity. The extent of statistical heterogeneity was evaluated using the I2-statistic. When the I2-statistic exceeded 50%, heterogeneity was considered large. We also evaluated heterogeneity using the 95% PI. This measure assesses the uncertainty of expected outcomes in new studies of the same association.29

  • Small-study effect. The small-study effect refers to the observation that studies that include smaller sample sizes tend to yield larger ES than studies with larger study samples. The potential reasons for this include publication bias, reporting bias, and real heterogeneity. The Egger’s regression asymmetry test was used to assess whether or not a small-study effect was present. A P value <0.10 with a more conservative effect in larger studies was considered evidence of small-study effect.30

  • Excess significance bias. This measure was used to evaluate whether there is evidence of an excessive number of studies with statistically significant results in the meta-analysis. It may result from reporting bias and data dredging.31 The excess statistical significance test was used, with a P value <0.10 considered to be evidence of excess significance bias.

When these statistics were not available, a re-estimate based on the ES of primary studies in the included review was conducted. In line with up-to-date recommendations, the level of robustness for each pooled result was based on the following criteria28:

  • Strong evidence: P value <10−6 of the pooled estimate of meta-analysis, > 1000 individuals of the total number of participants in the primary studies that were included in the review, P value <0.05 of the largest study in the meta-analysis, I2-statistic <50%, no evidence of small-study effects, no evidence of excess significance bias, and the null value does not fall in the 95% PI.

  • Highly suggestive evidence: P value <10−6 of the meta-analysis, > 1000 individuals in the review, and P value <0.05 of the largest study in the meta-analysis.

  • Suggestive evidence: P value <10−3 of the meta-analysis and > 1000 individuals in the review.

  • Weak evidence: P value <0.05 of the meta-analysis.

Within each category, all criteria had to be met.

We conducted meta-meta-analyses to combine the results from meta-analyses with comparable exposure and outcome.27 We selected meta-analyses with comparable study populations, exposure and outcome assessment methods, and measure of association [relative risk (RR) or hazard ratio (HR)]. By matching meta-analyses, we extracted the unique primary ES included in the pooled analyses. After the removal of duplicates, random-effect meta-analyses were conducted with restricted maximum likelihood approach for the estimation of variance components. The Wald method was used for estimating 95% CIs. Heterogeneity was investigated with the I2-statistic. The Egger’s regression asymmetry test was conducted to examine the small-study effect, and excess statistical significance was tested for. To account for variability of covariate adjustment, we conducted sensitivity analyses by only including primary ES with similar covariate adjustment sets. All statistical analyses were conducted with the metaphor package in R software.32,33

Results

Literature search results

The literature search identified 3304 unique publications (Figure 1). After screening all titles and abstracts, we excluded a total of 3164 studies. After reading the full texts, we included a total of 51 eligible. Additional details are presented in the PRISMA article selection process flow chart. A full list of included reviews is presented in supplementary material online, Appendix S3.

Flowchart of study selection.
Figure 1

Flowchart of study selection.

Characteristics of included reviews

The characteristics and a summary of the results of all 51 included systematic reviews are presented in Table 1. The number of relevant primary studies included in the reviews ranged from 2 to 67. Most reviews (n = 43) were not restricted to specific countries or regions in the search, but most evidence was obtained in Europe (n = 43), East and South Asia (n = 38), and North America (n = 37); relatively few studies were based in South America (n = 10), Middle East (n = 8), Oceania (n = 8), and Africa (n = 6). A variety of designs were used in primary studies, including ecological studies, cohort studies, cross-sectional studies, case-control studies, case-crossover studies, small-area studies, panel studies, and time-series studies. Over one-third of the reviews (n = 20) included only longitudinal studies.

Table 1

Summary of included systematic reviews (n = 51)

First author and year by domainaPopulation, year coverage, and country/regionStudy designExposuresbSummary of resultsPercentage of results in expected directionQuality assessment (ROBIS)
Air pollution
Alexeeff et al.34General population, till 31 December 2019, country not restricted: Europe, Canada, USA, UK, Australia, China, South Korea, and Israel42 CSPM2.5Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs were 1.23 (1.15–1.31) for IHD mortality, 1.08 (0.99–1.18) for incident acute MI, 1.24 (1.13–1.36) for CeVD mortality, and 1.13 (1.11–1.15) for incident stroke.83%High risk of bias
Atkinson et al. 2016General population, till October 2015, country not restricted: USA, UK, China (Taiwan), and FranceTotal 22 studies, relevant 8 studies: 8 CSO3HRs expressed per 10 ppb increase in O3. For long-term annual O3 concentrations, the standardized effect estimates (HRs and 95% CIs) were 1.01 (0.99–1.03) for CVD mortality, 1.02 (1.00–1.04) for IHD mortality, and 1.01 (0.97–1.05) for stroke mortality. For long-term annual O3 concentrations, the random-effects summary estimates (HR and 95% CI) were 0.98 (0.93–1.04) for CVD mortality and 1.00 (0.92–1.09) for IHD mortality. For the warm season/peak O3, random-effects summary estimates were 1.01 (1.00 to 1.02).42%High risk of bias
Atkinson et al.35General population, 1996–October 2016 (Medline, EMBASE), 1970–October 2016 (Web of Science), 1966–October 2016 (PubMed), country not restricted: Europe, North America, China (mainland and Taiwan), and JapanTotal 48 studies, relevant 22 studies: 22 CSNO2 (annual or multi-year averages)Per 10 µg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.03 (1.021.05) for CVD mortality, 1.05 (1.031.06) for CHD mortality, and 1.01 (0.98–1.03) for CeVD mortality.91%High risk of bias
Chen et al. 2008Adults, 1 January 1950–31 December 2007, country not restricted: USA, Norway, France, the Netherlands, Canada, and GermanyTotal 32 studies, relevant 17 studies: 14 CS, 3 CCSO3, SO2, NO/NO2, black smoke, PM10, PM2.5, CO, benzene, and polycyclic aromatic hydrocarbonsRR per 10 µg/m3 increase. For PM2.5, the pooled RRs and 95% CIs were 1.14 (1.091.18) for CVD mortality and 1.16 (0.961.40) for CHD mortality. For other particulate and gaseous pollutants, the paucity of data precludes drawing conclusions.79%High risk of bias
Chen et al. 2020General population, till 9 October 2018, country not restricted: Europe, Canada, UK, USA, Israel, New Zealand, South Korea, Japan, and China (mainland, Taiwan, and Hong Kong)67 CSPM2.5 and PM10Per 10 µg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.091.14) for CVD mortality, 1.16 (1.101.21) for IHD mortality, and 1.11 (1.041.18) for stroke mortality. The estimates of PM10 were 1.04 (0.99–1.10) for CVD mortality, 1.06 (1.011.10) for IHD mortality, and 1.01 (0.83–1.21) for stroke mortality.
The certainty of evidence was high for PM2.5 and CVD mortality and was moderate for PM10 and CVD mortality, as measured by GRADE framework.
81%Low risk of bias
Chen et al.36General population, till October 2019, country not restricted: South Korea, UK, Denmark, Sweden, and CanadaTotal 18 studies, relevant 6 studies: 6 CSPM2.5, PM10, NO2, SO2, O3, and COPer 10 μg/m3 increase in long-term exposure, the pooled HRs, and 95% CIs of AF were 1.116 (1.031–1.207) for PM2.5, 1.034 (1.032–1.035) for PM10, 1.017 (1.001–1.033) for NO2, 1.005 (1.004–1.007) for SO2, 1.017 (1.013–1.022) for CO, and 1.007 (0.927–1.094) for O3.83%Low risk of bias
Faustini et al. 2014General population, January 2004–January 2013, country not restricted: identified countries: Japan, China, Canada, USA, UK, Italy, Germany, Sweden, the Netherlands, and NorwayTotal 23 studies, relevant 17 studies: 2 CCS, 15 CSNO2RR per 10 µg/m3 increase. The pooled RRs and 95% CIs for CVD mortality were 1.13 (1.09–1.18) for NO2 and 1.20 (1.09–1.31) for PM2.5.94%High risk of bias
Hak-Kan et al. 2013Chinese population, till 30 June 2012, 80 major Chinese cities in Mainland China, Hong Kong, and TaiwanTotal 48 studies, relevant 3 studies: 3 CSPM10, NO2, SO2, and O3RR per 10 µg/m3 increase. In one cohort study examining PM10 and NO2, the corresponding RRs and 95% CIs were 1.0155 (1.0151–1.0160) and 1.0246 (1.0231–1.0263) for CVD mortality and 1.0149 (1.0145–1.0153) and 1.0244 (1.0227–1.0262) for CeVD mortality. In another cohort study examining SO2 and CVD, the corresponding RR was 1.032 (1.023–1.040).100%High risk of bias
Hoek et al. 2013Not specified (adults), till January 2013, country not restricted: identified countries: USA, Germany, the Netherlands, Switzerland, Canada, China, New Zealand, Japan, Italy, France, and DenmarkTotal 67 studies, relevant 34 studies: 34 CSLong-term exposure to fine particulate matter (PM2.5, PM10, NO2, elemental carbon, and coarse particles)RR per 10 µg/m3 increase. For PM2.5, the pooled RR and 95% CI was 1.11 (1.05–1.16) for CVD mortality. There was no consistent evidence that long-term exposure to coarse PM or elemental carbon is associated with CVD mortality. Several studies found positive associations between NO2 exposure and fatal MI, but not non-fatal MI. The evidence for an association between air pollution and CeVD mortality was inconsistent.88%High risk of bias
Huang et al. 2021General population, till 2020.02.29, country not restricted: USA, Canada, Norway, the Netherlands, UK, Italy, Denmark, France, Spain, Japan, China, South Korea, Australia, Sweden, Norway, Germany, Austria, Switzerland, France, Italy, Spain, Greece, and Finland32 CSNO2Per 10 ppb increase in annual NO2 concentration, the pooled HR and 95% CI was 1.11 (1.07–1.16) for cardiovascular mortality.71%High risk of bias
Jadambaa et al.37Mongolian population (adults and children), till April 2014, MongoliaTotal 59 studies, relevant 2 studies: 2 CSSNO2 and PM2.5Two studies found an increased risk of CVD with increased exposure to NO2 and PM2.5.100%Unclear
Jaganathan et al.38General population, 1 January 1948–6 March 2018, country restricted to low- and middle-income countries, Mexico (Mexico City), Brazil (São José dos Campos, Cuiabá, and Várzea Grande), China, and India (Varanasi)Total 17 studies, relevant 12 studies: 8 LS, 2 CSS, 1 CCR, 1 CSPM2.5 (annual average or average measure of more than 3 days)Eight out of nine studies (91%) reported significant effects on CVD mortality. Per 10 µg/m3 increase in long-term exposure, the effect estimates of CVD mortality ranged from 0.24 to 6.11%. All four studies reported significant effects of long-term exposure on CVD hospitalization.
Few studies have evaluated this association in LMICs. No studies were found in North and Sub-Saharan Africa.
92%Low risk of bias
Kan et al. 2005General population, 1990–2002, China and worldwideTotal 26 studies, relevant 7 studies: 7 CSEffects of particulate air pollution. PM10 was selected as the indicator particulate matter.RR per 10 µg/m3 increase. For PM10, the pooled RRs and 95% CIs were 1.0095 (1.0060–1.0130) for CHA, 1.013 (1.007–1.019) for CHA based on four European studies, and 1.008 (1.004–1.011) for CHA based on three US and Canadian studies.100%High risk of bias
Karimi et al. 2019Iran population, January 1980–January 2018, country restricted to IranTotal 38 studies, relevant 28 studies: 27 CSS, 1 ESO3, PM2.5, PM10, NO2, NOx, SO2, and CO measured by environmental protection organization and air quality control centrePer 10 µg/m3 increase in all air pollutants, the pooled increased risk (95% CI) in CVD mortality was 0.5% (0.4–0.6%). The estimate for PM2.5 and PM10 was 0.7% (0.4–1%).NAUnclear
Liu et al. 2018General population, adults, January 1974–July 2017, country not restricted: USA, UK, Italy, Canada, China (mainland and Hong Kong), Europe, New Zealand, and Japan16 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of CVD mortality were 1.12 (1.08–1.16) for PM2.5, 1.02 (0.89–1.16) for PM10, and 1.10 (1.06–1.14) for combined. In subgroup analyses, there is no difference in the association stratified by categories of WHO PM levels or smoking status. The estimates of PM2.5 were 1.19 (1.11–1.27) for studies with ≥ 11 years of follow-up, higher than those <11 years: 1.07 (1.04–1.11).88%Low risk of bias
Lu et al. 2015Chinese population (adults only), 1990–2013, Mainland China, Hong Kong, and TaiwanTotal 59 studies, relevant 2 studies: 2 CSPM10 and PM2.5RR per 10 μg/m3 increase. For the annual average concentration of PM10, the RR and 95% CI was 1.23 (1.19–1.26) for CVD mortality in one study and 1.55 (1.51–1.60) for CVD mortality in another study.100%High risk of bias
Luben et al. 2017Adults, till 15 June 2017, country not restricted: USA, China (mainland and Taiwan), the Netherlands, Canada, South Korea, Spain, and ItalyTotal 24 studies, relevant, 3 studies: 2 CS, 1 LSAmbient black carbonThere are generally modest, positive associations of long-term exposure to black carbon and elemental carbon with cardiovascular hospital admissions and mortality.100%High risk of bias
Niu et al. 2021General population, till 1 February 2020, country not restricted: China, Europe, England, Japan (Shizuoka), USA (California), Ghana, India, Mexico, Russia, and South AfricaTotal 68 studies, relevant 13 studies: 13 CSPM2.5, PM10, and NO2Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of stroke incidence were 1.081 (0.971–1.023) for PM2.5, 1.033 (0.907–1.175) for PM10, and 1.005 (0.977–1.034) for NO2; the HRs and 95%CI of stroke mortality were 1.047 (0.995–1.101) for NO2.82%High risk of bias
Prueitt et al.39General population, 1 January 2006–4 November 2013, country not restricted: USA, UK, Canada (Toronto), and China (Liaoning)Total 25 studies, relevant 11 studies: 8 CS, 2 CSS, 1 ESO3For long-term O3 exposure and CVD morbidity, studies were rare and reports were inconsistent. For CVD mortality, of 10 high-quality studies, 5 reported positive association, and the other 5 reported null or negative association.17%High risk of bias
Scheers et al. 2015General population, till 20 July 2015, country not restricted: Japan, China, UK, the Netherlands, Switzerland, Greece, USA, Canada, Finland, Norway, Sweden, Denmark, Germany, Austria, Italy, Greece, and FranceTotal 20 studies, relevant 20 studies: 14 CS, 6 ESPM10 or PM2.5HR per 10 μg/m3 increase. For PM10, the pooled HRs and 95% CIs were 1.061 (1.018–1.105) for overall stroke events and 1.080 (0.992–1.177) for stroke mortality. For PM2.5, the pooled HRs and 95% CIs were 1.064 (1.021–1.109) for overall stroke events and 1.125 (1.007–1.256) for stroke mortality.50%High risk of bias
Shin et al. 2014Not specified (adults), from 1990, country not restricted: USA and UKTotal 20 studies, relevant 4 studies: 4 CSPM2.5RR per 10 μg/m3 increase. In the frequentist meta-analysis, the pooled RR and 95% CI for long-term exposure to PM2.5 was 1.06 (1.00–1.13) for non-fatal strokes. The Bayesian meta-analysis found a posterior mean 1.08 (0.96–1.26) from a normal prior and 1.05 (1.02–1.10) from a gamma prior.100%High risk of bias
Stieb et al.40General population, till 25 February 2020, country not restricted: Canada, USA, UK, Europe, China (mainland, Hong Kong, and Taipei), Australia, South Korea (Seoul), and Japan (Shizuoka)49 CSNO2Per 10 ppb increase in long-term exposure, the pooled HRs and 95% CIs were 1.139 (0.997–1.301) for CVD mortality, 1.128 (1.076–1.182) for IHD mortality, and 1.167 (0.936–1.456) for CeVD mortality. After excluding studies with probably high or high risk of bias, the pooled HRs and 95% CIs were 1.058 (1.026–1.091) for CVD mortality, 1.111 (1.079–1.144) for IHD mortality, and 1.014 (0.997–1.032) for CeVD mortality.74%Low risk of bias
Wang et al. 2020Older adults aged ≥ 55 years, till January 2020, country not restricted: USA (Steubenville, Eastern Massachusetts, Boston), Germany (Erfurt), Finland (Helsinki), the Netherlands (Amsterdam), UK (Scotland: Aberdeen), and China (Beijing and Taipei)Total 19 studies, relevant 10 studies: 10 LSConcentration of PM2.5Per 10 mg/m3 increase in long-term exposure, the pooled estimates and 95% CIs of HRV were −0.92% (−2.14 to 0.31%) for SDNN, −1.96% (−3.48 to −0.44%) for RMSSD in time-domain measurements, −2.78% (−4.02 to −1.55%) for LF, and −1.61% (−4.02 to 0.80%) for HF in frequency domain measurements.68%High risk of bias
Yang et al. 201941General population, till 25 April 2018, country not restricted: Europe, UK, Canada, USA, South Korea, China, Ghana, India, Mexico, Russia, South Africa, and Japan35 CSPM2.5, PM10, O3, and NO2Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.07–1.15) for CVD events, 1.12 (1.05–1.19) for stroke incidence, 1.12 (1.08–1.16) for stroke events, 1.19 (1.09–1.30) for IHD incidence, and 1.14 (1.08–1.21) for IHD events. The estimates of CVD mortality were 1.11 (1.07–1.15) for PM2.5, 1.09 (1.02–1.16) for PM10, 1.23 (1.15–1.31) for NO2, and 1.03 (1.02–1.05) for O3. The estimates of NO2 and IHD events were 1.05 (1.04–1.06). No significant associations were found between PM10 and CVD, stroke and IHD incidence.87%High risk of bias
Yuan et al. 2019General population, 1980–December 2018, country not restricted: Europe, USA, China (Hong Kong), Ghana, India, Mexico, Russia, South Africa, UK, Sweden (Gothenburg), and Italy16 CSPM2.5Per 5 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.11 (1.05–1.17) for stroke incidence and 1.11 (1.05–1.17) for stroke mortality. In subgroup analysis, the estimates of stroke incidence were 1.09 (1.05–1.14) for North America (5 CS), 1.07 (1.05–1.10) for Europe (4 CS), and 2.31 (0.49–10.95) for Asia (2 CS). The associations were insignificant in both sex and significant in both ischaemic and haemorrhagic stroke. The estimates of stroke incidence were 1.08 (1.03–1.13) for never smokers, 1.11 (1.01–1.22) for former smokers, and 1.08 (0.94–1.25) for current smokers.95%Low risk of bias
Zhao et al. 2017General population, 1990–2016, country not restricted: USA, Israel, Japan, UK, China, Italy, Norway, Greece, Canada, Denmark, France, South Korea, Iran, Germany, Finland, Sweden, Spain, and the NetherlandsTotal 48 studies, relevant 48 studies: 25 CS, 23 LSPM10, PM2.5, SO2, NO2, CO, and O3HR per 10 μg/m3 increase. For CHD mortality, the pooled HRs and 95% CIs were 1.12 (1.04–1.20) for PM10, 1.17 (1.12–1.22) for PM2.5, 1.03 (1.00–1.07) for SO2, 1.04 (1.01–1.06) for NO2, 1.04 (0.98–1.10) for CO, and 1.06 (1.01–1.11) for O3 (10 mg/m3 increase). For CHD incidence, the pooled HRs and 95% CIs were 1.01 (1.00–1.02) for PM10, 1.02 (1.00–1.03) for PM2.5, 1.01 (1.00–1.02) for SO2, 1.04 (1.03–1.06) for NO2, 1.01 (0.97–1.04) for O3, and 1.03 (1.00–1.05) for CO (10 mg/m3 increase).NAHigh risk of bias
Zhao et al. 2021General population, time and country not restricted: China, Norway, UK, the Netherlands, China (Hong Kong), and Canada (Ontario)7 CSPM2.5 acquired through satellite-based model (5 studies) and outdoor-automated monitoring stations (2 studies)Per 1.4–10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs of haemorrhagic stroke were 1.16 (1.03–1.30) for total, 1.41 (0.92–2.15) for current smoker, and 1.04 (0.74–1.46) for never and former smoker.71%Low risk of bias
Zhu et al. 2021General population, till 2 August 2020, country not restricted: Canada, Denmark, the Netherlands, China, USA, South Korea, Israel, and UK (London)12 CSPM2.5Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs were 1.10 (1.02–1.18) for MI incidence and 1.07 (1.04–1.09) for post-MI mortality.75%Unclear
Zou et al.42General population, till September 2019, country not restricted: USA, South Korea, UK, Canada, Sweden, Israel, Italy, the Netherlands, Switzerland, and Finland27 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs of MI were 1.18 (1.11–1.26) for PM2.5 and 1.03 (1.00–1.05) for PM10.91%Unclear
Physical activity environment
Gascon et al. 2016Adults, till 14 November 2014, country not restricted: USA, UK, New Zealand, Lithuania, and CanadaTotal 12 studies, relevant 8 studies; 4 ES, 2 CS, 1 CSSResidential natural outdoor environments, particularly green and blue spacesFor each 10% increase of greenness, the RR and 95% CI was 0.993 (0.985–1.001) for CVD mortality. For high vs. low categories of greenness, the RR and 95% CI was 0.96 (0.94–0.97) for CVD mortality.75%Unclear
Twohig-Bennett et al.43General population, till January 2017, country not restricted: USA, UK, and LithuaniaTotal 143 studies, relevant 4 studies: 3 CS, 1 ESGreenspace measured by residential NVDI, distance to the nearest greenspace, and proportion of city area covered by green landComparing higher to lower greenspace exposure, the pooled ORs and 95% CIs were 0.82 (0.61–1.11) for stroke (3 studies), 0.84 (0.76–0.93) for CVD mortality (2 studies), and 0.92 (0.78–1.07) for CHD (2 studies).86%High risk of bias
Yuan et al. 2020Older adults (mostly ≥ 60 years), 1 January 2000–1 July 2020, country not restricted: Japan, Canada, USA, Finland, China, Rome, Australia, the Netherlands, Lithuania, Brazil, Israel, South Korea, Iran, and UKTotal 22 studies, relevant 17 studies:12 CS, 5 CSSGreenspace measured by NDVI (mostly), percent of greenspace coverage, distance to the nearest green space, park visitation and length of stay, and loss of trees from emerald ash bore diseaseOf 8 studies in total CVD, 7 found beneficial effects of green space, and the other study showed a lower risk of CVD with higher percentage of tree canopy, but not total green space. Evidence for stroke and MI was less consistent.
Only cohort studies measuring NDVI and mortality were included in meta-analysis. Per 0.1 unit increase in NDVI, the pooled HRs and 95% CIs were 0.99 (0.89–1.09) for CVD mortality, 0.96 (0.88–1.05) for IHD mortality, and 0.77 (0.59–1.00) for stroke mortality.
67%Low risk of bias
Urbanization
Angkurawaranon et al.44Southeast Asian populations, till April 2013, SE Asia countries: Brunei Darussalam, Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor Leste, and VietnamTotal 37 studies, relevant 7 studies: 7 CSSUrban exposureFor urban exposure, the pooled ORs and 95% CIs were 1.01 (0.56–1.82) for stroke, 1.19 (0.35–4.07) for non-specific heart disease in the elderly, 2.48 (1.20–5.11) for CHD, and 0.31 (0.13–0.76) for RHD.56%Unclear
Residential noisec
Babisch et al.45Not specified (adults), time and country not restricted: identified countries: UK, the Netherlands, Canada, Denmark, Germany, Sweden, and Japan5 CS, 4 CCS, 5 CSSRoad traffic noise. L Aeq16hr, L Aeq24hr, L DEN, LDay, LNightRelative risk per increase of the traffic noise level of 10 dB. For road traffic noise, the pooled OR and 95% CI was 1.08 (1.04–1.13) for CHD.71%High risk of bias
Banerjee et al. 2014Adult population, 1980–2010, country not restricted: the Netherlands, UK, Germany, Serbia, Sweden, Austria, Italy, Lithuania, Portugal, Switzerland, France, Slovakia, and Hungary14 CSSTransportation noise exposure(No information on unit) For traffic noise (all sources), the pooled RRs and 95% CIs were 1.04 (0.96–1.12) for CVD, 1.01 (0.89–1.14) for MI, 1.08 (0.80–1.36) for AP, and 1.00 (0.73–1.26) for IHD. The estimates for air traffic noise exposure were 1.00 (0.91–1.09) for CVD, 1.04 (0.80–1.28) for AP, 1.02 (0.89–1.14) for MI, and 0.96 (0.80–1.12) for IHD. The pooled RR for road traffic noise was 1.03 (0.97–1.09) for CVD, 1.23 (0.38–2.09) for AP, 0.85 (−0.58 to 2.29) for MI, and 1.35 (0.78–1.92) for IHD.73%High risk of bias
Cai et al. 2021Adults, general population, 1 January 2000–5 October 2020, country not restricted: Denmark (Copenhagen and Aarhus), France (Paris, Lyon, and Toulouse), Switzerland, Sweden (Gothenburg), Spain (Barcelona), the Netherlands, UK (London), and Canada (Vancouver)Total 12 studies, relevant 10 studies: 8 CS, 1 CSS, 2 ESResidential traffic noise from road, rail, and aircraft, measured or modelled: mostly Lden, LAeq24hr, LAeq16hr, LDN, Lday, LnightFor road traffic, per 10 dB increase in Lden, the pooled HRs and 95% CIs were 1.01 (0.98–1.05) for CVD mortality, 1.03 (0.99–1.08) for IHD mortality, and 1.05 (0.97–1.14) for stroke mortality.
For aircraft traffic, the estimates based on three studies were 1.17 (1.10–1.25) for CVD mortality, 1.03 (0.82–1.29) for IHD mortality, and 1.06 (0.93–1.20) for stroke mortality.
For rail traffic, the estimates were 0.98 (0.94–1.01) for CVD mortality (1 study) and 1.02 (0.91–1.14) for IHD mortality (2 studies).
68%Unclear
Dzhambov et al. 2016Adults, till 24 November 2015, country not restricted: the Netherlands, UK, Denmark, Germany, France, Switzerland, USA, Canada, Sweden, Greece, and Italy7 CS, 2 CSS, ES 4Traffic noiseRR per 10 dB noise increase. For road traffic noise, the pooled RR and 95% CI was 1.03 (0.87–1.22). For air traffic noise, the pooled RR was 1.05 (1.00–1.10).72%High risk of bias
Khosravipour et al. 2020General population, time and country not restricted: till 29 November 2019, UK, Germany, Sweden, Lithuania, Denmark, and the Netherlands7 CS, 5 CCS, 1 CSSRoad traffic noiseComparing highest to lowest category of noise exposure (results from categorical analysis), the pooled RR and 95% CI of MI were 1.03 (0.93–1.13). Per 10 dB increment (results from exposure–response analysis and transformed from categorical analysis), the pooled estimate was 1.02 (1.00–1.05). In subgroup analysis, pooled estimates were significant for CCS and CSS, but not for CS. Estimates for the exposure–response analyses were 1.03 (1.00–1.05) after excluding two conference papers and 1.02 (1.01–1.03) after further excluding the studies with only results from categorical analysis.57%Low risk of bias
van Kempen et al. 2002Adults, 1970–1999, country not restricted: Iran, Belgium, Germany, Canada, India, Finland, Italy, the Netherlands, Russia, USA, Poland, Japan, Israel, China, France, South Africa, China (Taiwan), and UK.Total 43 studies, relevant 10 studies: 6 CSS, 2CCS, 2 CSCommunity noise exposure (road and air traffic) assessed by calculations, personal dosimeter, or sound level meterRR per 5 dB(A) noise increase. For road traffic noise, the pooled RRs and 95% CIs were 1.09 (1.05–1.13) for IHD, 0.99 (0.84–1.16) for AP, and 1.03 (0.99–1.09) for MI. For air traffic noise, the pooled RR was 1.03 (0.90–1.18) for AP.25%High risk of bias
van Kempen, et al.46European, 2000–October 2014, European countriesTotal 61 studies, relevant 32 studies: 14 CSS, 5 ES, 8 CS, 5 CCSNoise from road, rail, and air traffic and wind turbines: LDENRoad, rail, and air traffic noise in relation to prevalence, incidence, and mortality of IHD and stroke were analysed, respectively. Number of studies for each analysis is small. Per 10 dB increase in exposure, the pooled RR and 95% CI of IHD was 1.08 (1.01–1.15) for road traffic. Estimates for other associations were of low quality or from <3 studies, and mostly insignificant.NALow risk of bias
Vienneau et al.47Not specified (general population), January 1994–January 2014, country not restricted: Germany, UK, the Netherlands, Sweden, Switzerland, Denmark, Canada, and USA3 CCS, 5 CS, 2 LSTransportation noise exposureRR per 10 dB increase in exposure. The pooled RR and 95% CI for IHD was 1.06 (1.03–1.09).75%High risk of bias
Weihofen et al.48General population, till 31 August 2017, country not restricted: USA, France (Paris, Lyon Saint, and Toulouse), Canada (Vancouver), UK (London), Switzerland, Germany (Berlin and Frankfurt), the Netherlands (Amsterdam), Sweden (Stockholm), Greece (Athens), and Italy (Milan)3 CSS, 1 ES, 4 CS, 1 CCSAircraft noise: LAeq, LDay, LNight, LDN, Lden, LDENAEIPer 10 dB increase in Lden, the pooled RR and 95% CI of stroke was 1.013 (0.998–1.028) from seven studies.71%Low risk of bias
Ambient temperature
Bunker et al.49Elderly (65+), 1 January 1975–24 July 2015, country not restricted: USA, Bangladesh, China (mainland, Taiwan, and Hong Kong), Portugal, UK, Denmark, Australia, Russia, Italy, Hungary, Brazil, Vietnam, Sweden, Thailand, Norway, South Korea, and GermanyTotal 60 studies, relevant 47 studies; 47 LSAmbient hot and cold temperaturePer 1°C temperature change, for heat, the pooled percentage changes and 95% CIs were 3.79 (3.40–4.18) for CVD mortality, 1.62 (0.24–3.03) for IHD mortality, 1.40 (0.06–2.75) for CeVD mortality, 0.33 (−0.09 to 0.75) for IS, −0.66 (−2.13 to 0.84) for ICH, −0.17(−0.96 to 0.63) for CeVD, −0.16(−2.05 to 1.77) for MI, and 0.30(−0.12 to 0.81) for CVD.
For cold, the estimates were 1.84 (0.85–2.84) for CVD mortality, 0.45 (−0.01 to 0.91) for IHD mortality, 1.21 (0.66–1.77) for CeVD mortality, 3.63 (−3.94 to 11.8) for IS, 1.49 (1.04–1.94) for ICH, −0.46 (−1.12 to 0.2) for CeVD, 0.66 (−0.14 to 1.48) for MI, −0.80 (−2.21 to 0.64) for AP, −0.67 (−2.15 to 0.83) for HF, and −0.28 (−1.39 to 0.84) for CVD.
73%High risk of bias
Kofi Amegah et al. 2016Sub-Saharan African populations, till December 2014, Sub-Saharan AfricaTotal 23 studies, relevant 5 studies: 4 LS, 1 CSSTemperatureOne study found that low temperature was associated with increased risk of CVD. Two studies found associations of low and high temperatures with CVD mortality. One study found no association between mean monthly temperature and CVD mortality. One study found 5°C change in the monthly mean temperature to be associated with decreased risk of hospitalization for venous thromboembolism, stroke, and acute MI.56%High risk of bias
Ma et al. 2020Chinese population, January 2010–January 2020, country restricted to ChinaTotal 175 studies, relevant 19 studies: 19 LS(i) Every 1°C temperature increase/decrease beyond certain reference points
(ii) Comparison between extreme temperatures and reference normal temperatures
Pooled RRs and 95% CIs of CVD were 1.089 (1.062–1.116) and 1.171 (1.125–1.218), respectively, for hot and cold temperatures as compared with normal temperatures.100%High risk of bias
Moghadamnia et al.50General population, January 2000–31 December 2015, country not restricted: China (mainland, Taiwan, and Hong Kong), Australia, Thailand, Philippines, South Korea, Germany, and Spain26 LSAmbient temperatureRR per 1°C change of temperature. For CVD mortality, the RRs and 95% CIs were 1.055 (1.050–1.060) for cold exposure and 1.013 (1.011–1.015) for heat exposure. Coefficient per 1°C change in mean annual temperature. For CVD mortality, the pooled estimates were 0.026 (−0.019 to 0.072) for cold exposure and 0.008 (−0.015 to 0.031) for heat exposure.96%High risk of bias
Odame et al. 2018Rural population, till April 2018, country not restricted: Bangladesh (MATLAB), Czech Republic, and China (Naidong and Jiangzi in Tibet)All 14 studies, relevant 3 studies: 3 LSDaily mean temperaturePer 1°C increase, the pooled RR and 95% CI of CVD mortality was 1.111 (1.045–1.181). The associations were significant in subgroup analyses of both developing and developed countries.100%High risk of bias
Turner et al. 2012Not specified (general population), time and country not restricted: South Korea (Incheon), USA, UK (London and Scotland), Europe, Australia (Brisbane), and Thailand (Muang)Total 21 studies, relevant 18 studies: 18 LSEffects of ambient temperature. Maximum, minimum, and mean daily temperatureRR per 1°C increase in temperature. The pooled RRs and 95% CI were 0.999 (0.982–1.016) for CVD morbidities, 0.990 (0.887–1.105) for stroke, and 1.010 (0.930–1.097) for ACS/MI.43%High risk of bias
Wang et al. 2016Adults, till 16 October 2015, country not restricted: Japan, UK, Russia, Spain, China, Portugal, Italy, South Korea, China (Taiwan), Mozambique, USA, France, and Australia7 CS, 13 LS, 1 CSSAmbient temperatureOR per 1°C increase in mean ambient temperature. The pooled ORs and 95% CIs were 0.97 (0.94–1.00) for ICH, 1.00 (0.99–1.01) for IS, and 1.00 (0.98–1.01) for SAH. The pooled estimates for ambient minimum and maximum temperature and IS were OR 0.99 (0.96–1.01) and 0.98 (0.94–1.02), respectively.19%Unclear
Zafeiratou et al. 2021General population, 1990–2020, country not restricted: Serbia (Belgrade), China (Hong Kong), UK (London), USA (New England), Finland (Helsinki), Switzerland, and South KoreaTotal 34 studies, relevant 6 studies: 4 ES, 2 CSMean annual temperature or variability, seasonal temperature or variability, annual temperature categories, and mean annual degrees above/below minimum mortality temperatureIn temporal comparisons within the same area, increased cardiovascular mortality was associated with both increased and decreased temperature. Stronger association was found with cold rather than hot temperature. In geographical comparison in just one study, people living in areas with higher temperature were found a lower rate of IHD mortality, though no dose–response.5 studies on CVD mortality: 60%High risk of bias
Multiple domains
Rugel et al. 2020Urban residents, 1 January 2003–November 2019, country not restricted: the Netherlands, Sweden (Skåne), UK (London), Canada, Denmark (Copenhagen and Aarhus), Germany (Bochum, Essen, and Mülheim/Ruhr), South Korea (Seoul, Ulsan, and Cheonan), France, Spain, Norway, Greece, Italy (Rome and Verona), Switzerland, USA (California), and China (Shenyang, Anshan, Jinzhou, and Taiwan)Total 51 studies, relevant 21 studies: 15 CS, 5 CSS, 1 ESTraffic-related air pollution; natural spaces, neighbourhood walkability; noiseBased on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for assessing the quality of the synthesized evidence base, evidence was sufficient for higher noise exposure with increased CVD. And evidence was sufficient for no association between traffic-related air pollution and CVD.NAHigh risk of bias
First author and year by domainaPopulation, year coverage, and country/regionStudy designExposuresbSummary of resultsPercentage of results in expected directionQuality assessment (ROBIS)
Air pollution
Alexeeff et al.34General population, till 31 December 2019, country not restricted: Europe, Canada, USA, UK, Australia, China, South Korea, and Israel42 CSPM2.5Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs were 1.23 (1.15–1.31) for IHD mortality, 1.08 (0.99–1.18) for incident acute MI, 1.24 (1.13–1.36) for CeVD mortality, and 1.13 (1.11–1.15) for incident stroke.83%High risk of bias
Atkinson et al. 2016General population, till October 2015, country not restricted: USA, UK, China (Taiwan), and FranceTotal 22 studies, relevant 8 studies: 8 CSO3HRs expressed per 10 ppb increase in O3. For long-term annual O3 concentrations, the standardized effect estimates (HRs and 95% CIs) were 1.01 (0.99–1.03) for CVD mortality, 1.02 (1.00–1.04) for IHD mortality, and 1.01 (0.97–1.05) for stroke mortality. For long-term annual O3 concentrations, the random-effects summary estimates (HR and 95% CI) were 0.98 (0.93–1.04) for CVD mortality and 1.00 (0.92–1.09) for IHD mortality. For the warm season/peak O3, random-effects summary estimates were 1.01 (1.00 to 1.02).42%High risk of bias
Atkinson et al.35General population, 1996–October 2016 (Medline, EMBASE), 1970–October 2016 (Web of Science), 1966–October 2016 (PubMed), country not restricted: Europe, North America, China (mainland and Taiwan), and JapanTotal 48 studies, relevant 22 studies: 22 CSNO2 (annual or multi-year averages)Per 10 µg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.03 (1.021.05) for CVD mortality, 1.05 (1.031.06) for CHD mortality, and 1.01 (0.98–1.03) for CeVD mortality.91%High risk of bias
Chen et al. 2008Adults, 1 January 1950–31 December 2007, country not restricted: USA, Norway, France, the Netherlands, Canada, and GermanyTotal 32 studies, relevant 17 studies: 14 CS, 3 CCSO3, SO2, NO/NO2, black smoke, PM10, PM2.5, CO, benzene, and polycyclic aromatic hydrocarbonsRR per 10 µg/m3 increase. For PM2.5, the pooled RRs and 95% CIs were 1.14 (1.091.18) for CVD mortality and 1.16 (0.961.40) for CHD mortality. For other particulate and gaseous pollutants, the paucity of data precludes drawing conclusions.79%High risk of bias
Chen et al. 2020General population, till 9 October 2018, country not restricted: Europe, Canada, UK, USA, Israel, New Zealand, South Korea, Japan, and China (mainland, Taiwan, and Hong Kong)67 CSPM2.5 and PM10Per 10 µg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.091.14) for CVD mortality, 1.16 (1.101.21) for IHD mortality, and 1.11 (1.041.18) for stroke mortality. The estimates of PM10 were 1.04 (0.99–1.10) for CVD mortality, 1.06 (1.011.10) for IHD mortality, and 1.01 (0.83–1.21) for stroke mortality.
The certainty of evidence was high for PM2.5 and CVD mortality and was moderate for PM10 and CVD mortality, as measured by GRADE framework.
81%Low risk of bias
Chen et al.36General population, till October 2019, country not restricted: South Korea, UK, Denmark, Sweden, and CanadaTotal 18 studies, relevant 6 studies: 6 CSPM2.5, PM10, NO2, SO2, O3, and COPer 10 μg/m3 increase in long-term exposure, the pooled HRs, and 95% CIs of AF were 1.116 (1.031–1.207) for PM2.5, 1.034 (1.032–1.035) for PM10, 1.017 (1.001–1.033) for NO2, 1.005 (1.004–1.007) for SO2, 1.017 (1.013–1.022) for CO, and 1.007 (0.927–1.094) for O3.83%Low risk of bias
Faustini et al. 2014General population, January 2004–January 2013, country not restricted: identified countries: Japan, China, Canada, USA, UK, Italy, Germany, Sweden, the Netherlands, and NorwayTotal 23 studies, relevant 17 studies: 2 CCS, 15 CSNO2RR per 10 µg/m3 increase. The pooled RRs and 95% CIs for CVD mortality were 1.13 (1.09–1.18) for NO2 and 1.20 (1.09–1.31) for PM2.5.94%High risk of bias
Hak-Kan et al. 2013Chinese population, till 30 June 2012, 80 major Chinese cities in Mainland China, Hong Kong, and TaiwanTotal 48 studies, relevant 3 studies: 3 CSPM10, NO2, SO2, and O3RR per 10 µg/m3 increase. In one cohort study examining PM10 and NO2, the corresponding RRs and 95% CIs were 1.0155 (1.0151–1.0160) and 1.0246 (1.0231–1.0263) for CVD mortality and 1.0149 (1.0145–1.0153) and 1.0244 (1.0227–1.0262) for CeVD mortality. In another cohort study examining SO2 and CVD, the corresponding RR was 1.032 (1.023–1.040).100%High risk of bias
Hoek et al. 2013Not specified (adults), till January 2013, country not restricted: identified countries: USA, Germany, the Netherlands, Switzerland, Canada, China, New Zealand, Japan, Italy, France, and DenmarkTotal 67 studies, relevant 34 studies: 34 CSLong-term exposure to fine particulate matter (PM2.5, PM10, NO2, elemental carbon, and coarse particles)RR per 10 µg/m3 increase. For PM2.5, the pooled RR and 95% CI was 1.11 (1.05–1.16) for CVD mortality. There was no consistent evidence that long-term exposure to coarse PM or elemental carbon is associated with CVD mortality. Several studies found positive associations between NO2 exposure and fatal MI, but not non-fatal MI. The evidence for an association between air pollution and CeVD mortality was inconsistent.88%High risk of bias
Huang et al. 2021General population, till 2020.02.29, country not restricted: USA, Canada, Norway, the Netherlands, UK, Italy, Denmark, France, Spain, Japan, China, South Korea, Australia, Sweden, Norway, Germany, Austria, Switzerland, France, Italy, Spain, Greece, and Finland32 CSNO2Per 10 ppb increase in annual NO2 concentration, the pooled HR and 95% CI was 1.11 (1.07–1.16) for cardiovascular mortality.71%High risk of bias
Jadambaa et al.37Mongolian population (adults and children), till April 2014, MongoliaTotal 59 studies, relevant 2 studies: 2 CSSNO2 and PM2.5Two studies found an increased risk of CVD with increased exposure to NO2 and PM2.5.100%Unclear
Jaganathan et al.38General population, 1 January 1948–6 March 2018, country restricted to low- and middle-income countries, Mexico (Mexico City), Brazil (São José dos Campos, Cuiabá, and Várzea Grande), China, and India (Varanasi)Total 17 studies, relevant 12 studies: 8 LS, 2 CSS, 1 CCR, 1 CSPM2.5 (annual average or average measure of more than 3 days)Eight out of nine studies (91%) reported significant effects on CVD mortality. Per 10 µg/m3 increase in long-term exposure, the effect estimates of CVD mortality ranged from 0.24 to 6.11%. All four studies reported significant effects of long-term exposure on CVD hospitalization.
Few studies have evaluated this association in LMICs. No studies were found in North and Sub-Saharan Africa.
92%Low risk of bias
Kan et al. 2005General population, 1990–2002, China and worldwideTotal 26 studies, relevant 7 studies: 7 CSEffects of particulate air pollution. PM10 was selected as the indicator particulate matter.RR per 10 µg/m3 increase. For PM10, the pooled RRs and 95% CIs were 1.0095 (1.0060–1.0130) for CHA, 1.013 (1.007–1.019) for CHA based on four European studies, and 1.008 (1.004–1.011) for CHA based on three US and Canadian studies.100%High risk of bias
Karimi et al. 2019Iran population, January 1980–January 2018, country restricted to IranTotal 38 studies, relevant 28 studies: 27 CSS, 1 ESO3, PM2.5, PM10, NO2, NOx, SO2, and CO measured by environmental protection organization and air quality control centrePer 10 µg/m3 increase in all air pollutants, the pooled increased risk (95% CI) in CVD mortality was 0.5% (0.4–0.6%). The estimate for PM2.5 and PM10 was 0.7% (0.4–1%).NAUnclear
Liu et al. 2018General population, adults, January 1974–July 2017, country not restricted: USA, UK, Italy, Canada, China (mainland and Hong Kong), Europe, New Zealand, and Japan16 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of CVD mortality were 1.12 (1.08–1.16) for PM2.5, 1.02 (0.89–1.16) for PM10, and 1.10 (1.06–1.14) for combined. In subgroup analyses, there is no difference in the association stratified by categories of WHO PM levels or smoking status. The estimates of PM2.5 were 1.19 (1.11–1.27) for studies with ≥ 11 years of follow-up, higher than those <11 years: 1.07 (1.04–1.11).88%Low risk of bias
Lu et al. 2015Chinese population (adults only), 1990–2013, Mainland China, Hong Kong, and TaiwanTotal 59 studies, relevant 2 studies: 2 CSPM10 and PM2.5RR per 10 μg/m3 increase. For the annual average concentration of PM10, the RR and 95% CI was 1.23 (1.19–1.26) for CVD mortality in one study and 1.55 (1.51–1.60) for CVD mortality in another study.100%High risk of bias
Luben et al. 2017Adults, till 15 June 2017, country not restricted: USA, China (mainland and Taiwan), the Netherlands, Canada, South Korea, Spain, and ItalyTotal 24 studies, relevant, 3 studies: 2 CS, 1 LSAmbient black carbonThere are generally modest, positive associations of long-term exposure to black carbon and elemental carbon with cardiovascular hospital admissions and mortality.100%High risk of bias
Niu et al. 2021General population, till 1 February 2020, country not restricted: China, Europe, England, Japan (Shizuoka), USA (California), Ghana, India, Mexico, Russia, and South AfricaTotal 68 studies, relevant 13 studies: 13 CSPM2.5, PM10, and NO2Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of stroke incidence were 1.081 (0.971–1.023) for PM2.5, 1.033 (0.907–1.175) for PM10, and 1.005 (0.977–1.034) for NO2; the HRs and 95%CI of stroke mortality were 1.047 (0.995–1.101) for NO2.82%High risk of bias
Prueitt et al.39General population, 1 January 2006–4 November 2013, country not restricted: USA, UK, Canada (Toronto), and China (Liaoning)Total 25 studies, relevant 11 studies: 8 CS, 2 CSS, 1 ESO3For long-term O3 exposure and CVD morbidity, studies were rare and reports were inconsistent. For CVD mortality, of 10 high-quality studies, 5 reported positive association, and the other 5 reported null or negative association.17%High risk of bias
Scheers et al. 2015General population, till 20 July 2015, country not restricted: Japan, China, UK, the Netherlands, Switzerland, Greece, USA, Canada, Finland, Norway, Sweden, Denmark, Germany, Austria, Italy, Greece, and FranceTotal 20 studies, relevant 20 studies: 14 CS, 6 ESPM10 or PM2.5HR per 10 μg/m3 increase. For PM10, the pooled HRs and 95% CIs were 1.061 (1.018–1.105) for overall stroke events and 1.080 (0.992–1.177) for stroke mortality. For PM2.5, the pooled HRs and 95% CIs were 1.064 (1.021–1.109) for overall stroke events and 1.125 (1.007–1.256) for stroke mortality.50%High risk of bias
Shin et al. 2014Not specified (adults), from 1990, country not restricted: USA and UKTotal 20 studies, relevant 4 studies: 4 CSPM2.5RR per 10 μg/m3 increase. In the frequentist meta-analysis, the pooled RR and 95% CI for long-term exposure to PM2.5 was 1.06 (1.00–1.13) for non-fatal strokes. The Bayesian meta-analysis found a posterior mean 1.08 (0.96–1.26) from a normal prior and 1.05 (1.02–1.10) from a gamma prior.100%High risk of bias
Stieb et al.40General population, till 25 February 2020, country not restricted: Canada, USA, UK, Europe, China (mainland, Hong Kong, and Taipei), Australia, South Korea (Seoul), and Japan (Shizuoka)49 CSNO2Per 10 ppb increase in long-term exposure, the pooled HRs and 95% CIs were 1.139 (0.997–1.301) for CVD mortality, 1.128 (1.076–1.182) for IHD mortality, and 1.167 (0.936–1.456) for CeVD mortality. After excluding studies with probably high or high risk of bias, the pooled HRs and 95% CIs were 1.058 (1.026–1.091) for CVD mortality, 1.111 (1.079–1.144) for IHD mortality, and 1.014 (0.997–1.032) for CeVD mortality.74%Low risk of bias
Wang et al. 2020Older adults aged ≥ 55 years, till January 2020, country not restricted: USA (Steubenville, Eastern Massachusetts, Boston), Germany (Erfurt), Finland (Helsinki), the Netherlands (Amsterdam), UK (Scotland: Aberdeen), and China (Beijing and Taipei)Total 19 studies, relevant 10 studies: 10 LSConcentration of PM2.5Per 10 mg/m3 increase in long-term exposure, the pooled estimates and 95% CIs of HRV were −0.92% (−2.14 to 0.31%) for SDNN, −1.96% (−3.48 to −0.44%) for RMSSD in time-domain measurements, −2.78% (−4.02 to −1.55%) for LF, and −1.61% (−4.02 to 0.80%) for HF in frequency domain measurements.68%High risk of bias
Yang et al. 201941General population, till 25 April 2018, country not restricted: Europe, UK, Canada, USA, South Korea, China, Ghana, India, Mexico, Russia, South Africa, and Japan35 CSPM2.5, PM10, O3, and NO2Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.07–1.15) for CVD events, 1.12 (1.05–1.19) for stroke incidence, 1.12 (1.08–1.16) for stroke events, 1.19 (1.09–1.30) for IHD incidence, and 1.14 (1.08–1.21) for IHD events. The estimates of CVD mortality were 1.11 (1.07–1.15) for PM2.5, 1.09 (1.02–1.16) for PM10, 1.23 (1.15–1.31) for NO2, and 1.03 (1.02–1.05) for O3. The estimates of NO2 and IHD events were 1.05 (1.04–1.06). No significant associations were found between PM10 and CVD, stroke and IHD incidence.87%High risk of bias
Yuan et al. 2019General population, 1980–December 2018, country not restricted: Europe, USA, China (Hong Kong), Ghana, India, Mexico, Russia, South Africa, UK, Sweden (Gothenburg), and Italy16 CSPM2.5Per 5 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.11 (1.05–1.17) for stroke incidence and 1.11 (1.05–1.17) for stroke mortality. In subgroup analysis, the estimates of stroke incidence were 1.09 (1.05–1.14) for North America (5 CS), 1.07 (1.05–1.10) for Europe (4 CS), and 2.31 (0.49–10.95) for Asia (2 CS). The associations were insignificant in both sex and significant in both ischaemic and haemorrhagic stroke. The estimates of stroke incidence were 1.08 (1.03–1.13) for never smokers, 1.11 (1.01–1.22) for former smokers, and 1.08 (0.94–1.25) for current smokers.95%Low risk of bias
Zhao et al. 2017General population, 1990–2016, country not restricted: USA, Israel, Japan, UK, China, Italy, Norway, Greece, Canada, Denmark, France, South Korea, Iran, Germany, Finland, Sweden, Spain, and the NetherlandsTotal 48 studies, relevant 48 studies: 25 CS, 23 LSPM10, PM2.5, SO2, NO2, CO, and O3HR per 10 μg/m3 increase. For CHD mortality, the pooled HRs and 95% CIs were 1.12 (1.04–1.20) for PM10, 1.17 (1.12–1.22) for PM2.5, 1.03 (1.00–1.07) for SO2, 1.04 (1.01–1.06) for NO2, 1.04 (0.98–1.10) for CO, and 1.06 (1.01–1.11) for O3 (10 mg/m3 increase). For CHD incidence, the pooled HRs and 95% CIs were 1.01 (1.00–1.02) for PM10, 1.02 (1.00–1.03) for PM2.5, 1.01 (1.00–1.02) for SO2, 1.04 (1.03–1.06) for NO2, 1.01 (0.97–1.04) for O3, and 1.03 (1.00–1.05) for CO (10 mg/m3 increase).NAHigh risk of bias
Zhao et al. 2021General population, time and country not restricted: China, Norway, UK, the Netherlands, China (Hong Kong), and Canada (Ontario)7 CSPM2.5 acquired through satellite-based model (5 studies) and outdoor-automated monitoring stations (2 studies)Per 1.4–10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs of haemorrhagic stroke were 1.16 (1.03–1.30) for total, 1.41 (0.92–2.15) for current smoker, and 1.04 (0.74–1.46) for never and former smoker.71%Low risk of bias
Zhu et al. 2021General population, till 2 August 2020, country not restricted: Canada, Denmark, the Netherlands, China, USA, South Korea, Israel, and UK (London)12 CSPM2.5Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs were 1.10 (1.02–1.18) for MI incidence and 1.07 (1.04–1.09) for post-MI mortality.75%Unclear
Zou et al.42General population, till September 2019, country not restricted: USA, South Korea, UK, Canada, Sweden, Israel, Italy, the Netherlands, Switzerland, and Finland27 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs of MI were 1.18 (1.11–1.26) for PM2.5 and 1.03 (1.00–1.05) for PM10.91%Unclear
Physical activity environment
Gascon et al. 2016Adults, till 14 November 2014, country not restricted: USA, UK, New Zealand, Lithuania, and CanadaTotal 12 studies, relevant 8 studies; 4 ES, 2 CS, 1 CSSResidential natural outdoor environments, particularly green and blue spacesFor each 10% increase of greenness, the RR and 95% CI was 0.993 (0.985–1.001) for CVD mortality. For high vs. low categories of greenness, the RR and 95% CI was 0.96 (0.94–0.97) for CVD mortality.75%Unclear
Twohig-Bennett et al.43General population, till January 2017, country not restricted: USA, UK, and LithuaniaTotal 143 studies, relevant 4 studies: 3 CS, 1 ESGreenspace measured by residential NVDI, distance to the nearest greenspace, and proportion of city area covered by green landComparing higher to lower greenspace exposure, the pooled ORs and 95% CIs were 0.82 (0.61–1.11) for stroke (3 studies), 0.84 (0.76–0.93) for CVD mortality (2 studies), and 0.92 (0.78–1.07) for CHD (2 studies).86%High risk of bias
Yuan et al. 2020Older adults (mostly ≥ 60 years), 1 January 2000–1 July 2020, country not restricted: Japan, Canada, USA, Finland, China, Rome, Australia, the Netherlands, Lithuania, Brazil, Israel, South Korea, Iran, and UKTotal 22 studies, relevant 17 studies:12 CS, 5 CSSGreenspace measured by NDVI (mostly), percent of greenspace coverage, distance to the nearest green space, park visitation and length of stay, and loss of trees from emerald ash bore diseaseOf 8 studies in total CVD, 7 found beneficial effects of green space, and the other study showed a lower risk of CVD with higher percentage of tree canopy, but not total green space. Evidence for stroke and MI was less consistent.
Only cohort studies measuring NDVI and mortality were included in meta-analysis. Per 0.1 unit increase in NDVI, the pooled HRs and 95% CIs were 0.99 (0.89–1.09) for CVD mortality, 0.96 (0.88–1.05) for IHD mortality, and 0.77 (0.59–1.00) for stroke mortality.
67%Low risk of bias
Urbanization
Angkurawaranon et al.44Southeast Asian populations, till April 2013, SE Asia countries: Brunei Darussalam, Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor Leste, and VietnamTotal 37 studies, relevant 7 studies: 7 CSSUrban exposureFor urban exposure, the pooled ORs and 95% CIs were 1.01 (0.56–1.82) for stroke, 1.19 (0.35–4.07) for non-specific heart disease in the elderly, 2.48 (1.20–5.11) for CHD, and 0.31 (0.13–0.76) for RHD.56%Unclear
Residential noisec
Babisch et al.45Not specified (adults), time and country not restricted: identified countries: UK, the Netherlands, Canada, Denmark, Germany, Sweden, and Japan5 CS, 4 CCS, 5 CSSRoad traffic noise. L Aeq16hr, L Aeq24hr, L DEN, LDay, LNightRelative risk per increase of the traffic noise level of 10 dB. For road traffic noise, the pooled OR and 95% CI was 1.08 (1.04–1.13) for CHD.71%High risk of bias
Banerjee et al. 2014Adult population, 1980–2010, country not restricted: the Netherlands, UK, Germany, Serbia, Sweden, Austria, Italy, Lithuania, Portugal, Switzerland, France, Slovakia, and Hungary14 CSSTransportation noise exposure(No information on unit) For traffic noise (all sources), the pooled RRs and 95% CIs were 1.04 (0.96–1.12) for CVD, 1.01 (0.89–1.14) for MI, 1.08 (0.80–1.36) for AP, and 1.00 (0.73–1.26) for IHD. The estimates for air traffic noise exposure were 1.00 (0.91–1.09) for CVD, 1.04 (0.80–1.28) for AP, 1.02 (0.89–1.14) for MI, and 0.96 (0.80–1.12) for IHD. The pooled RR for road traffic noise was 1.03 (0.97–1.09) for CVD, 1.23 (0.38–2.09) for AP, 0.85 (−0.58 to 2.29) for MI, and 1.35 (0.78–1.92) for IHD.73%High risk of bias
Cai et al. 2021Adults, general population, 1 January 2000–5 October 2020, country not restricted: Denmark (Copenhagen and Aarhus), France (Paris, Lyon, and Toulouse), Switzerland, Sweden (Gothenburg), Spain (Barcelona), the Netherlands, UK (London), and Canada (Vancouver)Total 12 studies, relevant 10 studies: 8 CS, 1 CSS, 2 ESResidential traffic noise from road, rail, and aircraft, measured or modelled: mostly Lden, LAeq24hr, LAeq16hr, LDN, Lday, LnightFor road traffic, per 10 dB increase in Lden, the pooled HRs and 95% CIs were 1.01 (0.98–1.05) for CVD mortality, 1.03 (0.99–1.08) for IHD mortality, and 1.05 (0.97–1.14) for stroke mortality.
For aircraft traffic, the estimates based on three studies were 1.17 (1.10–1.25) for CVD mortality, 1.03 (0.82–1.29) for IHD mortality, and 1.06 (0.93–1.20) for stroke mortality.
For rail traffic, the estimates were 0.98 (0.94–1.01) for CVD mortality (1 study) and 1.02 (0.91–1.14) for IHD mortality (2 studies).
68%Unclear
Dzhambov et al. 2016Adults, till 24 November 2015, country not restricted: the Netherlands, UK, Denmark, Germany, France, Switzerland, USA, Canada, Sweden, Greece, and Italy7 CS, 2 CSS, ES 4Traffic noiseRR per 10 dB noise increase. For road traffic noise, the pooled RR and 95% CI was 1.03 (0.87–1.22). For air traffic noise, the pooled RR was 1.05 (1.00–1.10).72%High risk of bias
Khosravipour et al. 2020General population, time and country not restricted: till 29 November 2019, UK, Germany, Sweden, Lithuania, Denmark, and the Netherlands7 CS, 5 CCS, 1 CSSRoad traffic noiseComparing highest to lowest category of noise exposure (results from categorical analysis), the pooled RR and 95% CI of MI were 1.03 (0.93–1.13). Per 10 dB increment (results from exposure–response analysis and transformed from categorical analysis), the pooled estimate was 1.02 (1.00–1.05). In subgroup analysis, pooled estimates were significant for CCS and CSS, but not for CS. Estimates for the exposure–response analyses were 1.03 (1.00–1.05) after excluding two conference papers and 1.02 (1.01–1.03) after further excluding the studies with only results from categorical analysis.57%Low risk of bias
van Kempen et al. 2002Adults, 1970–1999, country not restricted: Iran, Belgium, Germany, Canada, India, Finland, Italy, the Netherlands, Russia, USA, Poland, Japan, Israel, China, France, South Africa, China (Taiwan), and UK.Total 43 studies, relevant 10 studies: 6 CSS, 2CCS, 2 CSCommunity noise exposure (road and air traffic) assessed by calculations, personal dosimeter, or sound level meterRR per 5 dB(A) noise increase. For road traffic noise, the pooled RRs and 95% CIs were 1.09 (1.05–1.13) for IHD, 0.99 (0.84–1.16) for AP, and 1.03 (0.99–1.09) for MI. For air traffic noise, the pooled RR was 1.03 (0.90–1.18) for AP.25%High risk of bias
van Kempen, et al.46European, 2000–October 2014, European countriesTotal 61 studies, relevant 32 studies: 14 CSS, 5 ES, 8 CS, 5 CCSNoise from road, rail, and air traffic and wind turbines: LDENRoad, rail, and air traffic noise in relation to prevalence, incidence, and mortality of IHD and stroke were analysed, respectively. Number of studies for each analysis is small. Per 10 dB increase in exposure, the pooled RR and 95% CI of IHD was 1.08 (1.01–1.15) for road traffic. Estimates for other associations were of low quality or from <3 studies, and mostly insignificant.NALow risk of bias
Vienneau et al.47Not specified (general population), January 1994–January 2014, country not restricted: Germany, UK, the Netherlands, Sweden, Switzerland, Denmark, Canada, and USA3 CCS, 5 CS, 2 LSTransportation noise exposureRR per 10 dB increase in exposure. The pooled RR and 95% CI for IHD was 1.06 (1.03–1.09).75%High risk of bias
Weihofen et al.48General population, till 31 August 2017, country not restricted: USA, France (Paris, Lyon Saint, and Toulouse), Canada (Vancouver), UK (London), Switzerland, Germany (Berlin and Frankfurt), the Netherlands (Amsterdam), Sweden (Stockholm), Greece (Athens), and Italy (Milan)3 CSS, 1 ES, 4 CS, 1 CCSAircraft noise: LAeq, LDay, LNight, LDN, Lden, LDENAEIPer 10 dB increase in Lden, the pooled RR and 95% CI of stroke was 1.013 (0.998–1.028) from seven studies.71%Low risk of bias
Ambient temperature
Bunker et al.49Elderly (65+), 1 January 1975–24 July 2015, country not restricted: USA, Bangladesh, China (mainland, Taiwan, and Hong Kong), Portugal, UK, Denmark, Australia, Russia, Italy, Hungary, Brazil, Vietnam, Sweden, Thailand, Norway, South Korea, and GermanyTotal 60 studies, relevant 47 studies; 47 LSAmbient hot and cold temperaturePer 1°C temperature change, for heat, the pooled percentage changes and 95% CIs were 3.79 (3.40–4.18) for CVD mortality, 1.62 (0.24–3.03) for IHD mortality, 1.40 (0.06–2.75) for CeVD mortality, 0.33 (−0.09 to 0.75) for IS, −0.66 (−2.13 to 0.84) for ICH, −0.17(−0.96 to 0.63) for CeVD, −0.16(−2.05 to 1.77) for MI, and 0.30(−0.12 to 0.81) for CVD.
For cold, the estimates were 1.84 (0.85–2.84) for CVD mortality, 0.45 (−0.01 to 0.91) for IHD mortality, 1.21 (0.66–1.77) for CeVD mortality, 3.63 (−3.94 to 11.8) for IS, 1.49 (1.04–1.94) for ICH, −0.46 (−1.12 to 0.2) for CeVD, 0.66 (−0.14 to 1.48) for MI, −0.80 (−2.21 to 0.64) for AP, −0.67 (−2.15 to 0.83) for HF, and −0.28 (−1.39 to 0.84) for CVD.
73%High risk of bias
Kofi Amegah et al. 2016Sub-Saharan African populations, till December 2014, Sub-Saharan AfricaTotal 23 studies, relevant 5 studies: 4 LS, 1 CSSTemperatureOne study found that low temperature was associated with increased risk of CVD. Two studies found associations of low and high temperatures with CVD mortality. One study found no association between mean monthly temperature and CVD mortality. One study found 5°C change in the monthly mean temperature to be associated with decreased risk of hospitalization for venous thromboembolism, stroke, and acute MI.56%High risk of bias
Ma et al. 2020Chinese population, January 2010–January 2020, country restricted to ChinaTotal 175 studies, relevant 19 studies: 19 LS(i) Every 1°C temperature increase/decrease beyond certain reference points
(ii) Comparison between extreme temperatures and reference normal temperatures
Pooled RRs and 95% CIs of CVD were 1.089 (1.062–1.116) and 1.171 (1.125–1.218), respectively, for hot and cold temperatures as compared with normal temperatures.100%High risk of bias
Moghadamnia et al.50General population, January 2000–31 December 2015, country not restricted: China (mainland, Taiwan, and Hong Kong), Australia, Thailand, Philippines, South Korea, Germany, and Spain26 LSAmbient temperatureRR per 1°C change of temperature. For CVD mortality, the RRs and 95% CIs were 1.055 (1.050–1.060) for cold exposure and 1.013 (1.011–1.015) for heat exposure. Coefficient per 1°C change in mean annual temperature. For CVD mortality, the pooled estimates were 0.026 (−0.019 to 0.072) for cold exposure and 0.008 (−0.015 to 0.031) for heat exposure.96%High risk of bias
Odame et al. 2018Rural population, till April 2018, country not restricted: Bangladesh (MATLAB), Czech Republic, and China (Naidong and Jiangzi in Tibet)All 14 studies, relevant 3 studies: 3 LSDaily mean temperaturePer 1°C increase, the pooled RR and 95% CI of CVD mortality was 1.111 (1.045–1.181). The associations were significant in subgroup analyses of both developing and developed countries.100%High risk of bias
Turner et al. 2012Not specified (general population), time and country not restricted: South Korea (Incheon), USA, UK (London and Scotland), Europe, Australia (Brisbane), and Thailand (Muang)Total 21 studies, relevant 18 studies: 18 LSEffects of ambient temperature. Maximum, minimum, and mean daily temperatureRR per 1°C increase in temperature. The pooled RRs and 95% CI were 0.999 (0.982–1.016) for CVD morbidities, 0.990 (0.887–1.105) for stroke, and 1.010 (0.930–1.097) for ACS/MI.43%High risk of bias
Wang et al. 2016Adults, till 16 October 2015, country not restricted: Japan, UK, Russia, Spain, China, Portugal, Italy, South Korea, China (Taiwan), Mozambique, USA, France, and Australia7 CS, 13 LS, 1 CSSAmbient temperatureOR per 1°C increase in mean ambient temperature. The pooled ORs and 95% CIs were 0.97 (0.94–1.00) for ICH, 1.00 (0.99–1.01) for IS, and 1.00 (0.98–1.01) for SAH. The pooled estimates for ambient minimum and maximum temperature and IS were OR 0.99 (0.96–1.01) and 0.98 (0.94–1.02), respectively.19%Unclear
Zafeiratou et al. 2021General population, 1990–2020, country not restricted: Serbia (Belgrade), China (Hong Kong), UK (London), USA (New England), Finland (Helsinki), Switzerland, and South KoreaTotal 34 studies, relevant 6 studies: 4 ES, 2 CSMean annual temperature or variability, seasonal temperature or variability, annual temperature categories, and mean annual degrees above/below minimum mortality temperatureIn temporal comparisons within the same area, increased cardiovascular mortality was associated with both increased and decreased temperature. Stronger association was found with cold rather than hot temperature. In geographical comparison in just one study, people living in areas with higher temperature were found a lower rate of IHD mortality, though no dose–response.5 studies on CVD mortality: 60%High risk of bias
Multiple domains
Rugel et al. 2020Urban residents, 1 January 2003–November 2019, country not restricted: the Netherlands, Sweden (Skåne), UK (London), Canada, Denmark (Copenhagen and Aarhus), Germany (Bochum, Essen, and Mülheim/Ruhr), South Korea (Seoul, Ulsan, and Cheonan), France, Spain, Norway, Greece, Italy (Rome and Verona), Switzerland, USA (California), and China (Shenyang, Anshan, Jinzhou, and Taiwan)Total 51 studies, relevant 21 studies: 15 CS, 5 CSS, 1 ESTraffic-related air pollution; natural spaces, neighbourhood walkability; noiseBased on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for assessing the quality of the synthesized evidence base, evidence was sufficient for higher noise exposure with increased CVD. And evidence was sufficient for no association between traffic-related air pollution and CVD.NAHigh risk of bias

ES, ecological studies; CS, cohort studies; CSS, cross-sectional studies; CCS, case-control studies; CCR, case-crossover studies; SAS, small-area studies; longitudinal study, LS (e.g. panel study and time-series); RR, relative risk; HR, hazard ratio; MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH, intracerebral haemorrhage; IS, ischaemic stroke; SAH, subarachnoid haemorrhage; HF, heart failure. The significant pooled results are in bold.

A bibliography of all included reviews is presented in Supplementary material online, Appendix S3.

There were no systematic reviews found in the domains of food environment and light pollution.

LAeq16hr, annual non-weighted 16 h average noise level during the day; LAeq24hr, the annual non-weighted day–night average noise level; LDEN, the annual weighted (day + 0 dB, evening + 5 dB, and night + 10 dB) day–evening–night average noise level; LAeq, A-weighted average of an energy-equivalent continuous sound level over a period of time (A-weighting: in noise research, typically, the A filter is used which adjusts for deep and high frequencies, as these are perceived as less loud); LDay, LAeq for the day (usually 7:00 a.m.–7:00 p.m.) for all day periods of a year; LNight, LAeq for the night (usually from 11:00 p.m. to 7:00 a.m.) for all night periods of a year; LDN, all 24 h LAeq periods of a year with additional 10 dB for nighttime noise annoyance (usually from 11:00 p.m. to 7:00 a.m.); LDENAEI, see LDEN, but in addition, weighted average exposure on municipal level.

Table 1

Summary of included systematic reviews (n = 51)

First author and year by domainaPopulation, year coverage, and country/regionStudy designExposuresbSummary of resultsPercentage of results in expected directionQuality assessment (ROBIS)
Air pollution
Alexeeff et al.34General population, till 31 December 2019, country not restricted: Europe, Canada, USA, UK, Australia, China, South Korea, and Israel42 CSPM2.5Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs were 1.23 (1.15–1.31) for IHD mortality, 1.08 (0.99–1.18) for incident acute MI, 1.24 (1.13–1.36) for CeVD mortality, and 1.13 (1.11–1.15) for incident stroke.83%High risk of bias
Atkinson et al. 2016General population, till October 2015, country not restricted: USA, UK, China (Taiwan), and FranceTotal 22 studies, relevant 8 studies: 8 CSO3HRs expressed per 10 ppb increase in O3. For long-term annual O3 concentrations, the standardized effect estimates (HRs and 95% CIs) were 1.01 (0.99–1.03) for CVD mortality, 1.02 (1.00–1.04) for IHD mortality, and 1.01 (0.97–1.05) for stroke mortality. For long-term annual O3 concentrations, the random-effects summary estimates (HR and 95% CI) were 0.98 (0.93–1.04) for CVD mortality and 1.00 (0.92–1.09) for IHD mortality. For the warm season/peak O3, random-effects summary estimates were 1.01 (1.00 to 1.02).42%High risk of bias
Atkinson et al.35General population, 1996–October 2016 (Medline, EMBASE), 1970–October 2016 (Web of Science), 1966–October 2016 (PubMed), country not restricted: Europe, North America, China (mainland and Taiwan), and JapanTotal 48 studies, relevant 22 studies: 22 CSNO2 (annual or multi-year averages)Per 10 µg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.03 (1.021.05) for CVD mortality, 1.05 (1.031.06) for CHD mortality, and 1.01 (0.98–1.03) for CeVD mortality.91%High risk of bias
Chen et al. 2008Adults, 1 January 1950–31 December 2007, country not restricted: USA, Norway, France, the Netherlands, Canada, and GermanyTotal 32 studies, relevant 17 studies: 14 CS, 3 CCSO3, SO2, NO/NO2, black smoke, PM10, PM2.5, CO, benzene, and polycyclic aromatic hydrocarbonsRR per 10 µg/m3 increase. For PM2.5, the pooled RRs and 95% CIs were 1.14 (1.091.18) for CVD mortality and 1.16 (0.961.40) for CHD mortality. For other particulate and gaseous pollutants, the paucity of data precludes drawing conclusions.79%High risk of bias
Chen et al. 2020General population, till 9 October 2018, country not restricted: Europe, Canada, UK, USA, Israel, New Zealand, South Korea, Japan, and China (mainland, Taiwan, and Hong Kong)67 CSPM2.5 and PM10Per 10 µg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.091.14) for CVD mortality, 1.16 (1.101.21) for IHD mortality, and 1.11 (1.041.18) for stroke mortality. The estimates of PM10 were 1.04 (0.99–1.10) for CVD mortality, 1.06 (1.011.10) for IHD mortality, and 1.01 (0.83–1.21) for stroke mortality.
The certainty of evidence was high for PM2.5 and CVD mortality and was moderate for PM10 and CVD mortality, as measured by GRADE framework.
81%Low risk of bias
Chen et al.36General population, till October 2019, country not restricted: South Korea, UK, Denmark, Sweden, and CanadaTotal 18 studies, relevant 6 studies: 6 CSPM2.5, PM10, NO2, SO2, O3, and COPer 10 μg/m3 increase in long-term exposure, the pooled HRs, and 95% CIs of AF were 1.116 (1.031–1.207) for PM2.5, 1.034 (1.032–1.035) for PM10, 1.017 (1.001–1.033) for NO2, 1.005 (1.004–1.007) for SO2, 1.017 (1.013–1.022) for CO, and 1.007 (0.927–1.094) for O3.83%Low risk of bias
Faustini et al. 2014General population, January 2004–January 2013, country not restricted: identified countries: Japan, China, Canada, USA, UK, Italy, Germany, Sweden, the Netherlands, and NorwayTotal 23 studies, relevant 17 studies: 2 CCS, 15 CSNO2RR per 10 µg/m3 increase. The pooled RRs and 95% CIs for CVD mortality were 1.13 (1.09–1.18) for NO2 and 1.20 (1.09–1.31) for PM2.5.94%High risk of bias
Hak-Kan et al. 2013Chinese population, till 30 June 2012, 80 major Chinese cities in Mainland China, Hong Kong, and TaiwanTotal 48 studies, relevant 3 studies: 3 CSPM10, NO2, SO2, and O3RR per 10 µg/m3 increase. In one cohort study examining PM10 and NO2, the corresponding RRs and 95% CIs were 1.0155 (1.0151–1.0160) and 1.0246 (1.0231–1.0263) for CVD mortality and 1.0149 (1.0145–1.0153) and 1.0244 (1.0227–1.0262) for CeVD mortality. In another cohort study examining SO2 and CVD, the corresponding RR was 1.032 (1.023–1.040).100%High risk of bias
Hoek et al. 2013Not specified (adults), till January 2013, country not restricted: identified countries: USA, Germany, the Netherlands, Switzerland, Canada, China, New Zealand, Japan, Italy, France, and DenmarkTotal 67 studies, relevant 34 studies: 34 CSLong-term exposure to fine particulate matter (PM2.5, PM10, NO2, elemental carbon, and coarse particles)RR per 10 µg/m3 increase. For PM2.5, the pooled RR and 95% CI was 1.11 (1.05–1.16) for CVD mortality. There was no consistent evidence that long-term exposure to coarse PM or elemental carbon is associated with CVD mortality. Several studies found positive associations between NO2 exposure and fatal MI, but not non-fatal MI. The evidence for an association between air pollution and CeVD mortality was inconsistent.88%High risk of bias
Huang et al. 2021General population, till 2020.02.29, country not restricted: USA, Canada, Norway, the Netherlands, UK, Italy, Denmark, France, Spain, Japan, China, South Korea, Australia, Sweden, Norway, Germany, Austria, Switzerland, France, Italy, Spain, Greece, and Finland32 CSNO2Per 10 ppb increase in annual NO2 concentration, the pooled HR and 95% CI was 1.11 (1.07–1.16) for cardiovascular mortality.71%High risk of bias
Jadambaa et al.37Mongolian population (adults and children), till April 2014, MongoliaTotal 59 studies, relevant 2 studies: 2 CSSNO2 and PM2.5Two studies found an increased risk of CVD with increased exposure to NO2 and PM2.5.100%Unclear
Jaganathan et al.38General population, 1 January 1948–6 March 2018, country restricted to low- and middle-income countries, Mexico (Mexico City), Brazil (São José dos Campos, Cuiabá, and Várzea Grande), China, and India (Varanasi)Total 17 studies, relevant 12 studies: 8 LS, 2 CSS, 1 CCR, 1 CSPM2.5 (annual average or average measure of more than 3 days)Eight out of nine studies (91%) reported significant effects on CVD mortality. Per 10 µg/m3 increase in long-term exposure, the effect estimates of CVD mortality ranged from 0.24 to 6.11%. All four studies reported significant effects of long-term exposure on CVD hospitalization.
Few studies have evaluated this association in LMICs. No studies were found in North and Sub-Saharan Africa.
92%Low risk of bias
Kan et al. 2005General population, 1990–2002, China and worldwideTotal 26 studies, relevant 7 studies: 7 CSEffects of particulate air pollution. PM10 was selected as the indicator particulate matter.RR per 10 µg/m3 increase. For PM10, the pooled RRs and 95% CIs were 1.0095 (1.0060–1.0130) for CHA, 1.013 (1.007–1.019) for CHA based on four European studies, and 1.008 (1.004–1.011) for CHA based on three US and Canadian studies.100%High risk of bias
Karimi et al. 2019Iran population, January 1980–January 2018, country restricted to IranTotal 38 studies, relevant 28 studies: 27 CSS, 1 ESO3, PM2.5, PM10, NO2, NOx, SO2, and CO measured by environmental protection organization and air quality control centrePer 10 µg/m3 increase in all air pollutants, the pooled increased risk (95% CI) in CVD mortality was 0.5% (0.4–0.6%). The estimate for PM2.5 and PM10 was 0.7% (0.4–1%).NAUnclear
Liu et al. 2018General population, adults, January 1974–July 2017, country not restricted: USA, UK, Italy, Canada, China (mainland and Hong Kong), Europe, New Zealand, and Japan16 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of CVD mortality were 1.12 (1.08–1.16) for PM2.5, 1.02 (0.89–1.16) for PM10, and 1.10 (1.06–1.14) for combined. In subgroup analyses, there is no difference in the association stratified by categories of WHO PM levels or smoking status. The estimates of PM2.5 were 1.19 (1.11–1.27) for studies with ≥ 11 years of follow-up, higher than those <11 years: 1.07 (1.04–1.11).88%Low risk of bias
Lu et al. 2015Chinese population (adults only), 1990–2013, Mainland China, Hong Kong, and TaiwanTotal 59 studies, relevant 2 studies: 2 CSPM10 and PM2.5RR per 10 μg/m3 increase. For the annual average concentration of PM10, the RR and 95% CI was 1.23 (1.19–1.26) for CVD mortality in one study and 1.55 (1.51–1.60) for CVD mortality in another study.100%High risk of bias
Luben et al. 2017Adults, till 15 June 2017, country not restricted: USA, China (mainland and Taiwan), the Netherlands, Canada, South Korea, Spain, and ItalyTotal 24 studies, relevant, 3 studies: 2 CS, 1 LSAmbient black carbonThere are generally modest, positive associations of long-term exposure to black carbon and elemental carbon with cardiovascular hospital admissions and mortality.100%High risk of bias
Niu et al. 2021General population, till 1 February 2020, country not restricted: China, Europe, England, Japan (Shizuoka), USA (California), Ghana, India, Mexico, Russia, and South AfricaTotal 68 studies, relevant 13 studies: 13 CSPM2.5, PM10, and NO2Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of stroke incidence were 1.081 (0.971–1.023) for PM2.5, 1.033 (0.907–1.175) for PM10, and 1.005 (0.977–1.034) for NO2; the HRs and 95%CI of stroke mortality were 1.047 (0.995–1.101) for NO2.82%High risk of bias
Prueitt et al.39General population, 1 January 2006–4 November 2013, country not restricted: USA, UK, Canada (Toronto), and China (Liaoning)Total 25 studies, relevant 11 studies: 8 CS, 2 CSS, 1 ESO3For long-term O3 exposure and CVD morbidity, studies were rare and reports were inconsistent. For CVD mortality, of 10 high-quality studies, 5 reported positive association, and the other 5 reported null or negative association.17%High risk of bias
Scheers et al. 2015General population, till 20 July 2015, country not restricted: Japan, China, UK, the Netherlands, Switzerland, Greece, USA, Canada, Finland, Norway, Sweden, Denmark, Germany, Austria, Italy, Greece, and FranceTotal 20 studies, relevant 20 studies: 14 CS, 6 ESPM10 or PM2.5HR per 10 μg/m3 increase. For PM10, the pooled HRs and 95% CIs were 1.061 (1.018–1.105) for overall stroke events and 1.080 (0.992–1.177) for stroke mortality. For PM2.5, the pooled HRs and 95% CIs were 1.064 (1.021–1.109) for overall stroke events and 1.125 (1.007–1.256) for stroke mortality.50%High risk of bias
Shin et al. 2014Not specified (adults), from 1990, country not restricted: USA and UKTotal 20 studies, relevant 4 studies: 4 CSPM2.5RR per 10 μg/m3 increase. In the frequentist meta-analysis, the pooled RR and 95% CI for long-term exposure to PM2.5 was 1.06 (1.00–1.13) for non-fatal strokes. The Bayesian meta-analysis found a posterior mean 1.08 (0.96–1.26) from a normal prior and 1.05 (1.02–1.10) from a gamma prior.100%High risk of bias
Stieb et al.40General population, till 25 February 2020, country not restricted: Canada, USA, UK, Europe, China (mainland, Hong Kong, and Taipei), Australia, South Korea (Seoul), and Japan (Shizuoka)49 CSNO2Per 10 ppb increase in long-term exposure, the pooled HRs and 95% CIs were 1.139 (0.997–1.301) for CVD mortality, 1.128 (1.076–1.182) for IHD mortality, and 1.167 (0.936–1.456) for CeVD mortality. After excluding studies with probably high or high risk of bias, the pooled HRs and 95% CIs were 1.058 (1.026–1.091) for CVD mortality, 1.111 (1.079–1.144) for IHD mortality, and 1.014 (0.997–1.032) for CeVD mortality.74%Low risk of bias
Wang et al. 2020Older adults aged ≥ 55 years, till January 2020, country not restricted: USA (Steubenville, Eastern Massachusetts, Boston), Germany (Erfurt), Finland (Helsinki), the Netherlands (Amsterdam), UK (Scotland: Aberdeen), and China (Beijing and Taipei)Total 19 studies, relevant 10 studies: 10 LSConcentration of PM2.5Per 10 mg/m3 increase in long-term exposure, the pooled estimates and 95% CIs of HRV were −0.92% (−2.14 to 0.31%) for SDNN, −1.96% (−3.48 to −0.44%) for RMSSD in time-domain measurements, −2.78% (−4.02 to −1.55%) for LF, and −1.61% (−4.02 to 0.80%) for HF in frequency domain measurements.68%High risk of bias
Yang et al. 201941General population, till 25 April 2018, country not restricted: Europe, UK, Canada, USA, South Korea, China, Ghana, India, Mexico, Russia, South Africa, and Japan35 CSPM2.5, PM10, O3, and NO2Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.07–1.15) for CVD events, 1.12 (1.05–1.19) for stroke incidence, 1.12 (1.08–1.16) for stroke events, 1.19 (1.09–1.30) for IHD incidence, and 1.14 (1.08–1.21) for IHD events. The estimates of CVD mortality were 1.11 (1.07–1.15) for PM2.5, 1.09 (1.02–1.16) for PM10, 1.23 (1.15–1.31) for NO2, and 1.03 (1.02–1.05) for O3. The estimates of NO2 and IHD events were 1.05 (1.04–1.06). No significant associations were found between PM10 and CVD, stroke and IHD incidence.87%High risk of bias
Yuan et al. 2019General population, 1980–December 2018, country not restricted: Europe, USA, China (Hong Kong), Ghana, India, Mexico, Russia, South Africa, UK, Sweden (Gothenburg), and Italy16 CSPM2.5Per 5 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.11 (1.05–1.17) for stroke incidence and 1.11 (1.05–1.17) for stroke mortality. In subgroup analysis, the estimates of stroke incidence were 1.09 (1.05–1.14) for North America (5 CS), 1.07 (1.05–1.10) for Europe (4 CS), and 2.31 (0.49–10.95) for Asia (2 CS). The associations were insignificant in both sex and significant in both ischaemic and haemorrhagic stroke. The estimates of stroke incidence were 1.08 (1.03–1.13) for never smokers, 1.11 (1.01–1.22) for former smokers, and 1.08 (0.94–1.25) for current smokers.95%Low risk of bias
Zhao et al. 2017General population, 1990–2016, country not restricted: USA, Israel, Japan, UK, China, Italy, Norway, Greece, Canada, Denmark, France, South Korea, Iran, Germany, Finland, Sweden, Spain, and the NetherlandsTotal 48 studies, relevant 48 studies: 25 CS, 23 LSPM10, PM2.5, SO2, NO2, CO, and O3HR per 10 μg/m3 increase. For CHD mortality, the pooled HRs and 95% CIs were 1.12 (1.04–1.20) for PM10, 1.17 (1.12–1.22) for PM2.5, 1.03 (1.00–1.07) for SO2, 1.04 (1.01–1.06) for NO2, 1.04 (0.98–1.10) for CO, and 1.06 (1.01–1.11) for O3 (10 mg/m3 increase). For CHD incidence, the pooled HRs and 95% CIs were 1.01 (1.00–1.02) for PM10, 1.02 (1.00–1.03) for PM2.5, 1.01 (1.00–1.02) for SO2, 1.04 (1.03–1.06) for NO2, 1.01 (0.97–1.04) for O3, and 1.03 (1.00–1.05) for CO (10 mg/m3 increase).NAHigh risk of bias
Zhao et al. 2021General population, time and country not restricted: China, Norway, UK, the Netherlands, China (Hong Kong), and Canada (Ontario)7 CSPM2.5 acquired through satellite-based model (5 studies) and outdoor-automated monitoring stations (2 studies)Per 1.4–10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs of haemorrhagic stroke were 1.16 (1.03–1.30) for total, 1.41 (0.92–2.15) for current smoker, and 1.04 (0.74–1.46) for never and former smoker.71%Low risk of bias
Zhu et al. 2021General population, till 2 August 2020, country not restricted: Canada, Denmark, the Netherlands, China, USA, South Korea, Israel, and UK (London)12 CSPM2.5Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs were 1.10 (1.02–1.18) for MI incidence and 1.07 (1.04–1.09) for post-MI mortality.75%Unclear
Zou et al.42General population, till September 2019, country not restricted: USA, South Korea, UK, Canada, Sweden, Israel, Italy, the Netherlands, Switzerland, and Finland27 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs of MI were 1.18 (1.11–1.26) for PM2.5 and 1.03 (1.00–1.05) for PM10.91%Unclear
Physical activity environment
Gascon et al. 2016Adults, till 14 November 2014, country not restricted: USA, UK, New Zealand, Lithuania, and CanadaTotal 12 studies, relevant 8 studies; 4 ES, 2 CS, 1 CSSResidential natural outdoor environments, particularly green and blue spacesFor each 10% increase of greenness, the RR and 95% CI was 0.993 (0.985–1.001) for CVD mortality. For high vs. low categories of greenness, the RR and 95% CI was 0.96 (0.94–0.97) for CVD mortality.75%Unclear
Twohig-Bennett et al.43General population, till January 2017, country not restricted: USA, UK, and LithuaniaTotal 143 studies, relevant 4 studies: 3 CS, 1 ESGreenspace measured by residential NVDI, distance to the nearest greenspace, and proportion of city area covered by green landComparing higher to lower greenspace exposure, the pooled ORs and 95% CIs were 0.82 (0.61–1.11) for stroke (3 studies), 0.84 (0.76–0.93) for CVD mortality (2 studies), and 0.92 (0.78–1.07) for CHD (2 studies).86%High risk of bias
Yuan et al. 2020Older adults (mostly ≥ 60 years), 1 January 2000–1 July 2020, country not restricted: Japan, Canada, USA, Finland, China, Rome, Australia, the Netherlands, Lithuania, Brazil, Israel, South Korea, Iran, and UKTotal 22 studies, relevant 17 studies:12 CS, 5 CSSGreenspace measured by NDVI (mostly), percent of greenspace coverage, distance to the nearest green space, park visitation and length of stay, and loss of trees from emerald ash bore diseaseOf 8 studies in total CVD, 7 found beneficial effects of green space, and the other study showed a lower risk of CVD with higher percentage of tree canopy, but not total green space. Evidence for stroke and MI was less consistent.
Only cohort studies measuring NDVI and mortality were included in meta-analysis. Per 0.1 unit increase in NDVI, the pooled HRs and 95% CIs were 0.99 (0.89–1.09) for CVD mortality, 0.96 (0.88–1.05) for IHD mortality, and 0.77 (0.59–1.00) for stroke mortality.
67%Low risk of bias
Urbanization
Angkurawaranon et al.44Southeast Asian populations, till April 2013, SE Asia countries: Brunei Darussalam, Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor Leste, and VietnamTotal 37 studies, relevant 7 studies: 7 CSSUrban exposureFor urban exposure, the pooled ORs and 95% CIs were 1.01 (0.56–1.82) for stroke, 1.19 (0.35–4.07) for non-specific heart disease in the elderly, 2.48 (1.20–5.11) for CHD, and 0.31 (0.13–0.76) for RHD.56%Unclear
Residential noisec
Babisch et al.45Not specified (adults), time and country not restricted: identified countries: UK, the Netherlands, Canada, Denmark, Germany, Sweden, and Japan5 CS, 4 CCS, 5 CSSRoad traffic noise. L Aeq16hr, L Aeq24hr, L DEN, LDay, LNightRelative risk per increase of the traffic noise level of 10 dB. For road traffic noise, the pooled OR and 95% CI was 1.08 (1.04–1.13) for CHD.71%High risk of bias
Banerjee et al. 2014Adult population, 1980–2010, country not restricted: the Netherlands, UK, Germany, Serbia, Sweden, Austria, Italy, Lithuania, Portugal, Switzerland, France, Slovakia, and Hungary14 CSSTransportation noise exposure(No information on unit) For traffic noise (all sources), the pooled RRs and 95% CIs were 1.04 (0.96–1.12) for CVD, 1.01 (0.89–1.14) for MI, 1.08 (0.80–1.36) for AP, and 1.00 (0.73–1.26) for IHD. The estimates for air traffic noise exposure were 1.00 (0.91–1.09) for CVD, 1.04 (0.80–1.28) for AP, 1.02 (0.89–1.14) for MI, and 0.96 (0.80–1.12) for IHD. The pooled RR for road traffic noise was 1.03 (0.97–1.09) for CVD, 1.23 (0.38–2.09) for AP, 0.85 (−0.58 to 2.29) for MI, and 1.35 (0.78–1.92) for IHD.73%High risk of bias
Cai et al. 2021Adults, general population, 1 January 2000–5 October 2020, country not restricted: Denmark (Copenhagen and Aarhus), France (Paris, Lyon, and Toulouse), Switzerland, Sweden (Gothenburg), Spain (Barcelona), the Netherlands, UK (London), and Canada (Vancouver)Total 12 studies, relevant 10 studies: 8 CS, 1 CSS, 2 ESResidential traffic noise from road, rail, and aircraft, measured or modelled: mostly Lden, LAeq24hr, LAeq16hr, LDN, Lday, LnightFor road traffic, per 10 dB increase in Lden, the pooled HRs and 95% CIs were 1.01 (0.98–1.05) for CVD mortality, 1.03 (0.99–1.08) for IHD mortality, and 1.05 (0.97–1.14) for stroke mortality.
For aircraft traffic, the estimates based on three studies were 1.17 (1.10–1.25) for CVD mortality, 1.03 (0.82–1.29) for IHD mortality, and 1.06 (0.93–1.20) for stroke mortality.
For rail traffic, the estimates were 0.98 (0.94–1.01) for CVD mortality (1 study) and 1.02 (0.91–1.14) for IHD mortality (2 studies).
68%Unclear
Dzhambov et al. 2016Adults, till 24 November 2015, country not restricted: the Netherlands, UK, Denmark, Germany, France, Switzerland, USA, Canada, Sweden, Greece, and Italy7 CS, 2 CSS, ES 4Traffic noiseRR per 10 dB noise increase. For road traffic noise, the pooled RR and 95% CI was 1.03 (0.87–1.22). For air traffic noise, the pooled RR was 1.05 (1.00–1.10).72%High risk of bias
Khosravipour et al. 2020General population, time and country not restricted: till 29 November 2019, UK, Germany, Sweden, Lithuania, Denmark, and the Netherlands7 CS, 5 CCS, 1 CSSRoad traffic noiseComparing highest to lowest category of noise exposure (results from categorical analysis), the pooled RR and 95% CI of MI were 1.03 (0.93–1.13). Per 10 dB increment (results from exposure–response analysis and transformed from categorical analysis), the pooled estimate was 1.02 (1.00–1.05). In subgroup analysis, pooled estimates were significant for CCS and CSS, but not for CS. Estimates for the exposure–response analyses were 1.03 (1.00–1.05) after excluding two conference papers and 1.02 (1.01–1.03) after further excluding the studies with only results from categorical analysis.57%Low risk of bias
van Kempen et al. 2002Adults, 1970–1999, country not restricted: Iran, Belgium, Germany, Canada, India, Finland, Italy, the Netherlands, Russia, USA, Poland, Japan, Israel, China, France, South Africa, China (Taiwan), and UK.Total 43 studies, relevant 10 studies: 6 CSS, 2CCS, 2 CSCommunity noise exposure (road and air traffic) assessed by calculations, personal dosimeter, or sound level meterRR per 5 dB(A) noise increase. For road traffic noise, the pooled RRs and 95% CIs were 1.09 (1.05–1.13) for IHD, 0.99 (0.84–1.16) for AP, and 1.03 (0.99–1.09) for MI. For air traffic noise, the pooled RR was 1.03 (0.90–1.18) for AP.25%High risk of bias
van Kempen, et al.46European, 2000–October 2014, European countriesTotal 61 studies, relevant 32 studies: 14 CSS, 5 ES, 8 CS, 5 CCSNoise from road, rail, and air traffic and wind turbines: LDENRoad, rail, and air traffic noise in relation to prevalence, incidence, and mortality of IHD and stroke were analysed, respectively. Number of studies for each analysis is small. Per 10 dB increase in exposure, the pooled RR and 95% CI of IHD was 1.08 (1.01–1.15) for road traffic. Estimates for other associations were of low quality or from <3 studies, and mostly insignificant.NALow risk of bias
Vienneau et al.47Not specified (general population), January 1994–January 2014, country not restricted: Germany, UK, the Netherlands, Sweden, Switzerland, Denmark, Canada, and USA3 CCS, 5 CS, 2 LSTransportation noise exposureRR per 10 dB increase in exposure. The pooled RR and 95% CI for IHD was 1.06 (1.03–1.09).75%High risk of bias
Weihofen et al.48General population, till 31 August 2017, country not restricted: USA, France (Paris, Lyon Saint, and Toulouse), Canada (Vancouver), UK (London), Switzerland, Germany (Berlin and Frankfurt), the Netherlands (Amsterdam), Sweden (Stockholm), Greece (Athens), and Italy (Milan)3 CSS, 1 ES, 4 CS, 1 CCSAircraft noise: LAeq, LDay, LNight, LDN, Lden, LDENAEIPer 10 dB increase in Lden, the pooled RR and 95% CI of stroke was 1.013 (0.998–1.028) from seven studies.71%Low risk of bias
Ambient temperature
Bunker et al.49Elderly (65+), 1 January 1975–24 July 2015, country not restricted: USA, Bangladesh, China (mainland, Taiwan, and Hong Kong), Portugal, UK, Denmark, Australia, Russia, Italy, Hungary, Brazil, Vietnam, Sweden, Thailand, Norway, South Korea, and GermanyTotal 60 studies, relevant 47 studies; 47 LSAmbient hot and cold temperaturePer 1°C temperature change, for heat, the pooled percentage changes and 95% CIs were 3.79 (3.40–4.18) for CVD mortality, 1.62 (0.24–3.03) for IHD mortality, 1.40 (0.06–2.75) for CeVD mortality, 0.33 (−0.09 to 0.75) for IS, −0.66 (−2.13 to 0.84) for ICH, −0.17(−0.96 to 0.63) for CeVD, −0.16(−2.05 to 1.77) for MI, and 0.30(−0.12 to 0.81) for CVD.
For cold, the estimates were 1.84 (0.85–2.84) for CVD mortality, 0.45 (−0.01 to 0.91) for IHD mortality, 1.21 (0.66–1.77) for CeVD mortality, 3.63 (−3.94 to 11.8) for IS, 1.49 (1.04–1.94) for ICH, −0.46 (−1.12 to 0.2) for CeVD, 0.66 (−0.14 to 1.48) for MI, −0.80 (−2.21 to 0.64) for AP, −0.67 (−2.15 to 0.83) for HF, and −0.28 (−1.39 to 0.84) for CVD.
73%High risk of bias
Kofi Amegah et al. 2016Sub-Saharan African populations, till December 2014, Sub-Saharan AfricaTotal 23 studies, relevant 5 studies: 4 LS, 1 CSSTemperatureOne study found that low temperature was associated with increased risk of CVD. Two studies found associations of low and high temperatures with CVD mortality. One study found no association between mean monthly temperature and CVD mortality. One study found 5°C change in the monthly mean temperature to be associated with decreased risk of hospitalization for venous thromboembolism, stroke, and acute MI.56%High risk of bias
Ma et al. 2020Chinese population, January 2010–January 2020, country restricted to ChinaTotal 175 studies, relevant 19 studies: 19 LS(i) Every 1°C temperature increase/decrease beyond certain reference points
(ii) Comparison between extreme temperatures and reference normal temperatures
Pooled RRs and 95% CIs of CVD were 1.089 (1.062–1.116) and 1.171 (1.125–1.218), respectively, for hot and cold temperatures as compared with normal temperatures.100%High risk of bias
Moghadamnia et al.50General population, January 2000–31 December 2015, country not restricted: China (mainland, Taiwan, and Hong Kong), Australia, Thailand, Philippines, South Korea, Germany, and Spain26 LSAmbient temperatureRR per 1°C change of temperature. For CVD mortality, the RRs and 95% CIs were 1.055 (1.050–1.060) for cold exposure and 1.013 (1.011–1.015) for heat exposure. Coefficient per 1°C change in mean annual temperature. For CVD mortality, the pooled estimates were 0.026 (−0.019 to 0.072) for cold exposure and 0.008 (−0.015 to 0.031) for heat exposure.96%High risk of bias
Odame et al. 2018Rural population, till April 2018, country not restricted: Bangladesh (MATLAB), Czech Republic, and China (Naidong and Jiangzi in Tibet)All 14 studies, relevant 3 studies: 3 LSDaily mean temperaturePer 1°C increase, the pooled RR and 95% CI of CVD mortality was 1.111 (1.045–1.181). The associations were significant in subgroup analyses of both developing and developed countries.100%High risk of bias
Turner et al. 2012Not specified (general population), time and country not restricted: South Korea (Incheon), USA, UK (London and Scotland), Europe, Australia (Brisbane), and Thailand (Muang)Total 21 studies, relevant 18 studies: 18 LSEffects of ambient temperature. Maximum, minimum, and mean daily temperatureRR per 1°C increase in temperature. The pooled RRs and 95% CI were 0.999 (0.982–1.016) for CVD morbidities, 0.990 (0.887–1.105) for stroke, and 1.010 (0.930–1.097) for ACS/MI.43%High risk of bias
Wang et al. 2016Adults, till 16 October 2015, country not restricted: Japan, UK, Russia, Spain, China, Portugal, Italy, South Korea, China (Taiwan), Mozambique, USA, France, and Australia7 CS, 13 LS, 1 CSSAmbient temperatureOR per 1°C increase in mean ambient temperature. The pooled ORs and 95% CIs were 0.97 (0.94–1.00) for ICH, 1.00 (0.99–1.01) for IS, and 1.00 (0.98–1.01) for SAH. The pooled estimates for ambient minimum and maximum temperature and IS were OR 0.99 (0.96–1.01) and 0.98 (0.94–1.02), respectively.19%Unclear
Zafeiratou et al. 2021General population, 1990–2020, country not restricted: Serbia (Belgrade), China (Hong Kong), UK (London), USA (New England), Finland (Helsinki), Switzerland, and South KoreaTotal 34 studies, relevant 6 studies: 4 ES, 2 CSMean annual temperature or variability, seasonal temperature or variability, annual temperature categories, and mean annual degrees above/below minimum mortality temperatureIn temporal comparisons within the same area, increased cardiovascular mortality was associated with both increased and decreased temperature. Stronger association was found with cold rather than hot temperature. In geographical comparison in just one study, people living in areas with higher temperature were found a lower rate of IHD mortality, though no dose–response.5 studies on CVD mortality: 60%High risk of bias
Multiple domains
Rugel et al. 2020Urban residents, 1 January 2003–November 2019, country not restricted: the Netherlands, Sweden (Skåne), UK (London), Canada, Denmark (Copenhagen and Aarhus), Germany (Bochum, Essen, and Mülheim/Ruhr), South Korea (Seoul, Ulsan, and Cheonan), France, Spain, Norway, Greece, Italy (Rome and Verona), Switzerland, USA (California), and China (Shenyang, Anshan, Jinzhou, and Taiwan)Total 51 studies, relevant 21 studies: 15 CS, 5 CSS, 1 ESTraffic-related air pollution; natural spaces, neighbourhood walkability; noiseBased on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for assessing the quality of the synthesized evidence base, evidence was sufficient for higher noise exposure with increased CVD. And evidence was sufficient for no association between traffic-related air pollution and CVD.NAHigh risk of bias
First author and year by domainaPopulation, year coverage, and country/regionStudy designExposuresbSummary of resultsPercentage of results in expected directionQuality assessment (ROBIS)
Air pollution
Alexeeff et al.34General population, till 31 December 2019, country not restricted: Europe, Canada, USA, UK, Australia, China, South Korea, and Israel42 CSPM2.5Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs were 1.23 (1.15–1.31) for IHD mortality, 1.08 (0.99–1.18) for incident acute MI, 1.24 (1.13–1.36) for CeVD mortality, and 1.13 (1.11–1.15) for incident stroke.83%High risk of bias
Atkinson et al. 2016General population, till October 2015, country not restricted: USA, UK, China (Taiwan), and FranceTotal 22 studies, relevant 8 studies: 8 CSO3HRs expressed per 10 ppb increase in O3. For long-term annual O3 concentrations, the standardized effect estimates (HRs and 95% CIs) were 1.01 (0.99–1.03) for CVD mortality, 1.02 (1.00–1.04) for IHD mortality, and 1.01 (0.97–1.05) for stroke mortality. For long-term annual O3 concentrations, the random-effects summary estimates (HR and 95% CI) were 0.98 (0.93–1.04) for CVD mortality and 1.00 (0.92–1.09) for IHD mortality. For the warm season/peak O3, random-effects summary estimates were 1.01 (1.00 to 1.02).42%High risk of bias
Atkinson et al.35General population, 1996–October 2016 (Medline, EMBASE), 1970–October 2016 (Web of Science), 1966–October 2016 (PubMed), country not restricted: Europe, North America, China (mainland and Taiwan), and JapanTotal 48 studies, relevant 22 studies: 22 CSNO2 (annual or multi-year averages)Per 10 µg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.03 (1.021.05) for CVD mortality, 1.05 (1.031.06) for CHD mortality, and 1.01 (0.98–1.03) for CeVD mortality.91%High risk of bias
Chen et al. 2008Adults, 1 January 1950–31 December 2007, country not restricted: USA, Norway, France, the Netherlands, Canada, and GermanyTotal 32 studies, relevant 17 studies: 14 CS, 3 CCSO3, SO2, NO/NO2, black smoke, PM10, PM2.5, CO, benzene, and polycyclic aromatic hydrocarbonsRR per 10 µg/m3 increase. For PM2.5, the pooled RRs and 95% CIs were 1.14 (1.091.18) for CVD mortality and 1.16 (0.961.40) for CHD mortality. For other particulate and gaseous pollutants, the paucity of data precludes drawing conclusions.79%High risk of bias
Chen et al. 2020General population, till 9 October 2018, country not restricted: Europe, Canada, UK, USA, Israel, New Zealand, South Korea, Japan, and China (mainland, Taiwan, and Hong Kong)67 CSPM2.5 and PM10Per 10 µg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.091.14) for CVD mortality, 1.16 (1.101.21) for IHD mortality, and 1.11 (1.041.18) for stroke mortality. The estimates of PM10 were 1.04 (0.99–1.10) for CVD mortality, 1.06 (1.011.10) for IHD mortality, and 1.01 (0.83–1.21) for stroke mortality.
The certainty of evidence was high for PM2.5 and CVD mortality and was moderate for PM10 and CVD mortality, as measured by GRADE framework.
81%Low risk of bias
Chen et al.36General population, till October 2019, country not restricted: South Korea, UK, Denmark, Sweden, and CanadaTotal 18 studies, relevant 6 studies: 6 CSPM2.5, PM10, NO2, SO2, O3, and COPer 10 μg/m3 increase in long-term exposure, the pooled HRs, and 95% CIs of AF were 1.116 (1.031–1.207) for PM2.5, 1.034 (1.032–1.035) for PM10, 1.017 (1.001–1.033) for NO2, 1.005 (1.004–1.007) for SO2, 1.017 (1.013–1.022) for CO, and 1.007 (0.927–1.094) for O3.83%Low risk of bias
Faustini et al. 2014General population, January 2004–January 2013, country not restricted: identified countries: Japan, China, Canada, USA, UK, Italy, Germany, Sweden, the Netherlands, and NorwayTotal 23 studies, relevant 17 studies: 2 CCS, 15 CSNO2RR per 10 µg/m3 increase. The pooled RRs and 95% CIs for CVD mortality were 1.13 (1.09–1.18) for NO2 and 1.20 (1.09–1.31) for PM2.5.94%High risk of bias
Hak-Kan et al. 2013Chinese population, till 30 June 2012, 80 major Chinese cities in Mainland China, Hong Kong, and TaiwanTotal 48 studies, relevant 3 studies: 3 CSPM10, NO2, SO2, and O3RR per 10 µg/m3 increase. In one cohort study examining PM10 and NO2, the corresponding RRs and 95% CIs were 1.0155 (1.0151–1.0160) and 1.0246 (1.0231–1.0263) for CVD mortality and 1.0149 (1.0145–1.0153) and 1.0244 (1.0227–1.0262) for CeVD mortality. In another cohort study examining SO2 and CVD, the corresponding RR was 1.032 (1.023–1.040).100%High risk of bias
Hoek et al. 2013Not specified (adults), till January 2013, country not restricted: identified countries: USA, Germany, the Netherlands, Switzerland, Canada, China, New Zealand, Japan, Italy, France, and DenmarkTotal 67 studies, relevant 34 studies: 34 CSLong-term exposure to fine particulate matter (PM2.5, PM10, NO2, elemental carbon, and coarse particles)RR per 10 µg/m3 increase. For PM2.5, the pooled RR and 95% CI was 1.11 (1.05–1.16) for CVD mortality. There was no consistent evidence that long-term exposure to coarse PM or elemental carbon is associated with CVD mortality. Several studies found positive associations between NO2 exposure and fatal MI, but not non-fatal MI. The evidence for an association between air pollution and CeVD mortality was inconsistent.88%High risk of bias
Huang et al. 2021General population, till 2020.02.29, country not restricted: USA, Canada, Norway, the Netherlands, UK, Italy, Denmark, France, Spain, Japan, China, South Korea, Australia, Sweden, Norway, Germany, Austria, Switzerland, France, Italy, Spain, Greece, and Finland32 CSNO2Per 10 ppb increase in annual NO2 concentration, the pooled HR and 95% CI was 1.11 (1.07–1.16) for cardiovascular mortality.71%High risk of bias
Jadambaa et al.37Mongolian population (adults and children), till April 2014, MongoliaTotal 59 studies, relevant 2 studies: 2 CSSNO2 and PM2.5Two studies found an increased risk of CVD with increased exposure to NO2 and PM2.5.100%Unclear
Jaganathan et al.38General population, 1 January 1948–6 March 2018, country restricted to low- and middle-income countries, Mexico (Mexico City), Brazil (São José dos Campos, Cuiabá, and Várzea Grande), China, and India (Varanasi)Total 17 studies, relevant 12 studies: 8 LS, 2 CSS, 1 CCR, 1 CSPM2.5 (annual average or average measure of more than 3 days)Eight out of nine studies (91%) reported significant effects on CVD mortality. Per 10 µg/m3 increase in long-term exposure, the effect estimates of CVD mortality ranged from 0.24 to 6.11%. All four studies reported significant effects of long-term exposure on CVD hospitalization.
Few studies have evaluated this association in LMICs. No studies were found in North and Sub-Saharan Africa.
92%Low risk of bias
Kan et al. 2005General population, 1990–2002, China and worldwideTotal 26 studies, relevant 7 studies: 7 CSEffects of particulate air pollution. PM10 was selected as the indicator particulate matter.RR per 10 µg/m3 increase. For PM10, the pooled RRs and 95% CIs were 1.0095 (1.0060–1.0130) for CHA, 1.013 (1.007–1.019) for CHA based on four European studies, and 1.008 (1.004–1.011) for CHA based on three US and Canadian studies.100%High risk of bias
Karimi et al. 2019Iran population, January 1980–January 2018, country restricted to IranTotal 38 studies, relevant 28 studies: 27 CSS, 1 ESO3, PM2.5, PM10, NO2, NOx, SO2, and CO measured by environmental protection organization and air quality control centrePer 10 µg/m3 increase in all air pollutants, the pooled increased risk (95% CI) in CVD mortality was 0.5% (0.4–0.6%). The estimate for PM2.5 and PM10 was 0.7% (0.4–1%).NAUnclear
Liu et al. 2018General population, adults, January 1974–July 2017, country not restricted: USA, UK, Italy, Canada, China (mainland and Hong Kong), Europe, New Zealand, and Japan16 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of CVD mortality were 1.12 (1.08–1.16) for PM2.5, 1.02 (0.89–1.16) for PM10, and 1.10 (1.06–1.14) for combined. In subgroup analyses, there is no difference in the association stratified by categories of WHO PM levels or smoking status. The estimates of PM2.5 were 1.19 (1.11–1.27) for studies with ≥ 11 years of follow-up, higher than those <11 years: 1.07 (1.04–1.11).88%Low risk of bias
Lu et al. 2015Chinese population (adults only), 1990–2013, Mainland China, Hong Kong, and TaiwanTotal 59 studies, relevant 2 studies: 2 CSPM10 and PM2.5RR per 10 μg/m3 increase. For the annual average concentration of PM10, the RR and 95% CI was 1.23 (1.19–1.26) for CVD mortality in one study and 1.55 (1.51–1.60) for CVD mortality in another study.100%High risk of bias
Luben et al. 2017Adults, till 15 June 2017, country not restricted: USA, China (mainland and Taiwan), the Netherlands, Canada, South Korea, Spain, and ItalyTotal 24 studies, relevant, 3 studies: 2 CS, 1 LSAmbient black carbonThere are generally modest, positive associations of long-term exposure to black carbon and elemental carbon with cardiovascular hospital admissions and mortality.100%High risk of bias
Niu et al. 2021General population, till 1 February 2020, country not restricted: China, Europe, England, Japan (Shizuoka), USA (California), Ghana, India, Mexico, Russia, and South AfricaTotal 68 studies, relevant 13 studies: 13 CSPM2.5, PM10, and NO2Per 10 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs of stroke incidence were 1.081 (0.971–1.023) for PM2.5, 1.033 (0.907–1.175) for PM10, and 1.005 (0.977–1.034) for NO2; the HRs and 95%CI of stroke mortality were 1.047 (0.995–1.101) for NO2.82%High risk of bias
Prueitt et al.39General population, 1 January 2006–4 November 2013, country not restricted: USA, UK, Canada (Toronto), and China (Liaoning)Total 25 studies, relevant 11 studies: 8 CS, 2 CSS, 1 ESO3For long-term O3 exposure and CVD morbidity, studies were rare and reports were inconsistent. For CVD mortality, of 10 high-quality studies, 5 reported positive association, and the other 5 reported null or negative association.17%High risk of bias
Scheers et al. 2015General population, till 20 July 2015, country not restricted: Japan, China, UK, the Netherlands, Switzerland, Greece, USA, Canada, Finland, Norway, Sweden, Denmark, Germany, Austria, Italy, Greece, and FranceTotal 20 studies, relevant 20 studies: 14 CS, 6 ESPM10 or PM2.5HR per 10 μg/m3 increase. For PM10, the pooled HRs and 95% CIs were 1.061 (1.018–1.105) for overall stroke events and 1.080 (0.992–1.177) for stroke mortality. For PM2.5, the pooled HRs and 95% CIs were 1.064 (1.021–1.109) for overall stroke events and 1.125 (1.007–1.256) for stroke mortality.50%High risk of bias
Shin et al. 2014Not specified (adults), from 1990, country not restricted: USA and UKTotal 20 studies, relevant 4 studies: 4 CSPM2.5RR per 10 μg/m3 increase. In the frequentist meta-analysis, the pooled RR and 95% CI for long-term exposure to PM2.5 was 1.06 (1.00–1.13) for non-fatal strokes. The Bayesian meta-analysis found a posterior mean 1.08 (0.96–1.26) from a normal prior and 1.05 (1.02–1.10) from a gamma prior.100%High risk of bias
Stieb et al.40General population, till 25 February 2020, country not restricted: Canada, USA, UK, Europe, China (mainland, Hong Kong, and Taipei), Australia, South Korea (Seoul), and Japan (Shizuoka)49 CSNO2Per 10 ppb increase in long-term exposure, the pooled HRs and 95% CIs were 1.139 (0.997–1.301) for CVD mortality, 1.128 (1.076–1.182) for IHD mortality, and 1.167 (0.936–1.456) for CeVD mortality. After excluding studies with probably high or high risk of bias, the pooled HRs and 95% CIs were 1.058 (1.026–1.091) for CVD mortality, 1.111 (1.079–1.144) for IHD mortality, and 1.014 (0.997–1.032) for CeVD mortality.74%Low risk of bias
Wang et al. 2020Older adults aged ≥ 55 years, till January 2020, country not restricted: USA (Steubenville, Eastern Massachusetts, Boston), Germany (Erfurt), Finland (Helsinki), the Netherlands (Amsterdam), UK (Scotland: Aberdeen), and China (Beijing and Taipei)Total 19 studies, relevant 10 studies: 10 LSConcentration of PM2.5Per 10 mg/m3 increase in long-term exposure, the pooled estimates and 95% CIs of HRV were −0.92% (−2.14 to 0.31%) for SDNN, −1.96% (−3.48 to −0.44%) for RMSSD in time-domain measurements, −2.78% (−4.02 to −1.55%) for LF, and −1.61% (−4.02 to 0.80%) for HF in frequency domain measurements.68%High risk of bias
Yang et al. 201941General population, till 25 April 2018, country not restricted: Europe, UK, Canada, USA, South Korea, China, Ghana, India, Mexico, Russia, South Africa, and Japan35 CSPM2.5, PM10, O3, and NO2Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled RRs and 95% CIs were 1.11 (1.07–1.15) for CVD events, 1.12 (1.05–1.19) for stroke incidence, 1.12 (1.08–1.16) for stroke events, 1.19 (1.09–1.30) for IHD incidence, and 1.14 (1.08–1.21) for IHD events. The estimates of CVD mortality were 1.11 (1.07–1.15) for PM2.5, 1.09 (1.02–1.16) for PM10, 1.23 (1.15–1.31) for NO2, and 1.03 (1.02–1.05) for O3. The estimates of NO2 and IHD events were 1.05 (1.04–1.06). No significant associations were found between PM10 and CVD, stroke and IHD incidence.87%High risk of bias
Yuan et al. 2019General population, 1980–December 2018, country not restricted: Europe, USA, China (Hong Kong), Ghana, India, Mexico, Russia, South Africa, UK, Sweden (Gothenburg), and Italy16 CSPM2.5Per 5 μg/m3 increase in long-term exposure, the pooled HRs and 95% CIs were 1.11 (1.05–1.17) for stroke incidence and 1.11 (1.05–1.17) for stroke mortality. In subgroup analysis, the estimates of stroke incidence were 1.09 (1.05–1.14) for North America (5 CS), 1.07 (1.05–1.10) for Europe (4 CS), and 2.31 (0.49–10.95) for Asia (2 CS). The associations were insignificant in both sex and significant in both ischaemic and haemorrhagic stroke. The estimates of stroke incidence were 1.08 (1.03–1.13) for never smokers, 1.11 (1.01–1.22) for former smokers, and 1.08 (0.94–1.25) for current smokers.95%Low risk of bias
Zhao et al. 2017General population, 1990–2016, country not restricted: USA, Israel, Japan, UK, China, Italy, Norway, Greece, Canada, Denmark, France, South Korea, Iran, Germany, Finland, Sweden, Spain, and the NetherlandsTotal 48 studies, relevant 48 studies: 25 CS, 23 LSPM10, PM2.5, SO2, NO2, CO, and O3HR per 10 μg/m3 increase. For CHD mortality, the pooled HRs and 95% CIs were 1.12 (1.04–1.20) for PM10, 1.17 (1.12–1.22) for PM2.5, 1.03 (1.00–1.07) for SO2, 1.04 (1.01–1.06) for NO2, 1.04 (0.98–1.10) for CO, and 1.06 (1.01–1.11) for O3 (10 mg/m3 increase). For CHD incidence, the pooled HRs and 95% CIs were 1.01 (1.00–1.02) for PM10, 1.02 (1.00–1.03) for PM2.5, 1.01 (1.00–1.02) for SO2, 1.04 (1.03–1.06) for NO2, 1.01 (0.97–1.04) for O3, and 1.03 (1.00–1.05) for CO (10 mg/m3 increase).NAHigh risk of bias
Zhao et al. 2021General population, time and country not restricted: China, Norway, UK, the Netherlands, China (Hong Kong), and Canada (Ontario)7 CSPM2.5 acquired through satellite-based model (5 studies) and outdoor-automated monitoring stations (2 studies)Per 1.4–10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs of haemorrhagic stroke were 1.16 (1.03–1.30) for total, 1.41 (0.92–2.15) for current smoker, and 1.04 (0.74–1.46) for never and former smoker.71%Low risk of bias
Zhu et al. 2021General population, till 2 August 2020, country not restricted: Canada, Denmark, the Netherlands, China, USA, South Korea, Israel, and UK (London)12 CSPM2.5Per 10 μg/m3 increase in long-term PM2.5 exposure, the pooled HRs and 95% CIs were 1.10 (1.02–1.18) for MI incidence and 1.07 (1.04–1.09) for post-MI mortality.75%Unclear
Zou et al.42General population, till September 2019, country not restricted: USA, South Korea, UK, Canada, Sweden, Israel, Italy, the Netherlands, Switzerland, and Finland27 CSPM2.5 and PM10Per 10 μg/m3 increase in long-term exposure, the pooled RRs and 95% CIs of MI were 1.18 (1.11–1.26) for PM2.5 and 1.03 (1.00–1.05) for PM10.91%Unclear
Physical activity environment
Gascon et al. 2016Adults, till 14 November 2014, country not restricted: USA, UK, New Zealand, Lithuania, and CanadaTotal 12 studies, relevant 8 studies; 4 ES, 2 CS, 1 CSSResidential natural outdoor environments, particularly green and blue spacesFor each 10% increase of greenness, the RR and 95% CI was 0.993 (0.985–1.001) for CVD mortality. For high vs. low categories of greenness, the RR and 95% CI was 0.96 (0.94–0.97) for CVD mortality.75%Unclear
Twohig-Bennett et al.43General population, till January 2017, country not restricted: USA, UK, and LithuaniaTotal 143 studies, relevant 4 studies: 3 CS, 1 ESGreenspace measured by residential NVDI, distance to the nearest greenspace, and proportion of city area covered by green landComparing higher to lower greenspace exposure, the pooled ORs and 95% CIs were 0.82 (0.61–1.11) for stroke (3 studies), 0.84 (0.76–0.93) for CVD mortality (2 studies), and 0.92 (0.78–1.07) for CHD (2 studies).86%High risk of bias
Yuan et al. 2020Older adults (mostly ≥ 60 years), 1 January 2000–1 July 2020, country not restricted: Japan, Canada, USA, Finland, China, Rome, Australia, the Netherlands, Lithuania, Brazil, Israel, South Korea, Iran, and UKTotal 22 studies, relevant 17 studies:12 CS, 5 CSSGreenspace measured by NDVI (mostly), percent of greenspace coverage, distance to the nearest green space, park visitation and length of stay, and loss of trees from emerald ash bore diseaseOf 8 studies in total CVD, 7 found beneficial effects of green space, and the other study showed a lower risk of CVD with higher percentage of tree canopy, but not total green space. Evidence for stroke and MI was less consistent.
Only cohort studies measuring NDVI and mortality were included in meta-analysis. Per 0.1 unit increase in NDVI, the pooled HRs and 95% CIs were 0.99 (0.89–1.09) for CVD mortality, 0.96 (0.88–1.05) for IHD mortality, and 0.77 (0.59–1.00) for stroke mortality.
67%Low risk of bias
Urbanization
Angkurawaranon et al.44Southeast Asian populations, till April 2013, SE Asia countries: Brunei Darussalam, Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor Leste, and VietnamTotal 37 studies, relevant 7 studies: 7 CSSUrban exposureFor urban exposure, the pooled ORs and 95% CIs were 1.01 (0.56–1.82) for stroke, 1.19 (0.35–4.07) for non-specific heart disease in the elderly, 2.48 (1.20–5.11) for CHD, and 0.31 (0.13–0.76) for RHD.56%Unclear
Residential noisec
Babisch et al.45Not specified (adults), time and country not restricted: identified countries: UK, the Netherlands, Canada, Denmark, Germany, Sweden, and Japan5 CS, 4 CCS, 5 CSSRoad traffic noise. L Aeq16hr, L Aeq24hr, L DEN, LDay, LNightRelative risk per increase of the traffic noise level of 10 dB. For road traffic noise, the pooled OR and 95% CI was 1.08 (1.04–1.13) for CHD.71%High risk of bias
Banerjee et al. 2014Adult population, 1980–2010, country not restricted: the Netherlands, UK, Germany, Serbia, Sweden, Austria, Italy, Lithuania, Portugal, Switzerland, France, Slovakia, and Hungary14 CSSTransportation noise exposure(No information on unit) For traffic noise (all sources), the pooled RRs and 95% CIs were 1.04 (0.96–1.12) for CVD, 1.01 (0.89–1.14) for MI, 1.08 (0.80–1.36) for AP, and 1.00 (0.73–1.26) for IHD. The estimates for air traffic noise exposure were 1.00 (0.91–1.09) for CVD, 1.04 (0.80–1.28) for AP, 1.02 (0.89–1.14) for MI, and 0.96 (0.80–1.12) for IHD. The pooled RR for road traffic noise was 1.03 (0.97–1.09) for CVD, 1.23 (0.38–2.09) for AP, 0.85 (−0.58 to 2.29) for MI, and 1.35 (0.78–1.92) for IHD.73%High risk of bias
Cai et al. 2021Adults, general population, 1 January 2000–5 October 2020, country not restricted: Denmark (Copenhagen and Aarhus), France (Paris, Lyon, and Toulouse), Switzerland, Sweden (Gothenburg), Spain (Barcelona), the Netherlands, UK (London), and Canada (Vancouver)Total 12 studies, relevant 10 studies: 8 CS, 1 CSS, 2 ESResidential traffic noise from road, rail, and aircraft, measured or modelled: mostly Lden, LAeq24hr, LAeq16hr, LDN, Lday, LnightFor road traffic, per 10 dB increase in Lden, the pooled HRs and 95% CIs were 1.01 (0.98–1.05) for CVD mortality, 1.03 (0.99–1.08) for IHD mortality, and 1.05 (0.97–1.14) for stroke mortality.
For aircraft traffic, the estimates based on three studies were 1.17 (1.10–1.25) for CVD mortality, 1.03 (0.82–1.29) for IHD mortality, and 1.06 (0.93–1.20) for stroke mortality.
For rail traffic, the estimates were 0.98 (0.94–1.01) for CVD mortality (1 study) and 1.02 (0.91–1.14) for IHD mortality (2 studies).
68%Unclear
Dzhambov et al. 2016Adults, till 24 November 2015, country not restricted: the Netherlands, UK, Denmark, Germany, France, Switzerland, USA, Canada, Sweden, Greece, and Italy7 CS, 2 CSS, ES 4Traffic noiseRR per 10 dB noise increase. For road traffic noise, the pooled RR and 95% CI was 1.03 (0.87–1.22). For air traffic noise, the pooled RR was 1.05 (1.00–1.10).72%High risk of bias
Khosravipour et al. 2020General population, time and country not restricted: till 29 November 2019, UK, Germany, Sweden, Lithuania, Denmark, and the Netherlands7 CS, 5 CCS, 1 CSSRoad traffic noiseComparing highest to lowest category of noise exposure (results from categorical analysis), the pooled RR and 95% CI of MI were 1.03 (0.93–1.13). Per 10 dB increment (results from exposure–response analysis and transformed from categorical analysis), the pooled estimate was 1.02 (1.00–1.05). In subgroup analysis, pooled estimates were significant for CCS and CSS, but not for CS. Estimates for the exposure–response analyses were 1.03 (1.00–1.05) after excluding two conference papers and 1.02 (1.01–1.03) after further excluding the studies with only results from categorical analysis.57%Low risk of bias
van Kempen et al. 2002Adults, 1970–1999, country not restricted: Iran, Belgium, Germany, Canada, India, Finland, Italy, the Netherlands, Russia, USA, Poland, Japan, Israel, China, France, South Africa, China (Taiwan), and UK.Total 43 studies, relevant 10 studies: 6 CSS, 2CCS, 2 CSCommunity noise exposure (road and air traffic) assessed by calculations, personal dosimeter, or sound level meterRR per 5 dB(A) noise increase. For road traffic noise, the pooled RRs and 95% CIs were 1.09 (1.05–1.13) for IHD, 0.99 (0.84–1.16) for AP, and 1.03 (0.99–1.09) for MI. For air traffic noise, the pooled RR was 1.03 (0.90–1.18) for AP.25%High risk of bias
van Kempen, et al.46European, 2000–October 2014, European countriesTotal 61 studies, relevant 32 studies: 14 CSS, 5 ES, 8 CS, 5 CCSNoise from road, rail, and air traffic and wind turbines: LDENRoad, rail, and air traffic noise in relation to prevalence, incidence, and mortality of IHD and stroke were analysed, respectively. Number of studies for each analysis is small. Per 10 dB increase in exposure, the pooled RR and 95% CI of IHD was 1.08 (1.01–1.15) for road traffic. Estimates for other associations were of low quality or from <3 studies, and mostly insignificant.NALow risk of bias
Vienneau et al.47Not specified (general population), January 1994–January 2014, country not restricted: Germany, UK, the Netherlands, Sweden, Switzerland, Denmark, Canada, and USA3 CCS, 5 CS, 2 LSTransportation noise exposureRR per 10 dB increase in exposure. The pooled RR and 95% CI for IHD was 1.06 (1.03–1.09).75%High risk of bias
Weihofen et al.48General population, till 31 August 2017, country not restricted: USA, France (Paris, Lyon Saint, and Toulouse), Canada (Vancouver), UK (London), Switzerland, Germany (Berlin and Frankfurt), the Netherlands (Amsterdam), Sweden (Stockholm), Greece (Athens), and Italy (Milan)3 CSS, 1 ES, 4 CS, 1 CCSAircraft noise: LAeq, LDay, LNight, LDN, Lden, LDENAEIPer 10 dB increase in Lden, the pooled RR and 95% CI of stroke was 1.013 (0.998–1.028) from seven studies.71%Low risk of bias
Ambient temperature
Bunker et al.49Elderly (65+), 1 January 1975–24 July 2015, country not restricted: USA, Bangladesh, China (mainland, Taiwan, and Hong Kong), Portugal, UK, Denmark, Australia, Russia, Italy, Hungary, Brazil, Vietnam, Sweden, Thailand, Norway, South Korea, and GermanyTotal 60 studies, relevant 47 studies; 47 LSAmbient hot and cold temperaturePer 1°C temperature change, for heat, the pooled percentage changes and 95% CIs were 3.79 (3.40–4.18) for CVD mortality, 1.62 (0.24–3.03) for IHD mortality, 1.40 (0.06–2.75) for CeVD mortality, 0.33 (−0.09 to 0.75) for IS, −0.66 (−2.13 to 0.84) for ICH, −0.17(−0.96 to 0.63) for CeVD, −0.16(−2.05 to 1.77) for MI, and 0.30(−0.12 to 0.81) for CVD.
For cold, the estimates were 1.84 (0.85–2.84) for CVD mortality, 0.45 (−0.01 to 0.91) for IHD mortality, 1.21 (0.66–1.77) for CeVD mortality, 3.63 (−3.94 to 11.8) for IS, 1.49 (1.04–1.94) for ICH, −0.46 (−1.12 to 0.2) for CeVD, 0.66 (−0.14 to 1.48) for MI, −0.80 (−2.21 to 0.64) for AP, −0.67 (−2.15 to 0.83) for HF, and −0.28 (−1.39 to 0.84) for CVD.
73%High risk of bias
Kofi Amegah et al. 2016Sub-Saharan African populations, till December 2014, Sub-Saharan AfricaTotal 23 studies, relevant 5 studies: 4 LS, 1 CSSTemperatureOne study found that low temperature was associated with increased risk of CVD. Two studies found associations of low and high temperatures with CVD mortality. One study found no association between mean monthly temperature and CVD mortality. One study found 5°C change in the monthly mean temperature to be associated with decreased risk of hospitalization for venous thromboembolism, stroke, and acute MI.56%High risk of bias
Ma et al. 2020Chinese population, January 2010–January 2020, country restricted to ChinaTotal 175 studies, relevant 19 studies: 19 LS(i) Every 1°C temperature increase/decrease beyond certain reference points
(ii) Comparison between extreme temperatures and reference normal temperatures
Pooled RRs and 95% CIs of CVD were 1.089 (1.062–1.116) and 1.171 (1.125–1.218), respectively, for hot and cold temperatures as compared with normal temperatures.100%High risk of bias
Moghadamnia et al.50General population, January 2000–31 December 2015, country not restricted: China (mainland, Taiwan, and Hong Kong), Australia, Thailand, Philippines, South Korea, Germany, and Spain26 LSAmbient temperatureRR per 1°C change of temperature. For CVD mortality, the RRs and 95% CIs were 1.055 (1.050–1.060) for cold exposure and 1.013 (1.011–1.015) for heat exposure. Coefficient per 1°C change in mean annual temperature. For CVD mortality, the pooled estimates were 0.026 (−0.019 to 0.072) for cold exposure and 0.008 (−0.015 to 0.031) for heat exposure.96%High risk of bias
Odame et al. 2018Rural population, till April 2018, country not restricted: Bangladesh (MATLAB), Czech Republic, and China (Naidong and Jiangzi in Tibet)All 14 studies, relevant 3 studies: 3 LSDaily mean temperaturePer 1°C increase, the pooled RR and 95% CI of CVD mortality was 1.111 (1.045–1.181). The associations were significant in subgroup analyses of both developing and developed countries.100%High risk of bias
Turner et al. 2012Not specified (general population), time and country not restricted: South Korea (Incheon), USA, UK (London and Scotland), Europe, Australia (Brisbane), and Thailand (Muang)Total 21 studies, relevant 18 studies: 18 LSEffects of ambient temperature. Maximum, minimum, and mean daily temperatureRR per 1°C increase in temperature. The pooled RRs and 95% CI were 0.999 (0.982–1.016) for CVD morbidities, 0.990 (0.887–1.105) for stroke, and 1.010 (0.930–1.097) for ACS/MI.43%High risk of bias
Wang et al. 2016Adults, till 16 October 2015, country not restricted: Japan, UK, Russia, Spain, China, Portugal, Italy, South Korea, China (Taiwan), Mozambique, USA, France, and Australia7 CS, 13 LS, 1 CSSAmbient temperatureOR per 1°C increase in mean ambient temperature. The pooled ORs and 95% CIs were 0.97 (0.94–1.00) for ICH, 1.00 (0.99–1.01) for IS, and 1.00 (0.98–1.01) for SAH. The pooled estimates for ambient minimum and maximum temperature and IS were OR 0.99 (0.96–1.01) and 0.98 (0.94–1.02), respectively.19%Unclear
Zafeiratou et al. 2021General population, 1990–2020, country not restricted: Serbia (Belgrade), China (Hong Kong), UK (London), USA (New England), Finland (Helsinki), Switzerland, and South KoreaTotal 34 studies, relevant 6 studies: 4 ES, 2 CSMean annual temperature or variability, seasonal temperature or variability, annual temperature categories, and mean annual degrees above/below minimum mortality temperatureIn temporal comparisons within the same area, increased cardiovascular mortality was associated with both increased and decreased temperature. Stronger association was found with cold rather than hot temperature. In geographical comparison in just one study, people living in areas with higher temperature were found a lower rate of IHD mortality, though no dose–response.5 studies on CVD mortality: 60%High risk of bias
Multiple domains
Rugel et al. 2020Urban residents, 1 January 2003–November 2019, country not restricted: the Netherlands, Sweden (Skåne), UK (London), Canada, Denmark (Copenhagen and Aarhus), Germany (Bochum, Essen, and Mülheim/Ruhr), South Korea (Seoul, Ulsan, and Cheonan), France, Spain, Norway, Greece, Italy (Rome and Verona), Switzerland, USA (California), and China (Shenyang, Anshan, Jinzhou, and Taiwan)Total 51 studies, relevant 21 studies: 15 CS, 5 CSS, 1 ESTraffic-related air pollution; natural spaces, neighbourhood walkability; noiseBased on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for assessing the quality of the synthesized evidence base, evidence was sufficient for higher noise exposure with increased CVD. And evidence was sufficient for no association between traffic-related air pollution and CVD.NAHigh risk of bias

ES, ecological studies; CS, cohort studies; CSS, cross-sectional studies; CCS, case-control studies; CCR, case-crossover studies; SAS, small-area studies; longitudinal study, LS (e.g. panel study and time-series); RR, relative risk; HR, hazard ratio; MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH, intracerebral haemorrhage; IS, ischaemic stroke; SAH, subarachnoid haemorrhage; HF, heart failure. The significant pooled results are in bold.

A bibliography of all included reviews is presented in Supplementary material online, Appendix S3.

There were no systematic reviews found in the domains of food environment and light pollution.

LAeq16hr, annual non-weighted 16 h average noise level during the day; LAeq24hr, the annual non-weighted day–night average noise level; LDEN, the annual weighted (day + 0 dB, evening + 5 dB, and night + 10 dB) day–evening–night average noise level; LAeq, A-weighted average of an energy-equivalent continuous sound level over a period of time (A-weighting: in noise research, typically, the A filter is used which adjusts for deep and high frequencies, as these are perceived as less loud); LDay, LAeq for the day (usually 7:00 a.m.–7:00 p.m.) for all day periods of a year; LNight, LAeq for the night (usually from 11:00 p.m. to 7:00 a.m.) for all night periods of a year; LDN, all 24 h LAeq periods of a year with additional 10 dB for nighttime noise annoyance (usually from 11:00 p.m. to 7:00 a.m.); LDENAEI, see LDEN, but in addition, weighted average exposure on municipal level.

Thirty-three reviews studied the domain of air pollution, 4 studied physical activity environment, 1 studied urbanization, 10 studied residential noise, and 8 studied ambient temperature. There were no systematic reviews found in the domains of food environment and light pollution. Most reviews (n = 46) conducted one or multiple meta-analyses. Seven reviews only conducted narrative syntheses of the primary studies. In total, the meta-analyses summarized 180 pooled estimates of the association between specific built environmental factors and CVD events. The CCA-score for each domain was below 1, indicating only limited overlap of primary studies (see supplementary material online, Appendix S4).

Domain-specific results

Air pollution

Overall, long-term increased air pollution was associated with a higher risk of CVD events, based on a total of 105 meta-analyses. Among them, three reviews contained pooled results classified as strong evidence.34,36,41 Four air pollutants were associated with a higher risk of CVD events (Table 2). Chen et al.36 found that both a 10 μg/m3 higher ambient SO2 (HR, 1.005; 95% CI, 1.004–1.007) and CO concentration (HR, 1.017; 95% CI, 1.013–1.022) were associated with an increased incidence of AF. Furthermore, Yang et al.41 found that a 10 μg/m3 higher ambient NO2 concentration was associated with an increased risk of ischaemic heart disease (IHD) events (RR, 1.05; 95% CI, 1.04–1.06). Alexeeff et al.34 found that a 10 μg/m3 higher PM2.5 concentration was associated with an increased risk of incident stroke (RR, 1.13; 95% CI, 1.11–1.15). Among these three reviews that provide strong evidence, Chen et al. and Yang et al. had a low risk of bias, while Alexeeff et al. had a high risk of bias for study eligibility criteria, identification, and selection (Table 2).

Table 2

Robustness of evidence assessment and ROBIS quality assessment per review by domaina

Strong evidence by domainbRobustness of evidenceROBIS quality assessment (comments)
Level of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95%CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalStudy eligibility criteriaIdentification and selection of studiesData collection, appraisalSynthesis and findingsOverall
Air pollution
Chen et al.36RR per 10 μg/m3 increase in SO2 for AF1.005 (1.004–1.007); < 0.000001>1000; 2 studies1.005 (1.003–1.006)0.0%NA0.531.004–1.007Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Chen et al.36RR per 10 μg/m3 increase in CO for AF1.017 (1.013–1.022); < 0.000001>1000; 2 studies1.017 (1.013–1.022)0.0%NA0.531.013–1.022Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Alexeeff et al.34RR per 10 μg/m3 increase in PM2.5 for incident stroke1.13 (1.11–1.15); < 0.000001>1000; 14 studies1.12 (1.08–1.16)0.0%0.460.521.11–1.15High riskHigh riskHigh riskLow riskHigh risk
Yang et al. 201941RR per 10 μg/m3 increase in NO2 for IHD events (incidence and mortality)1.05 (1.04–1.06); < 0.000001>1000; 4 studies1.05 (1.03–1.06)0.0%0.680.271.04–1.07Low riskUnclear riskUnclear riskHigh riskHigh risk
Residential noise
Cai et al. 2021HR per 10 dB increase in aircraft traffic noise (Lden) for CVD mortality1.17 (1.10–1.25); < 0.000001>1000; 3 studies1.18 (1.10–1.26)0.0%0.820.771.10–1.25Low riskHigh risk (search strategy is simple and no MeSH terms used; language restricted to English; no information for two independent screeners)Unclear riskHigh riskUnclear risk
Strong evidence by domainbRobustness of evidenceROBIS quality assessment (comments)
Level of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95%CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalStudy eligibility criteriaIdentification and selection of studiesData collection, appraisalSynthesis and findingsOverall
Air pollution
Chen et al.36RR per 10 μg/m3 increase in SO2 for AF1.005 (1.004–1.007); < 0.000001>1000; 2 studies1.005 (1.003–1.006)0.0%NA0.531.004–1.007Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Chen et al.36RR per 10 μg/m3 increase in CO for AF1.017 (1.013–1.022); < 0.000001>1000; 2 studies1.017 (1.013–1.022)0.0%NA0.531.013–1.022Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Alexeeff et al.34RR per 10 μg/m3 increase in PM2.5 for incident stroke1.13 (1.11–1.15); < 0.000001>1000; 14 studies1.12 (1.08–1.16)0.0%0.460.521.11–1.15High riskHigh riskHigh riskLow riskHigh risk
Yang et al. 201941RR per 10 μg/m3 increase in NO2 for IHD events (incidence and mortality)1.05 (1.04–1.06); < 0.000001>1000; 4 studies1.05 (1.03–1.06)0.0%0.680.271.04–1.07Low riskUnclear riskUnclear riskHigh riskHigh risk
Residential noise
Cai et al. 2021HR per 10 dB increase in aircraft traffic noise (Lden) for CVD mortality1.17 (1.10–1.25); < 0.000001>1000; 3 studies1.18 (1.10–1.26)0.0%0.820.771.10–1.25Low riskHigh risk (search strategy is simple and no MeSH terms used; language restricted to English; no information for two independent screeners)Unclear riskHigh riskUnclear risk

RR, relative risk; HR, hazard ratio; MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH, intracerebral haemorrhage; IS, ischaemic stroke; SAH, subarachnoid haemorrhage; HF, heart failure.

Here, only results of strong evidence are presented. For complete assessment, please refer to Supplementary material online, Appendix S4.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

Table 2

Robustness of evidence assessment and ROBIS quality assessment per review by domaina

Strong evidence by domainbRobustness of evidenceROBIS quality assessment (comments)
Level of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95%CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalStudy eligibility criteriaIdentification and selection of studiesData collection, appraisalSynthesis and findingsOverall
Air pollution
Chen et al.36RR per 10 μg/m3 increase in SO2 for AF1.005 (1.004–1.007); < 0.000001>1000; 2 studies1.005 (1.003–1.006)0.0%NA0.531.004–1.007Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Chen et al.36RR per 10 μg/m3 increase in CO for AF1.017 (1.013–1.022); < 0.000001>1000; 2 studies1.017 (1.013–1.022)0.0%NA0.531.013–1.022Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Alexeeff et al.34RR per 10 μg/m3 increase in PM2.5 for incident stroke1.13 (1.11–1.15); < 0.000001>1000; 14 studies1.12 (1.08–1.16)0.0%0.460.521.11–1.15High riskHigh riskHigh riskLow riskHigh risk
Yang et al. 201941RR per 10 μg/m3 increase in NO2 for IHD events (incidence and mortality)1.05 (1.04–1.06); < 0.000001>1000; 4 studies1.05 (1.03–1.06)0.0%0.680.271.04–1.07Low riskUnclear riskUnclear riskHigh riskHigh risk
Residential noise
Cai et al. 2021HR per 10 dB increase in aircraft traffic noise (Lden) for CVD mortality1.17 (1.10–1.25); < 0.000001>1000; 3 studies1.18 (1.10–1.26)0.0%0.820.771.10–1.25Low riskHigh risk (search strategy is simple and no MeSH terms used; language restricted to English; no information for two independent screeners)Unclear riskHigh riskUnclear risk
Strong evidence by domainbRobustness of evidenceROBIS quality assessment (comments)
Level of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95%CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalStudy eligibility criteriaIdentification and selection of studiesData collection, appraisalSynthesis and findingsOverall
Air pollution
Chen et al.36RR per 10 μg/m3 increase in SO2 for AF1.005 (1.004–1.007); < 0.000001>1000; 2 studies1.005 (1.003–1.006)0.0%NA0.531.004–1.007Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Chen et al.36RR per 10 μg/m3 increase in CO for AF1.017 (1.013–1.022); < 0.000001>1000; 2 studies1.017 (1.013–1.022)0.0%NA0.531.013–1.022Low riskHigh risk (no additional methods to database search)Low riskLow riskLow risk
Alexeeff et al.34RR per 10 μg/m3 increase in PM2.5 for incident stroke1.13 (1.11–1.15); < 0.000001>1000; 14 studies1.12 (1.08–1.16)0.0%0.460.521.11–1.15High riskHigh riskHigh riskLow riskHigh risk
Yang et al. 201941RR per 10 μg/m3 increase in NO2 for IHD events (incidence and mortality)1.05 (1.04–1.06); < 0.000001>1000; 4 studies1.05 (1.03–1.06)0.0%0.680.271.04–1.07Low riskUnclear riskUnclear riskHigh riskHigh risk
Residential noise
Cai et al. 2021HR per 10 dB increase in aircraft traffic noise (Lden) for CVD mortality1.17 (1.10–1.25); < 0.000001>1000; 3 studies1.18 (1.10–1.26)0.0%0.820.771.10–1.25Low riskHigh risk (search strategy is simple and no MeSH terms used; language restricted to English; no information for two independent screeners)Unclear riskHigh riskUnclear risk

RR, relative risk; HR, hazard ratio; MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH, intracerebral haemorrhage; IS, ischaemic stroke; SAH, subarachnoid haemorrhage; HF, heart failure.

Here, only results of strong evidence are presented. For complete assessment, please refer to Supplementary material online, Appendix S4.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

Thirteen specific pooled results were supported by highly suggestive evidence (Table 3). Associations were found between a higher ambient PM2.5 concentration and higher risk of myocardial infarction (MI), IHD mortality, cerebrovascular disease (CeVD) mortality, CVD mortality, and stroke events. Associations were also found between a higher ambient PM10 concentration and higher risk of AF and for NO2 with CVD, ICH, and CHD mortalities. All evidence was limited by small-study effects, excess significance bias, or high heterogeneity. Only the studies by Alexeeff et al.34 and Zou et al.42 had a high risk of bias. Furthermore, 32 pooled estimates were found to be non-significant (Table 3); most of these included a small number of studies (i.e. 2–4 studies).

Table 3

Summary of evidence based on robustness and qualitya

Robustness of evidence by domainbSpecific exposure and outcome
Air pollution (positive association)
Strong (n = 4)PM2.5 and stroke (c,dAlexeeff et al.34), SO2 and AF (2 studies, Chen et al.36), CO and AF (2 studies, Chen et al.36), NO2 and IHD events (4 studies, Yang et al.41)
Highly suggestive (n = 13)PM2.5 for MI (d,eZou et al. 2021), IHD mortality (c,d,f,gAlexeeff et al.34) (gChen et al. 2020), CeVD mortality (c,d,gAlexeeff et al.34), CVD mortality (eYang et al.41) (e,f,gLiu et al. 2018) (g, Chen et al. 2020), CVD events (eYang et al.41), stroke events (eYang et al.41)
PM10 and AF (4 studies, e,fChen et al.36)
NO2 for CVD mortality (gHuang et al. 2021), ICH mortality (gStieb et al. 202140), CHD mortality (Atkinson et al. 201835)
Non-significant (n = 32)PM2.5 for CHD mortality (d,gChen et al. 2008), MI (c,d,gAlexeeff et al.34), CVD (gYang et al.41), HRV (c,dWang et al. 2020)
PM10 for stroke (gYang et al.41), stroke mortality (gYang et al.41) (gChen et al. 2020), stroke events (gYang et al.41), IHD (2 studies, Yang et al.41), IHD mortality (4 studies, gYang et al.41), IHD events (6 studies, gYang et al.41), CVD (3 studies, gYang et al. 201941), CVD mortality (e,f,gLiu et al. 2018) (gChen et al. 2020), CVD events (e,gYang et al.41)
NO2 for stroke (4 studies, Yang et al.41), stroke mortality (2 studies, Yang et al.41), stroke events (6 studies, Yang et al.41), CVD (2 studies, Yang et al.41), CeVD mortality (13 studies, Stieb et al.40) (dAtkinson et al.35)
O3 for AF (3 studies; Chen et al.36), stroke (2 studies, gYang et al.41), stroke mortality (3 studies, Yang et al.41) (dAtkinson et al. 2016), stroke events (5 studies, gYang et al.41), CVD mortality (d,eAtkinson et al. 2016), CVD events (e,gYang et al.41), IHD mortality (d,eAtkinson et al. 2016)
Physical activity environment (negative association)
Suggestive (n = 2)Greenspace and CVD mortality (dGascon et al. 2016) (2 studies, Twohig-Bennett et al.43)
Non-significant (n = 6)Greenspace and CVD mortality (gYuan et al. 2020) (dGascon et al. 2016), IHD mortality (3 studies, Yuan et al. 2020), stroke mortality (4 studies, e,gYuan et al. 2020), stroke (eTwohig-Bennett et al.43), CHD (2 studies, Twohig-Bennett et al. 201843)
Urbanization (insufficient and mixed evidence)
Weak (n = 2)Positive association: Urban exposure and CHD (c,eAngkurawaranona et al. 2014), Negative association: Urban exposure and RHD (cAngkurawaranona et al. 2014)
Non-significant (n = 2)Urban exposure for stroke (cAngkurawaranona et al. 2014), non-specific heart disease (c,f,gAngkurawaranona et al. 2014)
Residential noise (positive association)
Strong (n = 1)Aircraft traffic noise and CVD mortality (c,dCai et al. 2021)
Suggestive (n = 2)Road traffic noise and CHD (c,aBabisch et al.45), Traffic noise for IHD (c,dVienneau et al.47)
Non-significant (n = 17)Traffic noise and CVD (dBanerjee et al. 2014)
Road traffic noise and MI (dBanerjee et al. 2014) (dKhosravipour et al. 2020), stroke (d,gDzhambov et al. 2016), AP (dBanerjee et al. 2014), CVD mortality (dCai et al. 2021), IHD mortality (dCai et al. 2021), stroke mortality (d,eCai et al. 2021)
Aircraft traffic noise and MI (dBanerjee et al. 2014), AP (dBanerjee et al. 2014), IHD (d,eBanerjee et al. 2014), stroke (dDzhambov et al. 2016) (7 studies, Weihofen et al.48), IHD mortality (d,gCai et al. 2021), stroke mortality (dCai et al. 2021)
Rail traffic noise and IHD mortality (d,gCai et al. 2021)
Ambient temperature (positive association)
Suggestive (n = 8)Temperature and CVD mortality (dOdame et al. 2018)
Heat and CVD mortality (d,e,gBunker et al.49) (d,e,f,gMoghadamnia et al.50), combined CVD mortality (d,e,gBunker et al.49)
Cold and CVD mortality (d,e,f,gMoghadamnia et al.50), CeVD mortality (dBunker et al.49), ICH morbidity (dBunker et al.49), combined CVD mortality (d,e,gBunker et al.49)
Non-significant (n = 22)Temperature and CVD (c,d,gTurner et al. 2012), stroke (c,d,gTurner et al. 2012), ACS/MI (c,d,gTurner et al. 2012), IS (c,gWang et al. 2016), SAH (cWang et al. 2016)
Heat and IS (c,gWang et al. 2016) (d,e,f,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), CVD (d,e,f,gBunker et al.49), MI (d,e,gBunker et al.49), ICH mortality (d,gBunker et al.49), combined CVD (d,f,gBunker et al.49)
Cold and CVD (d,eBunker et al.49), combined CVD (d,gBunker et al.49), AP (d,gBunker et al.49), HF (d,gBunker et al.49), IHD mortality (d,gBunker et al.49), MI (d,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), combined CeVD (d,f,gBunker et al.49), IS (c,gWang et al. 2016) (d,gBunker et al.49)
Robustness of evidence by domainbSpecific exposure and outcome
Air pollution (positive association)
Strong (n = 4)PM2.5 and stroke (c,dAlexeeff et al.34), SO2 and AF (2 studies, Chen et al.36), CO and AF (2 studies, Chen et al.36), NO2 and IHD events (4 studies, Yang et al.41)
Highly suggestive (n = 13)PM2.5 for MI (d,eZou et al. 2021), IHD mortality (c,d,f,gAlexeeff et al.34) (gChen et al. 2020), CeVD mortality (c,d,gAlexeeff et al.34), CVD mortality (eYang et al.41) (e,f,gLiu et al. 2018) (g, Chen et al. 2020), CVD events (eYang et al.41), stroke events (eYang et al.41)
PM10 and AF (4 studies, e,fChen et al.36)
NO2 for CVD mortality (gHuang et al. 2021), ICH mortality (gStieb et al. 202140), CHD mortality (Atkinson et al. 201835)
Non-significant (n = 32)PM2.5 for CHD mortality (d,gChen et al. 2008), MI (c,d,gAlexeeff et al.34), CVD (gYang et al.41), HRV (c,dWang et al. 2020)
PM10 for stroke (gYang et al.41), stroke mortality (gYang et al.41) (gChen et al. 2020), stroke events (gYang et al.41), IHD (2 studies, Yang et al.41), IHD mortality (4 studies, gYang et al.41), IHD events (6 studies, gYang et al.41), CVD (3 studies, gYang et al. 201941), CVD mortality (e,f,gLiu et al. 2018) (gChen et al. 2020), CVD events (e,gYang et al.41)
NO2 for stroke (4 studies, Yang et al.41), stroke mortality (2 studies, Yang et al.41), stroke events (6 studies, Yang et al.41), CVD (2 studies, Yang et al.41), CeVD mortality (13 studies, Stieb et al.40) (dAtkinson et al.35)
O3 for AF (3 studies; Chen et al.36), stroke (2 studies, gYang et al.41), stroke mortality (3 studies, Yang et al.41) (dAtkinson et al. 2016), stroke events (5 studies, gYang et al.41), CVD mortality (d,eAtkinson et al. 2016), CVD events (e,gYang et al.41), IHD mortality (d,eAtkinson et al. 2016)
Physical activity environment (negative association)
Suggestive (n = 2)Greenspace and CVD mortality (dGascon et al. 2016) (2 studies, Twohig-Bennett et al.43)
Non-significant (n = 6)Greenspace and CVD mortality (gYuan et al. 2020) (dGascon et al. 2016), IHD mortality (3 studies, Yuan et al. 2020), stroke mortality (4 studies, e,gYuan et al. 2020), stroke (eTwohig-Bennett et al.43), CHD (2 studies, Twohig-Bennett et al. 201843)
Urbanization (insufficient and mixed evidence)
Weak (n = 2)Positive association: Urban exposure and CHD (c,eAngkurawaranona et al. 2014), Negative association: Urban exposure and RHD (cAngkurawaranona et al. 2014)
Non-significant (n = 2)Urban exposure for stroke (cAngkurawaranona et al. 2014), non-specific heart disease (c,f,gAngkurawaranona et al. 2014)
Residential noise (positive association)
Strong (n = 1)Aircraft traffic noise and CVD mortality (c,dCai et al. 2021)
Suggestive (n = 2)Road traffic noise and CHD (c,aBabisch et al.45), Traffic noise for IHD (c,dVienneau et al.47)
Non-significant (n = 17)Traffic noise and CVD (dBanerjee et al. 2014)
Road traffic noise and MI (dBanerjee et al. 2014) (dKhosravipour et al. 2020), stroke (d,gDzhambov et al. 2016), AP (dBanerjee et al. 2014), CVD mortality (dCai et al. 2021), IHD mortality (dCai et al. 2021), stroke mortality (d,eCai et al. 2021)
Aircraft traffic noise and MI (dBanerjee et al. 2014), AP (dBanerjee et al. 2014), IHD (d,eBanerjee et al. 2014), stroke (dDzhambov et al. 2016) (7 studies, Weihofen et al.48), IHD mortality (d,gCai et al. 2021), stroke mortality (dCai et al. 2021)
Rail traffic noise and IHD mortality (d,gCai et al. 2021)
Ambient temperature (positive association)
Suggestive (n = 8)Temperature and CVD mortality (dOdame et al. 2018)
Heat and CVD mortality (d,e,gBunker et al.49) (d,e,f,gMoghadamnia et al.50), combined CVD mortality (d,e,gBunker et al.49)
Cold and CVD mortality (d,e,f,gMoghadamnia et al.50), CeVD mortality (dBunker et al.49), ICH morbidity (dBunker et al.49), combined CVD mortality (d,e,gBunker et al.49)
Non-significant (n = 22)Temperature and CVD (c,d,gTurner et al. 2012), stroke (c,d,gTurner et al. 2012), ACS/MI (c,d,gTurner et al. 2012), IS (c,gWang et al. 2016), SAH (cWang et al. 2016)
Heat and IS (c,gWang et al. 2016) (d,e,f,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), CVD (d,e,f,gBunker et al.49), MI (d,e,gBunker et al.49), ICH mortality (d,gBunker et al.49), combined CVD (d,f,gBunker et al.49)
Cold and CVD (d,eBunker et al.49), combined CVD (d,gBunker et al.49), AP (d,gBunker et al.49), HF (d,gBunker et al.49), IHD mortality (d,gBunker et al.49), MI (d,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), combined CeVD (d,f,gBunker et al.49), IS (c,gWang et al. 2016) (d,gBunker et al.49)

MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH: intracerebral haemorrhage; IS: ischaemic stroke; SAH; subarachnoid haemorrhage; HF: heart failure.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

There were 17 suggestive, 16 weak, and 23 unclear associations in the domain of air pollution; 10 unclear associations in residential noise; and 6 weak and 1 unclear associations in ambient temperature. For complete summary, please refer to Supplementary material online, Appendix S5, and Table S1.

High risk or unclear risk in study eligibility criteria.

High risk or unclear risk in identification and selection.

Small-study effect.

Excess significance bias.

High heterogeneity.

Table 3

Summary of evidence based on robustness and qualitya

Robustness of evidence by domainbSpecific exposure and outcome
Air pollution (positive association)
Strong (n = 4)PM2.5 and stroke (c,dAlexeeff et al.34), SO2 and AF (2 studies, Chen et al.36), CO and AF (2 studies, Chen et al.36), NO2 and IHD events (4 studies, Yang et al.41)
Highly suggestive (n = 13)PM2.5 for MI (d,eZou et al. 2021), IHD mortality (c,d,f,gAlexeeff et al.34) (gChen et al. 2020), CeVD mortality (c,d,gAlexeeff et al.34), CVD mortality (eYang et al.41) (e,f,gLiu et al. 2018) (g, Chen et al. 2020), CVD events (eYang et al.41), stroke events (eYang et al.41)
PM10 and AF (4 studies, e,fChen et al.36)
NO2 for CVD mortality (gHuang et al. 2021), ICH mortality (gStieb et al. 202140), CHD mortality (Atkinson et al. 201835)
Non-significant (n = 32)PM2.5 for CHD mortality (d,gChen et al. 2008), MI (c,d,gAlexeeff et al.34), CVD (gYang et al.41), HRV (c,dWang et al. 2020)
PM10 for stroke (gYang et al.41), stroke mortality (gYang et al.41) (gChen et al. 2020), stroke events (gYang et al.41), IHD (2 studies, Yang et al.41), IHD mortality (4 studies, gYang et al.41), IHD events (6 studies, gYang et al.41), CVD (3 studies, gYang et al. 201941), CVD mortality (e,f,gLiu et al. 2018) (gChen et al. 2020), CVD events (e,gYang et al.41)
NO2 for stroke (4 studies, Yang et al.41), stroke mortality (2 studies, Yang et al.41), stroke events (6 studies, Yang et al.41), CVD (2 studies, Yang et al.41), CeVD mortality (13 studies, Stieb et al.40) (dAtkinson et al.35)
O3 for AF (3 studies; Chen et al.36), stroke (2 studies, gYang et al.41), stroke mortality (3 studies, Yang et al.41) (dAtkinson et al. 2016), stroke events (5 studies, gYang et al.41), CVD mortality (d,eAtkinson et al. 2016), CVD events (e,gYang et al.41), IHD mortality (d,eAtkinson et al. 2016)
Physical activity environment (negative association)
Suggestive (n = 2)Greenspace and CVD mortality (dGascon et al. 2016) (2 studies, Twohig-Bennett et al.43)
Non-significant (n = 6)Greenspace and CVD mortality (gYuan et al. 2020) (dGascon et al. 2016), IHD mortality (3 studies, Yuan et al. 2020), stroke mortality (4 studies, e,gYuan et al. 2020), stroke (eTwohig-Bennett et al.43), CHD (2 studies, Twohig-Bennett et al. 201843)
Urbanization (insufficient and mixed evidence)
Weak (n = 2)Positive association: Urban exposure and CHD (c,eAngkurawaranona et al. 2014), Negative association: Urban exposure and RHD (cAngkurawaranona et al. 2014)
Non-significant (n = 2)Urban exposure for stroke (cAngkurawaranona et al. 2014), non-specific heart disease (c,f,gAngkurawaranona et al. 2014)
Residential noise (positive association)
Strong (n = 1)Aircraft traffic noise and CVD mortality (c,dCai et al. 2021)
Suggestive (n = 2)Road traffic noise and CHD (c,aBabisch et al.45), Traffic noise for IHD (c,dVienneau et al.47)
Non-significant (n = 17)Traffic noise and CVD (dBanerjee et al. 2014)
Road traffic noise and MI (dBanerjee et al. 2014) (dKhosravipour et al. 2020), stroke (d,gDzhambov et al. 2016), AP (dBanerjee et al. 2014), CVD mortality (dCai et al. 2021), IHD mortality (dCai et al. 2021), stroke mortality (d,eCai et al. 2021)
Aircraft traffic noise and MI (dBanerjee et al. 2014), AP (dBanerjee et al. 2014), IHD (d,eBanerjee et al. 2014), stroke (dDzhambov et al. 2016) (7 studies, Weihofen et al.48), IHD mortality (d,gCai et al. 2021), stroke mortality (dCai et al. 2021)
Rail traffic noise and IHD mortality (d,gCai et al. 2021)
Ambient temperature (positive association)
Suggestive (n = 8)Temperature and CVD mortality (dOdame et al. 2018)
Heat and CVD mortality (d,e,gBunker et al.49) (d,e,f,gMoghadamnia et al.50), combined CVD mortality (d,e,gBunker et al.49)
Cold and CVD mortality (d,e,f,gMoghadamnia et al.50), CeVD mortality (dBunker et al.49), ICH morbidity (dBunker et al.49), combined CVD mortality (d,e,gBunker et al.49)
Non-significant (n = 22)Temperature and CVD (c,d,gTurner et al. 2012), stroke (c,d,gTurner et al. 2012), ACS/MI (c,d,gTurner et al. 2012), IS (c,gWang et al. 2016), SAH (cWang et al. 2016)
Heat and IS (c,gWang et al. 2016) (d,e,f,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), CVD (d,e,f,gBunker et al.49), MI (d,e,gBunker et al.49), ICH mortality (d,gBunker et al.49), combined CVD (d,f,gBunker et al.49)
Cold and CVD (d,eBunker et al.49), combined CVD (d,gBunker et al.49), AP (d,gBunker et al.49), HF (d,gBunker et al.49), IHD mortality (d,gBunker et al.49), MI (d,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), combined CeVD (d,f,gBunker et al.49), IS (c,gWang et al. 2016) (d,gBunker et al.49)
Robustness of evidence by domainbSpecific exposure and outcome
Air pollution (positive association)
Strong (n = 4)PM2.5 and stroke (c,dAlexeeff et al.34), SO2 and AF (2 studies, Chen et al.36), CO and AF (2 studies, Chen et al.36), NO2 and IHD events (4 studies, Yang et al.41)
Highly suggestive (n = 13)PM2.5 for MI (d,eZou et al. 2021), IHD mortality (c,d,f,gAlexeeff et al.34) (gChen et al. 2020), CeVD mortality (c,d,gAlexeeff et al.34), CVD mortality (eYang et al.41) (e,f,gLiu et al. 2018) (g, Chen et al. 2020), CVD events (eYang et al.41), stroke events (eYang et al.41)
PM10 and AF (4 studies, e,fChen et al.36)
NO2 for CVD mortality (gHuang et al. 2021), ICH mortality (gStieb et al. 202140), CHD mortality (Atkinson et al. 201835)
Non-significant (n = 32)PM2.5 for CHD mortality (d,gChen et al. 2008), MI (c,d,gAlexeeff et al.34), CVD (gYang et al.41), HRV (c,dWang et al. 2020)
PM10 for stroke (gYang et al.41), stroke mortality (gYang et al.41) (gChen et al. 2020), stroke events (gYang et al.41), IHD (2 studies, Yang et al.41), IHD mortality (4 studies, gYang et al.41), IHD events (6 studies, gYang et al.41), CVD (3 studies, gYang et al. 201941), CVD mortality (e,f,gLiu et al. 2018) (gChen et al. 2020), CVD events (e,gYang et al.41)
NO2 for stroke (4 studies, Yang et al.41), stroke mortality (2 studies, Yang et al.41), stroke events (6 studies, Yang et al.41), CVD (2 studies, Yang et al.41), CeVD mortality (13 studies, Stieb et al.40) (dAtkinson et al.35)
O3 for AF (3 studies; Chen et al.36), stroke (2 studies, gYang et al.41), stroke mortality (3 studies, Yang et al.41) (dAtkinson et al. 2016), stroke events (5 studies, gYang et al.41), CVD mortality (d,eAtkinson et al. 2016), CVD events (e,gYang et al.41), IHD mortality (d,eAtkinson et al. 2016)
Physical activity environment (negative association)
Suggestive (n = 2)Greenspace and CVD mortality (dGascon et al. 2016) (2 studies, Twohig-Bennett et al.43)
Non-significant (n = 6)Greenspace and CVD mortality (gYuan et al. 2020) (dGascon et al. 2016), IHD mortality (3 studies, Yuan et al. 2020), stroke mortality (4 studies, e,gYuan et al. 2020), stroke (eTwohig-Bennett et al.43), CHD (2 studies, Twohig-Bennett et al. 201843)
Urbanization (insufficient and mixed evidence)
Weak (n = 2)Positive association: Urban exposure and CHD (c,eAngkurawaranona et al. 2014), Negative association: Urban exposure and RHD (cAngkurawaranona et al. 2014)
Non-significant (n = 2)Urban exposure for stroke (cAngkurawaranona et al. 2014), non-specific heart disease (c,f,gAngkurawaranona et al. 2014)
Residential noise (positive association)
Strong (n = 1)Aircraft traffic noise and CVD mortality (c,dCai et al. 2021)
Suggestive (n = 2)Road traffic noise and CHD (c,aBabisch et al.45), Traffic noise for IHD (c,dVienneau et al.47)
Non-significant (n = 17)Traffic noise and CVD (dBanerjee et al. 2014)
Road traffic noise and MI (dBanerjee et al. 2014) (dKhosravipour et al. 2020), stroke (d,gDzhambov et al. 2016), AP (dBanerjee et al. 2014), CVD mortality (dCai et al. 2021), IHD mortality (dCai et al. 2021), stroke mortality (d,eCai et al. 2021)
Aircraft traffic noise and MI (dBanerjee et al. 2014), AP (dBanerjee et al. 2014), IHD (d,eBanerjee et al. 2014), stroke (dDzhambov et al. 2016) (7 studies, Weihofen et al.48), IHD mortality (d,gCai et al. 2021), stroke mortality (dCai et al. 2021)
Rail traffic noise and IHD mortality (d,gCai et al. 2021)
Ambient temperature (positive association)
Suggestive (n = 8)Temperature and CVD mortality (dOdame et al. 2018)
Heat and CVD mortality (d,e,gBunker et al.49) (d,e,f,gMoghadamnia et al.50), combined CVD mortality (d,e,gBunker et al.49)
Cold and CVD mortality (d,e,f,gMoghadamnia et al.50), CeVD mortality (dBunker et al.49), ICH morbidity (dBunker et al.49), combined CVD mortality (d,e,gBunker et al.49)
Non-significant (n = 22)Temperature and CVD (c,d,gTurner et al. 2012), stroke (c,d,gTurner et al. 2012), ACS/MI (c,d,gTurner et al. 2012), IS (c,gWang et al. 2016), SAH (cWang et al. 2016)
Heat and IS (c,gWang et al. 2016) (d,e,f,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), CVD (d,e,f,gBunker et al.49), MI (d,e,gBunker et al.49), ICH mortality (d,gBunker et al.49), combined CVD (d,f,gBunker et al.49)
Cold and CVD (d,eBunker et al.49), combined CVD (d,gBunker et al.49), AP (d,gBunker et al.49), HF (d,gBunker et al.49), IHD mortality (d,gBunker et al.49), MI (d,gBunker et al.49), CeVD (d,e,f,gBunker et al.49), combined CeVD (d,f,gBunker et al.49), IS (c,gWang et al. 2016) (d,gBunker et al.49)

MI, myocardial infarction; AP, angina pectoris; CHA, cardiovascular hospital admission; ACS, acute coronary syndrome; CVD, cardiovascular disease; CHD, coronary heart disease; AF, atrial fibrillation; IHD, ischaemic heart disease; CeVD, cerebrovascular disease; RHD, rheumatic heart disease; HRV, heart rate variability; SDNN, the standard deviation of NN intervals; RMSSD, root mean square of successive RR interval differences; LF, low-frequency bands; HF, high-frequency bands; RE, risk estimate; events include both morbidity and mortality; ICH: intracerebral haemorrhage; IS: ischaemic stroke; SAH; subarachnoid haemorrhage; HF: heart failure.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

There were 17 suggestive, 16 weak, and 23 unclear associations in the domain of air pollution; 10 unclear associations in residential noise; and 6 weak and 1 unclear associations in ambient temperature. For complete summary, please refer to Supplementary material online, Appendix S5, and Table S1.

High risk or unclear risk in study eligibility criteria.

High risk or unclear risk in identification and selection.

Small-study effect.

Excess significance bias.

High heterogeneity.

We identified three specific exposure and outcome analyses suitable for meta-meta-analyses (studies presented in bold in Table 3). Firstly, a meta-meta-analysis of 29 unique primary studies from Alexeeff et al. and Chen et al.34,51 showed that a 10 µg/m3 increase in PM2.5 was associated with increased IHD mortality (RR, 1.21; 95% CI, 1.10–1.33; I2, 98.16%) (Figure 2) with a large degree of heterogeneity across studies (high I2-statistic and larger 95% PI than the 95% CI) (Table 4). As a sensitivity analysis, we conducted the meta-meta-analysis excluding studies that did not adjust for smoking, which decreased the degree of heterogeneity, but did not affect the results (Table 4 and see Supplementary material online, Figure S1). Secondly, a meta-meta-analysis of 26 unique primary studies from Yang et al. and Chen et al.41,51 showed that each 10 µg/m3 increase in PM2.5 was associated with increased CVD mortality (RR, 1.11; 95% CI, 1.09–1.14; I2, 74.23%) (Figure 3) with a large degree of heterogeneity across these 26 studies (Table 4). Excluding studies that did not adjust for any lifestyle behaviour did not result in any substantial change in effect estimates (Table 4 and see Supplementary material online, Figure S2). Lastly, a meta-meta-analysis of 14 unique primary studies from Stieb et al. and Atkinson et al.35,40 showed a non-significant association of NO2 with CeVD mortality (HR, 1.03; 95% CI, 1.00–1.06; I2, 45.64%) (Figure 4). There was no evident small-study effect or excess significance bias in these three meta-analyses.

Meta-meta-analysis of the relative risk of ischaemic heart disease mortality per 10 µg/m3 in long-term fine particulate matter <2.5 μm in diameter exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.
Figure 2

Meta-meta-analysis of the relative risk of ischaemic heart disease mortality per 10 µg/m3 in long-term fine particulate matter <2.5 μm in diameter exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.

Meta-meta-analysis of the relative risk of cardiovascular disease mortality per 10 µg/m3 in long-term fine particulate matter <2.5 μm in diameter exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.
Figure 3

Meta-meta-analysis of the relative risk of cardiovascular disease mortality per 10 µg/m3 in long-term fine particulate matter <2.5 μm in diameter exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.

Meta-meta-analysis of the hazard ratio of cerebrovascular disease mortality per 10 parts per billion increase in NO2 exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.
Figure 4

Meta-meta-analysis of the hazard ratio of cerebrovascular disease mortality per 10 parts per billion increase in NO2 exposure. A bibliography of included studies is presented in supplementary material online, Appendix S3.

Table 4

Meta-meta-analyses and robustness of evidence assessment by domain

Included reviewsaLevel of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95% CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalRobustness of evidence
Air pollution
Alexeeff et al.34
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for IHD mortality1.21 (1.10–1.33); < 0.0001>1000; 29 studies1.64 (1.62–1.66)98.16%0.360.210.7852–1.8617Highly suggestive
Yang et al.41
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for CVD mortality1.11 (1.09–1.14); < 0.0001>1000; 26 studies1.06 (1.04–1.08)74.23%0.080.371.0303–1.1959Highly suggestive
Stieb et al.40
Atkinson et al.35
HR per 10 ppb increase in NO2 for CeVD mortality1.03 (1.00–1.06); 0.07>1000; 14 studies1.01 (0.98–1.05)45.64%0.090.410.9581–1.1044Non-significant
Ambient temperature
Bunker et al.49
Moghadamnia et al.50
RR per 1°C change of temperature (heat) for CVD mortality1.04 (1.03–1.04); < 0.0001>1000; 62 studies1.013 (1.010–1.015)98.63%< 0.0001< 0.011.0225–1.0538Highly suggestive
Included reviewsaLevel of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95% CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalRobustness of evidence
Air pollution
Alexeeff et al.34
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for IHD mortality1.21 (1.10–1.33); < 0.0001>1000; 29 studies1.64 (1.62–1.66)98.16%0.360.210.7852–1.8617Highly suggestive
Yang et al.41
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for CVD mortality1.11 (1.09–1.14); < 0.0001>1000; 26 studies1.06 (1.04–1.08)74.23%0.080.371.0303–1.1959Highly suggestive
Stieb et al.40
Atkinson et al.35
HR per 10 ppb increase in NO2 for CeVD mortality1.03 (1.00–1.06); 0.07>1000; 14 studies1.01 (0.98–1.05)45.64%0.090.410.9581–1.1044Non-significant
Ambient temperature
Bunker et al.49
Moghadamnia et al.50
RR per 1°C change of temperature (heat) for CVD mortality1.04 (1.03–1.04); < 0.0001>1000; 62 studies1.013 (1.010–1.015)98.63%< 0.0001< 0.011.0225–1.0538Highly suggestive

RR, relative risk; HR, hazard ratio; CVD, cardiovascular disease; IHD, ischaemic heart disease; CeVD, cerebrovascular disease.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

Table 4

Meta-meta-analyses and robustness of evidence assessment by domain

Included reviewsaLevel of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95% CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalRobustness of evidence
Air pollution
Alexeeff et al.34
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for IHD mortality1.21 (1.10–1.33); < 0.0001>1000; 29 studies1.64 (1.62–1.66)98.16%0.360.210.7852–1.8617Highly suggestive
Yang et al.41
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for CVD mortality1.11 (1.09–1.14); < 0.0001>1000; 26 studies1.06 (1.04–1.08)74.23%0.080.371.0303–1.1959Highly suggestive
Stieb et al.40
Atkinson et al.35
HR per 10 ppb increase in NO2 for CeVD mortality1.03 (1.00–1.06); 0.07>1000; 14 studies1.01 (0.98–1.05)45.64%0.090.410.9581–1.1044Non-significant
Ambient temperature
Bunker et al.49
Moghadamnia et al.50
RR per 1°C change of temperature (heat) for CVD mortality1.04 (1.03–1.04); < 0.0001>1000; 62 studies1.013 (1.010–1.015)98.63%< 0.0001< 0.011.0225–1.0538Highly suggestive
Included reviewsaLevel of comparisonRandom-effects summary ES (95% CI); P valueSample size; N of included studiesES (95% CI) in the largest studyI2 (%)Egger’s test P valueExcess statistical significance test P value95% prediction intervalRobustness of evidence
Air pollution
Alexeeff et al.34
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for IHD mortality1.21 (1.10–1.33); < 0.0001>1000; 29 studies1.64 (1.62–1.66)98.16%0.360.210.7852–1.8617Highly suggestive
Yang et al.41
Chen et al. 2020
RR per 10 µg/m3 increase in PM2.5 for CVD mortality1.11 (1.09–1.14); < 0.0001>1000; 26 studies1.06 (1.04–1.08)74.23%0.080.371.0303–1.1959Highly suggestive
Stieb et al.40
Atkinson et al.35
HR per 10 ppb increase in NO2 for CeVD mortality1.03 (1.00–1.06); 0.07>1000; 14 studies1.01 (0.98–1.05)45.64%0.090.410.9581–1.1044Non-significant
Ambient temperature
Bunker et al.49
Moghadamnia et al.50
RR per 1°C change of temperature (heat) for CVD mortality1.04 (1.03–1.04); < 0.0001>1000; 62 studies1.013 (1.010–1.015)98.63%< 0.0001< 0.011.0225–1.0538Highly suggestive

RR, relative risk; HR, hazard ratio; CVD, cardiovascular disease; IHD, ischaemic heart disease; CeVD, cerebrovascular disease.

A bibliography of the abovementioned reviews is presented in Supplementary material online, Appendix S3.

Five narrative reviews were found on air pollution with consistent results to other reviews (Table 1).37–39,52,53

Physical activity environment

Three reviews studied associations in the physical activity environment domain including eight meta-analyses. All reviews in this domain studied greenspace exposure. Two associations related to greenspace were supported by suggestive evidence (Table 3). Gascon et al. found an inverse association for 10% higher greenspace exposure and CVD mortality; however, their review was at high risk of bias for study identification.54 Six pooled estimates were not statistically significant. Among these, Yuan et al.55 reviewed the association between greenspace and IHD mortality and Twohig-Bennett et al.43 reviewed the association between greenspace and IHD incidence with no obvious risk of bias, though they comprised a small number of studies (i.e. 2–3 studies).

Urbanization

One review was identified in the urbanization domain.44 Angkurawaranon et al. reviewed studies focusing on Southeast Asian populations and included four meta-analyses. Two associations were supported by weak evidence. One pooled estimate showed that urban exposure was associated with higher odds of CHD (OR, 2.48; 95% CI, 1.20–5.11), while the other showed lower odds of rheumatic heart disease (RHD) (OR, 0.31; 95% CI, 0.13–0.76). The other two pooled estimates for stroke and non-specific heart disease were non-significant. The eligibility criteria were not clearly reported in this review, resulting in an unclear risk of bias (Table 3).

Residential noise

In the residential noise domain, 9 reviews were identified, including 30 meta-analyses (Table 3). Cai et al. found strong evidence of an association between 10 dB higher aircraft traffic noise and increased CVD mortality (HR, 1.17; 95% CI, 1.10–1.25), though this review had a high risk of bias in study eligibility criteria, identification, and selection.56 Two associations were supported by suggestive evidence. Babisch et al.45 found an association between 10 dB higher road traffic noise exposure and higher risk of CHD. Vienneau et al.47 found a similar association between traffic noise exposure and higher risk of IHD. Seventeen pooled estimates were non-significant. Among these, Weihofen et al.48 reviewed seven studies and found a marginal association between 10 dB higher aircraft traffic noise exposure and higher risk of stroke (RR, 1.013; 95% CI, 0.998–1.028). This review did not suffer from obvious risks of bias, heterogeneity, small-study effect, or excess significance bias.

One systematic review covered multiple domains: air pollution, greenspace, walkability, and noise. Using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, Rugel et al. found sufficient evidence of an association between increased noise and higher risk of CVD.57

Ambient temperature

In the ambient temperature domain, eight reviews were included. These reviews included 37 meta-analyses (Table 3). Associations between both higher and lower temperature in relation to higher risk of CVD were supported by suggestive evidence (3 reviews), 6 associations were supported by weak evidence, and 22 pooled estimates were non-significant. All results suffered from a high risk of bias. Two narrative reviews were found in this domain with inconsistent results.

In this domain, we identified one specific exposure and outcome analysis that was suitable for a meta-meta-analysis. Bunker et al.49 and Moghadamnia et al.50 meta-analysed the RR of CVD mortality per 1°C change in temperature. The meta-meta-analysis of 62 unique primary studies showed a significant association between increasing temperature and CVD mortality (RR, 1.04; 95% CI, 1.03–1.04; I2, 98.63%) (Figure 5). Both a small-study effect and excess significance bias were evident in this analysis. As sensitivity analyses, we conducted the meta-meta-analysis excluding studies that did not adjust for any confounders (see Supplementary material online, Appendix S7, and Figure S3), did not adjust for air pollution (see Supplementary material online, Appendix S7, and Figure S4), and adjusted only for air pollution (see Supplementary material online, Appendix S7, and Figure S5). These analyses did not substantially change the results of the main analyses.

Meta-meta-analysis of the relative risk of cardiovascular disease mortality per 1°C change of temperature (heat). A bibliography of included studies is presented in supplementary material online, Appendix S3.
Figure 5

Meta-meta-analysis of the relative risk of cardiovascular disease mortality per 1°C change of temperature (heat). A bibliography of included studies is presented in supplementary material online, Appendix S3.

Discussion

Principal findings

Our umbrella review found strong evidence of an association between increased air pollution, including increased ambient PM2.5, SO2, CO, and NO2 exposure, and CVD outcomes. There was also consistent evidence of associations between increased noise levels and CVD outcomes, including strong evidence for air traffic noise and CVD mortality. An association between increased ambient temperature and CVD mortality was supported by highly suggestive evidence. Review evidence in other domains including physical activity environment, food environment, light pollution, and urbanization in relation to CVD are scarce or lacking. However, the limited available evidence is suggestive of a protective effect of greenspace exposure in terms of CVD mortality.

Strengths and limitations

To the best of our knowledge, this is the first umbrella review to comprehensively summarize the relationship between aspects of the built environment and CVD. Following a pre-specified protocol, we conducted a wide-ranging search across seven databases. The included reviews underwent extensive critical appraisal using a validated risk of bias assessment method. Both methodological quality and statistical evidence were evaluated to determine the robustness of evidence. Finally, meta-meta-analyses were performed where possible to combine all available quantitative evidence.

To contextualize the findings, certain limitations of our umbrella review need to be addressed. Firstly, the search strategy was limited to reviews published in the English language. Therefore, we may have omitted key studies published in other languages. Secondly, we included systematic reviews published between 1 January 2000 and 16 April 2021. The most recently published evidence has not yet been taken up in systematic reviews and is, therefore, not included here. Lastly, many included reviews (and studies to date) report on cross-sectional analyses, which inhibits identification of causality.

Evidence in relation to other studies

Our results were generally consistent with the World Health Organization (WHO) 2021 global air quality guidelines, as well as earlier umbrella reviews investigating air pollution and CVD outcomes.58–62 Positive associations are consistently found for a variety of pollutants, as well as CVD outcomes. However, the association between PM2.5 and CVD was the most widely investigated. NO2 exposure was, thus far, not encompassed in the scope of the WHO guidelines because of the absence of clear quantitative evidence. Our results contribute strong evidence of an association between higher NO2 exposure and a higher risk of IHD and highly suggestive evidence of an association between higher NO2 exposure and a higher risk of CVD mortality. While earlier work demonstrated strong evidence of a positive association between PM2.5 and stroke only in Europe,62 our results show that this holds true when non-European countries are included.

This umbrella review indicates that studies of greenspace were heterogeneous in design and exposure assessment, which partly explains the limited combined evidence of an association between greenspace exposure and CVD. For example, greenspace assessment methods included the Normalized Different Vegetation Index (NDVI), percentage of greenspace coverage, and distance to the nearest greenspace. While the first two may be good indicators of the amount of greenspace in certain areas, they do not reflect access to those greenspaces. For distance to the nearest greenspace, the opposite may be true. Therefore, studies of greenspace using different assessment methods are not directly comparable.63,64 This same issue of limited combined evidence may also hold for other domains like physical activity, food environment, light pollution, and urbanization, although our results did not provide information to support this.

Our findings about traffic noise and CVD events are in line with those from two WHO reports.46,65 The WHO Environmental Noise Guidelines for the European Region (2015) included a systematic review (included in the current review).46 According to an adapted GRADE assessment, high-quality evidence was found on road traffic noise and IHD, and moderate-quality evidence was found for aircraft noise and stroke mortality, and for road traffic noise, IHD mortality, and stroke events. Our study updated the evidence base with strong evidence of an association between air traffic noise and CVD mortality. Furthermore, we observed that the existing evidence on rail traffic noise is still limited.

The 2019 Global Burden of Disease study estimated that global age-standardized CVD disability-adjusted life years (DALYs) attributable to high temperature was 25.59 per 100 000 people.66 The heat-related disease burden was the highest for stroke and was greater in regions with a lower socio-demographic index (SDI). However, the observational evidence on specific outcomes and regional differences, as reported in the current review, was insufficient. The effect estimate found in the current meta-meta-analysis might be small (Figure 5), but increasing temperature has a potentially large and increasing population reach.

Mutual confounding and interaction

Many aspects of the built environment may be interconnected, potentially leading to confounding and/or interaction effects. However, most existing reviews and meta-analyses focus on single (sub)domains of exposure. We only found one systematic review that covered multiple domains. This study observed sufficient evidence of an association between higher noise exposure and increased CVD morbidity, after adjusting for traffic-related air pollution.57 A meta-analysis by Vienneau et al.47 observed an association between higher noise levels and increased IHD which remained robust after including studies that adjusted for air pollution exposure. Despite the substantial amount of studies on the effects of air pollution and temperature on CVD, there is limited research available on their mutual confounding or interaction effects. One systematic review found that long-term air pollution exposure and colder temperatures are independently associated with an increased risk of CVD.67 Additionally, another US cohort study found that the association between higher PM2.5 and CVD was stronger in areas with higher green space, lower O3 levels, and lower temperatures.68 Furthermore, as a proxy for context, urbanization may also have significant confounding or interaction effects with various aspects of the built environment. For example, a Dutch cohort study indicated associations between fast-food restaurant density and CVD in urban areas but not in rural areas.69

Possible mechanisms and explanations

Several potential mechanisms have been theorized that may explain the associations found in this study. Exposure to air pollutants may promote systemic inflammation and oxidative stress in the lungs, which eventually increases systemic inflammation and oxidative stress.17 As a result, a variety of pathological processes could take place that eventually lead to CVD, such as increased thrombosis, hypercoagulability, endothelial dysfunction, atherosclerosis progression, insulin resistance, and dyslipidaemia.16,17 Pollutants can also induce oxidative stress and inflammation in the central nervous system, especially in the hypothalamus, leading to an imbalance in the cardiac autonomic nervous system.17 Moreover, smaller size pollutants can directly enter the circulation and damage the cardiovascular system and organs.17 These mechanisms are better understood for PM exposure than for other pollutants. Carbon monoxide typically hampers oxygenation of tissues via carboxyhaemoglobin production, which has a more significant influence on the myocardium than peripheral tissues.70 These mechanisms may explain the more evident associations found for AF. Atrial fibrillation is an early CVD endpoint that can lead to other CVD outcomes in the long term. For residential noise exposure, both direct and indirect pathways have been theorized.18 The direct pathway is induced by the instant interaction between the acoustic nerve and the central nervous system. The indirect pathway relates to cognitive perception and subsequent cortical activation and emotional response. Both pathways can cause physiological stress responses, and, in the long term, pathophysiologic alterations and CVD. The adverse effect of residential noise has been reported independent of sleep quality and self-reported noise sensitivity. But noise can indeed disturb sleep and subsequently cause reduced immune function and a pro-inflammatory state.21 Changes in temperature can cause typical physiological responses that might lead to MI, including tachycardia and increased blood viscosity.19 Both cold and heat exposure may increase sympathetic activation, which could lead to high blood pressure.19 Lastly, it is hypothesized that greenspace improves air quality. By reducing the concentration of air pollutants, greenspace may reduce the impact of air pollution on CVD.63 Additionally, greenspaces may facilitate physical activity, thereby promoting cardiovascular health.63

Gaps in current knowledge and suggestions for future research

Future primary studies should investigate the effects of PM10, SO2, CO, NO, and PM0.1, especially long-term exposure. As we observed evidence of early-onset CVD (e.g. AF), more studies of other CVD outcomes that occur later (e.g. IHD) are warranted. Research is needed on light pollution. Despite there being multiple primary studies on the food environment, they differ in definition of food environment and vary with regard to buffer size. As such, these studies cannot be meta-analysed. Standard design and exposure assessments should be developed and implemented to foster synthesis of evidence. More studies are also needed for residential noise and ambient temperature, especially from low-to-middle-income countries (LMICs). Future primary studies should preferably use prospective study designs in the domains of physical activity environment, urbanization, and residential noise to increase causal inference power. Furthermore, primary studies on interactions or interrelationships of built environmental aspects in relation to CVD are also warranted.

As for systematic reviews, future work should provide evidence on O3 that is of higher quality. Review evidence on the physical activity environment, food environment, and urbanization was limited. There are primary studies on these domains, but future reviews to harmonize research data (e.g. in terms of the heterogeneity in the definition and measurement of exposures) and synthesize evidence are required. For example, in terms of greenspace, accessibility and composition may be crucial to determining its effects.71 Furthermore, more high-quality review evidence is needed on residential noise and ambient temperature, especially for LMICs. It is highly recommended that future systematic reviews on the built environment adhere to the PRISMA reporting guidelines and pre-register a protocol in a dedicated registry such as PROSPERO to guarantee transparency, prevent overlap in topics, and promote methodological quality. Furthermore, the use of quality assessment should become common practice, using standardized, validated tools, as recommended by sources such as PRISMA and Cochrane.72,73 We also observed that most primary studies and reviews focus on one single built environment aspect. However, these aspects co-exist and act together. Accounting for multiple elements of the built environment may provide a better understanding of the relative contribution of each aspect to CVD risk. Systematic reviews should also consider comparing single-exposure to multi-exposure models to examine potential confounding effects between built environment exposures.

Implications for public health

There was strong evidence of a detrimental effect of air pollution on CVD. Therefore, it is important that governments and individuals take measures to reduce outdoor air pollution. The WHO has developed the 2021 long-term air quality guideline levels with interim targets.61 Each country should establish air quality standards with adapted interim targets, specified measurement, and statistical procedures to reduce CVD events attributable to air pollution. Another strategy could be the development of a framework for clinical recommendations and individual exposure mitigation strategies. The American Heart Association has stated such individual strategies to prevent air pollution, like using portable air cleaners, high-efficiency heating ventilation and air conditioning systems, and N95 respirator.74

We found suggestive evidence of a protective effect of greenspace on CVD. This supports the call for urban planners, city designers, project developers, and policymakers to take greenspace into account.75 There was also clear evidence of increased residential noise being associated with a higher CVD risk. The WHO developed guidelines pertaining to noise levels for the European regions in 2015.46 However, these recommendations may not be directly applicable to other regions. One general public health approach is to address the major sources of pollution (i.e. combustion, traffic, industry, and power generation). Another approach is to develop healthy building guidelines (e.g. including advanced insulation) to reduce the exposure to outdoor air pollution, light pollution, residential noise, and extreme temperatures.

Conclusion

This umbrella review provides a comprehensive overview of the observational evidence on the built environment and CVD. We found strong evidence of associations between increased air pollution, especially PM2.5, and increased residential noise with higher risk of CVD. The present meta-meta-analysis produced highly suggestive evidence of an association between temperature and CVD. Evidence on physical activity environment, food environment, light pollution, and urbanization is scarce or lacking. Our identification of several knowledge gaps and methodological limitations in the current literature may improve and inform future research and contribute to a better understanding of the effect of the built environment on CVD.

Author contributions

M.L., P.M., and J.L. designed the study and developed the review question. M.L. and P.M. performed the literature search and were the primary reviewers. T.M.L., E.J.T., I.V., and J.L. acted as additional reviewers where required. E.J.T., D.E.G., J.W.J.B., I.V., and J.L. supervised the study. M.L. and P.M. drafted the manuscript. All authors reviewed and revised the protocol and manuscript. J.L. acts as guarantor. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Supplementary material

Supplementary material is available at European Journal of Preventive Cardiology.

Funding

M.L. had financial support from China Scholarships Council; all other authors had financial support from NWO Gravitation grant Exposome-NL (Grant/Award Number: 024.004.017). The funders didn’t have any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. We confirm the independence of researchers from funders and that all authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.

Data availability

The data underlying this article are available in the article and in its online supplementary material.

References

1

Roth Gregory
A
,
Mensah George
A
,
Johnson Catherine
O
,
Addolorato
G
,
Ammirati
E
,
Baddour
LM
, et al.
Global burden of cardiovascular diseases and risk factors, 1990–2019
.
J Am Coll Cardiol
2020
;
76
:
2982
3021
.

2

Murray
CJ
,
Aravkin
AY
,
Zheng
P
,
Abbafati
C
,
Abbas
KM
,
Abbasi-Kangevari
M
, et al.
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
.
Lancet
2020
;
396
:
1223
1249
.

3

The Global Economic Burden of Non-communicable Diseases. https://www.weforum.org/reports/global-economic-burden-non-communicable-diseases/.

4

Timmis
A
,
Townsend
N
,
Gale
CP
,
Torbica
A
,
Lettino
M
,
Petersen
SE
, et al.
European Society of Cardiology: cardiovascular disease statistics 2019
.
Eur Heart J
2020
;
41
:
12
85
.

5

Sallis
JF
,
Floyd
MF
,
Rodríguez
DA
,
Saelens
BE
.
Role of built environments in physical activity, obesity, and cardiovascular disease
.
Circulation
2012
;
125
:
729
737
.

6

Sallis
JF
,
Owen
N
,
Fisher
E
.
Ecological models of health behavior. Health behavior: Theory, research, and practice 2015;5
.

7

Lakerveld
J
,
Mackenbach
J
.
The upstream determinants of adult obesity
.
Obes Facts
2017
;
10
:
216
222
.

8

Buck Louis
GM
,
Sundaram
R
.
Exposome: time for transformative research
.
Stat Med
2012
;
31
:
2569
2575
.

9

Juarez
PD
,
Hood
DB
,
Song
MA
,
Ramesh
A
.
Use of an exposome approach to understand the effects of exposures from the natural, built, and social environments on cardio-vascular disease onset, progression, and outcomes
.
Front Public Health
2020
;
8
:
379
.

10

Vineis
P
,
Chadeau-Hyam
M
,
Gmuender
H
,
Gulliver
J
,
Herceg
Z
,
Kleinjans
J
, et al.
The exposome in practice: design of the EXPOsOMICS project
.
Int J Hyg Environ Health
2017
;
220
:
142
151
.

11

Koohsari
MJ
,
McCormack
GR
,
Nakaya
T
,
Oka
K
.
Neighbourhood built environment and cardiovascular disease: knowledge and future directions
.
Nat Rev Cardiol
2020
;
17
:
261
263
.

12

Lawrence
DF
,
Nicole
I-E
,
Kara
EM
,
Andy
H
.
Pathways from built environment to health: a conceptual framework linking behavior and exposure-based impacts
.
J Transp Health
2019
;
12
:
319
335
.

13

Barnett
DW
,
Barnett
A
,
Nathan
A
,
Van Cauwenberg
J
,
Cerin
E
.
Built environmental correlates of older adults’ total physical activity and walking: a systematic review and meta-analysis
.
Int J Behav Nutr Phys Act
2017
;
14
:
103
.

14

Hajna
S
,
Ross
NA
,
Brazeau
A-S
,
Bélisle
P
,
Joseph
L
,
Dasgupta
K
.
Associations between neighbourhood walkability and daily steps in adults: a systematic review and meta-analysis
.
BMC Public Health
2015
;
15
:
768
.

15

Moore
LV
,
Diez Roux
AV
,
Nettleton
JA
,
Jacobs
DR
Jr
.
Associations of the local food environment with diet quality–a comparison of assessments based on surveys and geographic information systems: the multi-ethnic study of atherosclerosis
.
Am J Epidemiol
2008
;
167
:
917
924
.

16

Chin
MT
.
Basic mechanisms for adverse cardiovascular events associated with air pollution
.
Heart
2015
;
101
:
253
256
.

17

Giuliano
P
,
Stefania
C
,
Alessandra
S
,
Valentina
T
,
Alfredo
N
.
Effects of particulate matter (PM10, PM2.5 and PM1) on the cardiovascular system
.
Toxicology
2009
;
261
:
1
8
.

18

Babisch
W
.
Cardiovascular effects of noise
.
Noise and Health
2011
;
13
:
201
204
.

19

Giorgini
P
,
Di Giosia
P
,
Petrarca
M
,
Lattanzio
F
,
Stamerra
CA
,
Ferri
C
.
Climate changes and human health: a review of the effect of environmental stressors on cardiovascular diseases across epidemiology and biological mechanisms
.
Curr Pharm Des
2017
;
23
:
3247
3261
.

20

Howell
NA
,
Tu
JV
,
Moineddin
R
,
Chen
H
,
Chu
A
,
Hystad
P
, et al.
Interaction between neighborhood walkability and traffic-related air pollution on hypertension and diabetes: the CANHEART cohort
.
Environ Int
2019
;
132
:
104799
.

21

United Nations Department of Economic and Social Affairs Population Division Population Division
.
World Urbanization Prospects: The 2018 Revision (ST/ESA/SER. A/420). New York: United Nations. 2019
.

22

Ouzzani
M
,
Hammady
H
,
Fedorowicz
Z
,
Elmagarmid
A
.
Rayyan—a web and mobile app for systematic reviews
.
Sys Rev
2016
;
5
:
210
.

23

Dawid
P
,
Sunya-Lee
A
,
Tim
M
,
Neugebauer
EAM
,
Eikermann
M
.
Systematic review finds overlapping reviews were not mentioned in every other overview
.
J Clin Epidemiol
2014
;
67
:
368
375
.

24

Whiting
P
,
Savović
J
,
Higgins
JPT
,
Caldwell
DM
,
Reeves
BC
,
Shea
B
, et al.
ROBIS: a new tool to assess risk of bias in systematic reviews was developed
.
J Clin Epidemiol
2016
;
69
:
225
234
.

25

Aromataris
E
,
Fernandez
R
,
Godfrey
CM
,
Holly
C
,
Khalil
H
,
Tungpunkom
P
.
Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach
.
Int J Evid Based Healthc
2015
;
13
:
132
140
.

26

Aromataris
E
,
Fernandez
RS
,
Godfrey
C
Holly
C
,
Khalil
H
,
Tungpunkom
P
.
Methodology for JBI umbrella reviews
2014
;
1
.

27

Cleophas
TJ
,
Zwinderman
AH
. Meta-meta-analysis. In:
Modern meta-analysis: review and update of methodologies
.
Cham
:
Springer International Publishing
;
2017
, p
135
143
.

28

Fusar-Poli
P
,
Radua
J
.
Ten simple rules for conducting umbrella reviews
.
Evid Based Ment Health
2018
;
21
:
95
100
.

29

Ioannidis
JPA
,
Patsopoulos
NA
,
Evangelou
E
.
Uncertainty in heterogeneity estimates in meta-analyses
.
BMJ
2007
;
335
:
914
916
.

30

Hong
C
,
Salanti
G
,
Morton
SC
,
Riley
RD
,
Chu
H
,
Kimmel
SE
, et al.
Testing small study effects in multivariate meta-analysis
.
Biometrics
2020
;
76
:
1240
1250
.

31

John
PAI
,
Marcus
RM
,
Paolo
F-P
,
Brian
AN
,
Sean
PD
.
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention
.
Trends Cogn Sci
2014
;
18
:
235
241
.

32

R Core Team
.
R: a language and environmental for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017
.

33

Viechtbauer
W
.
Conducting meta-analyses in R with the metafor package
.
J Stat Soft
2010
;
36
:
1
48
.

34

Alexeeff
SE
,
Liao
NS
,
Liu
X
,
Van Den Eeden
SK
,
Sidney
S
.
Long-term PM2.5 exposure and risks of ischemic heart disease and stroke events: review and meta-analysis
.
J Am Heart Assoc
2021
;
10
:
e016890
.

35

Atkinson
RW
,
Butland
BK
,
Anderson
HR
,
Maynard
RL
.
Long-term concentrations of nitrogen dioxide and mortality: a meta-analysis of cohort studies
.
Epidemiology
2018
;
29
:
460
472
.

36

Chen
M
,
Zhao
J
,
Zhuo
C
,
Zheng
L
.
The association between ambient air pollution and atrial fibrillation
.
Int Heart J
2021
;
62
:
290
297
.

37

Jadambaa
A
,
Spickett
J
,
Badrakh
B
,
Norman
RE
.
The impact of the environment on health in Mongolia: a systematic review
.
Asia Pac J Public Health
2015
;
27
:
45
75
.

38

Jaganathan
S
,
Jaacks
LM
,
Magsumbol
M
,
Walia
GK
,
Sieber
NL
,
Shivasankar
R
, et al.
Association of long-term exposure to fine particulate matter and cardio-metabolic diseases in low- and middle-income countries: a systematic review
.
Int J Environ Res Public Health
2019
;
16
:
2541
.

39

Prueitt
RL
,
Lynch
HN
,
Zu
K
,
Sax
SN
,
Venditti
FJ
,
Goodman
JE
.
Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular effects
.
Critical Rev Toxicol
2014
;
44
:
791
822
.

40

Stieb
DM
,
Berjawi
R
,
Emode
M
,
Zheng
C
,
Salama
D
,
Hocking
R
, et al.
Systematic review and meta-analysis of cohort studies of long term outdoor nitrogen dioxide exposure and mortality
.
PLoS One
2021
;
16
:
e0246451
.

41

Yang
H
,
Li
S
,
Sun
L
,
Zhang
X
,
Cao
Z
,
Xu
C
, et al.
Smog and risk of overall and type-specific cardiovascular diseases: a pooled analysis of 53 cohort studies with 21.09 million participants
.
Environ Res
2019
;
172
:
375
383
.

42

Zou
L
,
Zong
Q
,
Fu
W
,
Zhang
Z
,
Xu
H
,
Yan
S
, et al.
Long-term exposure to ambient air pollution and myocardial infarction: a systematic review and meta-analysis
.
Front Med
2021
;
8
:
616355
.

43

Twohig-Bennett
C
,
Jones
A
.
The health benefits of the great outdoors: a systematic review and meta-analysis of greenspace exposure and health outcomes
.
Environ Res
2018
;
166
:
628
637
.

44

Angkurawaranon
C
,
Jiraporncharoen
W
,
Chenthanakij
B
,
Doyle
P
,
Nitsch
D
.
Urbanization and non-communicable disease in Southeast Asia: a review of current evidence
.
Public Health
2014
;
128
:
886
895
.

45

Babisch
W
.
Updated exposure-response relationship between road traffic noise and coronary heart diseases: a meta-analysis
.
Noise Health
2014
;
16
:
1
9
.

46

Van Kempen
E
,
Casas
M
,
Pershagen
G
,
Foraster
M
.
WHO Environmental Noise Guidelines for the European Region: a systematic review on environmental noise and cardiovascular and metabolic effects: a summary
.
Int J Environ Res Public Health
2018
;
15
:
379
.

47

Vienneau
D
,
Schindler
C
,
Perez
L
,
Probst-Hensch
N
,
Röösli
M
.
The relationship between transportation noise exposure and ischemic heart disease: a meta-analysis
.
Environ Res
2015
;
138
:
372
380
.

48

Weihofen
VM
,
Hegewald
J
,
Euler
U
,
Schlattmann
P
,
Zeeb
H
,
Seidler
A
, et al.
Aircraft noise and the risk of stroke
.
Dtsch Arztebl Int
2019
;
116
:
237
244
.

49

Bunker
A
,
Wildenhain
J
,
Vandenbergh
A
,
Henschke
N
,
Rocklöv
J
,
Hajat
S
, et al.
Effects of air temperature on climate-sensitive mortality and morbidity outcomes in the elderly; a systematic review and meta-analysis of epidemiological evidence
.
EBioMedicine
2016
;
6
:
258
268
.

50

Moghadamnia
MT
,
Ardalan
A
,
Mesdaghinia
A
,
Keshtkar
A
,
Naddafi
K
,
Yekaninejad
MS
, et al.
Ambient temperature and cardiovascular mortality: a systematic review and meta-analysis
.
PeerJ
2017
;
5
:
e3574
.

51

Jie
C
,
Gerard
H
.
Long-term exposure to PM and all-cause and cause-specific mortality: a systematic review and meta-analysis
.
Environ Int
2020
;
143
:
105974
.

52

Lai
H-K
,
Tsang
H
,
Wong
C-M
.
Meta-analysis of adverse health effects due to air pollution in Chinese populations
.
BMC Public Health
2013
;
13
:
360
.

53

Thomas
JL
,
Jennifer
LN
,
Dutton
SJ
,
Kirrane
E
,
Owens
EO
,
Datko-Williams
L
, et al.
A systematic review of cardiovascular emergency department visits, hospital admissions and mortality associated with ambient black carbon
.
Environ Int
2017
;
107
:
154
162
.

54

Mireia
G
,
Margarita
T-M
,
David
M
,
Dadvand
P
,
Rojas-Rueda
D
,
Plasència
A
, et al.
Residential green spaces and mortality: a systematic review
.
Environ Int
2016
;
86
:
60
67
.

55

Yuan
Y
,
Huang
F
,
Lin
F
,
Zhu
P
,
Zhu
P
.
Green space exposure on mortality and cardiovascular outcomes in older adults: a systematic review and meta-analysis of observational studies
.
Aging Clin Exp Res
2021
;
33
:
1783
1797
.

56

Yutong
C
,
Rema
R
,
Kazem
R
.
Long-term exposure to traffic noise and mortality: a systematic review and meta-analysis of epidemiological evidence between 2000 and 2020
.
Environ Pollution
2021
;
269
:
116222
.

57

Emily Jessica
R
,
Michael
B
.
Quiet, clean, green, and active: a navigation guide systematic review of the impacts of spatially correlated urban exposures on a range of physical health outcomes
.
Environ Res
2020
;
185
:
109388
.

58

de Bont
J
,
Jaganathan
S
,
Dahlquist
M
,
Persson
Å
,
Stafoggia
M
,
Ljungman
P
.
Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses
.
J Int Med
2022
;
291
:
779
800
.

59

Fábio Hech
D
,
Joaquim
H
,
Giorgio
B
,
Stabile
L
,
Gameiro da Silva
M
,
Andrade
A
.
Effects of air pollution on health: a mapping review of systematic reviews and meta-analyses
.
Environ Res
2021
;
201
:
111487
.

60

Rojas-Rueda
D
,
Morales-Zamora
E
,
Alsufyani
WA
, et al.
Environmental risk factors and health: an umbrella review of meta-analyses
.
Int J Environ Res Public Health
2021
;
18
:
704
.

61

World Health Organisation
.
WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. Geneva: World Health Organization; 2021. pxxi, 273 p
.

62

Zang
S-T
,
Wu
Q-J
,
Li
X-Y
,
Gao
C
,
Liu
Y-S
,
Jiang
Y-T
, et al.
Long-term PM2.5 exposure and various health outcomes: an umbrella review of systematic reviews and meta-analyses of observational studies
.
Sci Total Environ
2022
;
812
:
152381
.

63

Markevych
I
,
Schoierer
J
,
Hartig
T
,
Chudnovsky
A
,
Hystad
P
,
Dzhambov
AM
, et al.
Exploring pathways linking greenspace to health: theoretical and methodological guidance
.
Environ Res
2017
;
158
:
301
317
.

64

Hunter
AJ
,
Luck
GW
.
Defining and measuring the social-ecological quality of urban greenspace: a semi-systematic review
.
Urban Ecosyst
2015
;
18
:
1139
1163
.

65

World Health Organization
.
Regional Office for E. Burden of disease from environmental noise: quantification of healthy life years lost in Europe. Copenhagen: World Health Organization. Regional Office for Europe; 2011. pxvii, 106 p
.

66

Song
J
,
Pan
R
,
Yi
W
,
Wei
Q
,
Qin
W
,
Song
S
, et al.
Ambient high temperature exposure and global disease burden during 1990–2019: an analysis of the global burden of disease study 2019
.
Sci Total Environ
2021
;
787
:
147540
.

67

Danesh Yazdi
M
,
Wei
Y
,
Di
Q
,
Requia
WJ
,
Shi
L
,
Sabath
MB
, et al.
The effect of long-term exposure to air pollution and seasonal temperature on hospital admissions with cardiovascular and respiratory disease in the United States: a difference-in-differences analysis
.
Sci Total Environ
2022
;
843
:
156855
.

68

Klompmaker
JO
,
Hart
JE
,
James
P
,
Sabath
MB
,
Wu
X
,
Zanobetti
A
, et al.
Air pollution and cardiovascular disease hospitalization – are associations modified by greenness, temperature and humidity?
Environ Int
2021
;
156
:
106715
.

69

Poelman
M
,
Strak
M
,
Schmitz
O
,
Hoek
G
,
Karssenberg
D
,
Helbich
M
, et al.
Relations between the residential fast-food environment and the individual risk of cardiovascular diseases in The Netherlands: a nationwide follow-up study
.
Eur J Prev Cardiol
2018
;
25
:
1397
1405
.

70

Uzoigwe
JC
,
Prum
T
,
Bresnahan
E
,
Garelnabi
M
.
The emerging role of outdoor and indoor air pollution in cardiovascular disease
.
N Am J Med Sci
2013
;
5
:
445
453
.

71

Yue
Q
,
Shudi
Z
,
Zhaowu
Y
,
Yu
Z
,
Yin
R
.
Discovering the effects of integrated green space air regulation on human health: a bibliometric and meta-analysis
.
Ecol Indic
2021
;
132
:
108292
.

72

Higgins
JP
,
Thomas
J
,
Chandler
J
,
Cumpston
M
,
Li
T
,
Page
MJ
, et al.
Cochrane handbook for systematic reviews of interventions
.
Chichester, UK
:
John Wiley & Sons
;
2019
.

73

Page
MJ
,
McKenzie
JE
,
Bossuyt
PM
,
Boutron
I
,
Hoffmann
TC
,
Mulrow
CD
, et al.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
.
BMJ
2021
;
372
:
n71
.

74

Rajagopalan
S
,
Brauer
M
,
Bhatnagar
A
,
Bhatt
DL
,
Brook
JR
,
Huang
W
, et al.
Personal-level protective actions against particulate matter air pollution exposure: a scientific statement from the American Heart Association
.
Circulation
2020
;
142
:
e411
e431
.

75

Kostas
M
.
Urban planning and quality of life: a review of pathways linking the built environment to subjective well-being
.
Cities
2021
;
115
:
103229
.

Author notes

Mingwei Liu and Paul Meijer contributed equally to the study.

Conflict of interest: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare the following: M.L. had financial support from China Scholarships Council; all other authors had financial support from NWO Gravitation grant Exposome-NL; there are no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; and there are no other relationships or activities that could appear to have influenced the submitted work.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]

Supplementary data

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.